[P02BB01, trichlorfon, The therapeutic efficacy of Metrifonate can be decreased when used in combination with Dexamethasone acetate.]
[S02DA03, antipyrine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Antipyrine.]
[A14AA02, stanozolol, The risk or severity of fluid retention can be increased when Dexamethasone acetate is combined with Stanozolol.]
[G03XB02, ulipristal, The serum concentration of Dexamethasone acetate can be increased when it is combined with Ulipristal.]
[M03AB01, succinylcholine, The risk or severity of myopathy and weakness can be increased when Succinylcholine is combined with Dexamethasone acetate.]
[J01EC02, sulfadiazine, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Sulfadiazine.]
[J01EC01, sulfamethoxazole, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Sulfamethoxazole.]
[M04AB02, sulfinpyrazone, Dexamethasone acetate may increase the excretion rate of Sulfinpyrazone which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AB02, sulfisoxazole, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Sulfisoxazole.]
[M01AB02, sulindac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Sulindac.]
[N05AL01, sulpiride, The therapeutic efficacy of Sulpiride can be decreased when used in combination with Dexamethasone acetate.]
[A10BB04, glibornuride, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Glibornuride.]
[A10BC01, glymidine, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Glymidine.]
[M01AX04, apazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Azapropazone.]
[L01BB02, mercaptopurine, The excretion of Dexamethasone acetate can be decreased when combined with Mercaptopurine.]
[N06DA01, tacrine, The therapeutic efficacy of Tacrine can be decreased when used in combination with Dexamethasone acetate.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be increased when combined with Dexamethasone acetate.]
[L01CB02, teniposide, The metabolism of Teniposide can be increased when combined with Dexamethasone acetate.]
[R03CC03, terbutaline, The therapeutic efficacy of Terbutaline can be decreased when used in combination with Dexamethasone acetate.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabigatran etexilate can be decreased when it is combined with Dexamethasone acetate.]
[G03BA03, testosterone, The risk or severity of edema formation can be increased when Testosterone is combined with Dexamethasone acetate.]
[S03AA02, tetracycline, The excretion of Dexamethasone acetate can be decreased when combined with Tetracycline.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be increased when combined with Dexamethasone acetate.]
[L04AX02, thalidomide, The metabolism of Dexamethasone acetate can be increased when combined with Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be increased when combined with Dexamethasone acetate.]
[L01AC01, thiotepa, The therapeutic efficacy of Thiotepa can be decreased when used in combination with Dexamethasone acetate.]
[B02AB01, aprotinin, The therapeutic efficacy of Aprotinin can be decreased when used in combination with Dexamethasone acetate.]
[P01AB02, tinidazole, Dexamethasone acetate may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BB05, tolazamide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Tolazamide.]
[V04CA01, tolbutamide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Tolbutamide.]
[M02AA21, tolmetin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Tolmetin.]
[N02AX02, tramadol, The metabolism of Tramadol can be increased when combined with Dexamethasone acetate.]
[N06AX05, trazodone, The metabolism of Trazodone can be increased when combined with Dexamethasone acetate.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be increased when combined with Dexamethasone acetate.]
[S01BA05, triamcinolone, The metabolism of Triamcinolone can be increased when combined with Dexamethasone acetate.]
[N05CD05, triazolam, The metabolism of Triazolam can be increased when combined with Dexamethasone acetate.]
[C03AA06, trichlormethiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Trichlormethiazide.]
[S01EB04, demecarium, The therapeutic efficacy of Demecarium can be decreased when used in combination with Dexamethasone acetate.]
[N05AA05, triflupromazine, The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Dexamethasone acetate.]
[R03BA07, mometasone, The metabolism of Dexamethasone acetate can be increased when combined with Mometasone.]
[N06AA06, trimipramine, The serum concentration of Trimipramine can be decreased when it is combined with Dexamethasone acetate.]
[J01FA08, troleandomycin, The metabolism of Dexamethasone acetate can be decreased when combined with Troleandomycin.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be decreased when used in combination with Dexamethasone acetate.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be increased when combined with Dexamethasone acetate.]
[S01AA05, tyrothricin, The therapeutic efficacy of Tyrothricin can be decreased when used in combination with Dexamethasone acetate.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be increased when combined with Dexamethasone acetate.]
[A10BH05, linagliptin, The serum concentration of Linagliptin can be decreased when it is combined with Dexamethasone acetate.]
[J05AP03, boceprevir, The metabolism of Dexamethasone acetate can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Dexamethasone acetate can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be decreased when it is combined with Dexamethasone acetate.]
[B01AF01, rivaroxaban, Dexamethasone acetate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Indacaterol.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be increased when combined with Dexamethasone acetate.]
[C08DA01, verapamil, The metabolism of Dexamethasone acetate can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Dexamethasone acetate can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The serum concentration of Vinblastine can be decreased when it is combined with Dexamethasone acetate.]
[L01CA02, vincristine, The serum concentration of Vincristine can be decreased when it is combined with Dexamethasone acetate.]
[L01CA03, vindesine, The metabolism of Vindesine can be increased when combined with Dexamethasone acetate.]
[B01AA03, warfarin, Dexamethasone acetate may increase the anticoagulant activities of Warfarin.]
[J05AF01, zidovudine, The excretion of Dexamethasone acetate can be decreased when combined with Zidovudine.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be increased when combined with Dexamethasone acetate.]
[J05AE02, indinavir, The metabolism of Dexamethasone acetate can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The serum concentration of Vemurafenib can be decreased when it is combined with Dexamethasone acetate.]
[L01FX05, brentuximab vedotin, The serum concentration of Brentuximab vedotin can be decreased when it is combined with Dexamethasone acetate.]
[L01ED01, crizotinib, The serum concentration of Crizotinib can be decreased when it is combined with Dexamethasone acetate.]
[H05BX03, doxercalciferol, The therapeutic efficacy of Doxercalciferol can be decreased when used in combination with Dexamethasone acetate.]
[J01MA13, trovafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The metabolism of Ziprasidone can be increased when combined with Dexamethasone acetate.]
[G03AC10, drospirenone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Drospirenone.]
[N02BA01, aspirin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be increased when combined with Dexamethasone acetate.]
[C07AB03, atenolol, Dexamethasone acetate may increase the excretion rate of Atenolol which could result in a lower serum level and potentially a reduction in efficacy.]
[A11CC03, alfacalcidol, The therapeutic efficacy of Alfacalcidol can be decreased when used in combination with Dexamethasone acetate.]
[J02AC03, voriconazole, The serum concentration of Dexamethasone acetate can be increased when it is combined with Voriconazole.]
[M03AC04, atracurium, The risk or severity of myopathy and weakness can be increased when Atracurium is combined with Dexamethasone acetate.]
[S01FA01, atropine, Dexamethasone acetate may increase the excretion rate of Atropine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EK01, axitinib, The serum concentration of Axitinib can be decreased when it is combined with Dexamethasone acetate.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be increased when combined with Dexamethasone acetate.]
[H02AB11, prednylidene, The metabolism of Dexamethasone acetate can be increased when combined with Prednylidene.]
[L01BC05, gemcitabine, The serum concentration of Gemcitabine can be decreased when it is combined with Dexamethasone acetate.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Dexamethasone acetate.]
[L01XG02, carfilzomib, The serum concentration of Carfilzomib can be decreased when it is combined with Dexamethasone acetate.]
[V03AX03, cobicistat, The metabolism of Dexamethasone acetate can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Dexamethasone acetate can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be decreased when it is combined with Dexamethasone acetate.]
[L04AA31, teriflunomide, The excretion of Dexamethasone acetate can be decreased when combined with Teriflunomide.]
[L01EX05, regorafenib, The serum concentration of Regorafenib can be decreased when it is combined with Dexamethasone acetate.]
[C01AA01, acetyldigitoxin, The risk or severity of adverse effects can be increased when Dexamethasone acetate is combined with Acetyldigitoxin.]
[J05AE04, nelfinavir, The metabolism of Dexamethasone acetate can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be decreased when it is combined with Dexamethasone acetate.]
[C08CA13, lercanidipine, The metabolism of Lercanidipine can be increased when combined with Dexamethasone acetate.]
[N06DA02, donepezil, The therapeutic efficacy of Donepezil can be decreased when used in combination with Dexamethasone acetate.]
[N03AX22, perampanel, The metabolism of Perampanel can be increased when combined with Dexamethasone acetate.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be increased when combined with Dexamethasone acetate.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be increased when combined with Dexamethasone acetate.]
[B01AF02, apixaban, Dexamethasone acetate may decrease the excretion rate of Apixaban which could result in a higher serum level.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be increased when combined with Dexamethasone acetate.]
[A10BH04, alogliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Alogliptin.]
[A16AX09, glycerol phenylbutyrate, The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Dexamethasone acetate.]
[C03AA01, bendroflumethiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Bendroflumethiazide.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be decreased when it is combined with Dexamethasone acetate.]
[N02BA10, benorilate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Benorilate.]
[A10BK02, canagliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Canagliflozin.]
[J01MA15, gemifloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Gemifloxacin.]
[M04AB03, benzbromarone, Dexamethasone acetate may increase the excretion rate of Benzbromarone which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AE07, moxifloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Moxifloxacin.]
[A06AX06, tegaserod, Dexamethasone acetate may decrease the excretion rate of Tegaserod which could result in a higher serum level.]
[A10AE05, insulin detemir, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin detemir.]
[A10BX05, pramlintide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Pramlintide.]
[M01AH01, celecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Celecoxib.]
[L04AA18, everolimus, The serum concentration of Everolimus can be decreased when it is combined with Dexamethasone acetate.]
[L01EC02, dabrafenib, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Benzydamine.]
[L01EB03, afatinib, The serum concentration of Afatinib can be decreased when it is combined with Dexamethasone acetate.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be increased when combined with Dexamethasone acetate.]
[J05AJ03, dolutegravir, The excretion of Dexamethasone acetate can be decreased when combined with Dolutegravir.]
[C02KX05, riociguat, Dexamethasone acetate may decrease the excretion rate of Riociguat which could result in a higher serum level.]
[A10BJ03, lixisenatide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Lixisenatide.]
[A05AA03, cholic acid, The excretion of Dexamethasone acetate can be decreased when combined with Cholic Acid.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be increased when combined with Dexamethasone acetate.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be increased when combined with Dexamethasone acetate.]
[G03AC08, etonogestrel, The serum concentration of Dexamethasone acetate can be increased when it is combined with Etonogestrel.]
[J05AP05, simeprevir, The metabolism of Dexamethasone acetate can be decreased when combined with Simeprevir.]
[J05AP08, sofosbuvir, The serum concentration of Sofosbuvir can be decreased when it is combined with Dexamethasone acetate.]
[A10BK01, dapagliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Dapagliflozin.]
[C01CA27, droxidopa, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Droxidopa.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be increased when combined with Dexamethasone acetate.]
[A16AA07, metreleptin, The metabolism of Dexamethasone acetate can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Dexamethasone acetate can be increased when combined with Apremilast.]
[L02BG02, formestane, The risk or severity of edema formation can be increased when Formestane is combined with Dexamethasone acetate.]
[A16AA06, betaine, The therapeutic efficacy of Betaine can be decreased when used in combination with Dexamethasone acetate.]
[S03BA03, betamethasone, The metabolism of Dexamethasone acetate can be increased when combined with Betamethasone.]
[A10BJ04, albiglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Albiglutide.]
[L04AC11, siltuximab, The metabolism of Dexamethasone acetate can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Ceritinib.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be increased when combined with Dexamethasone acetate.]
[B01AA07, acenocoumarol, Dexamethasone acetate may increase the anticoagulant activities of Acenocoumarol.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be increased when combined with Dexamethasone acetate.]
[N07XX08, tafamidis, The excretion of Dexamethasone acetate can be decreased when combined with Tafamidis.]
[A10BK03, empagliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Empagliflozin.]
[R03AC19, olodaterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Olodaterol.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be increased when combined with Dexamethasone acetate.]
[A10BJ05, dulaglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Dulaglutide.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be increased when combined with Dexamethasone acetate.]
[L01XK01, olaparib, The metabolism of Olaparib can be increased when combined with Dexamethasone acetate.]
[B01AA01, dicumarol, Dexamethasone acetate may increase the anticoagulant activities of Dicoumarol.]
[L04AC10, secukinumab, The metabolism of Dexamethasone acetate can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be increased when combined with Dexamethasone acetate.]
[L01EX08, lenvatinib, The excretion of Dexamethasone acetate can be decreased when combined with Lenvatinib.]
[L01XH03, panobinostat, The serum concentration of Panobinostat can be decreased when it is combined with Dexamethasone acetate.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be increased when combined with Dexamethasone acetate.]
[B01AA11, tioclomarol, Dexamethasone acetate may increase the anticoagulant activities of Tioclomarol.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be increased when combined with Dexamethasone acetate.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be increased when combined with Dexamethasone acetate.]
[A04AD14, rolapitant, The metabolism of Rolapitant can be increased when combined with Dexamethasone acetate.]
[N05AX15, cariprazine, The metabolism of Cariprazine can be increased when combined with Dexamethasone acetate.]
[A10BF01, acarbose, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Acarbose.]
[M02AA25, aceclofenac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Acemetacin.]
[A10AE06, insulin degludec, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin degludec.]
[A02BC03, lansoprazole, The excretion of Dexamethasone acetate can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be increased when combined with Dexamethasone acetate.]
[J02AC05, isavuconazole, The metabolism of Isavuconazole can be increased when combined with Dexamethasone acetate.]
[L01EB04, osimertinib, The serum concentration of Osimertinib can be decreased when it is combined with Dexamethasone acetate.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Dexamethasone acetate.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be decreased when it is combined with Dexamethasone acetate.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be increased when combined with Dexamethasone acetate.]
[L01ED03, alectinib, The metabolism of Alectinib can be increased when combined with Dexamethasone acetate.]
[A10BB31, acetohexamide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Acetohexamide.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be increased when combined with Dexamethasone acetate.]
[M01AE16, alminoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Alminoprofen.]
[L01XX52, venetoclax, The serum concentration of Venetoclax can be decreased when it is combined with Dexamethasone acetate.]
[N04BC01, bromocriptine, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Bromocriptine.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be increased when combined with Dexamethasone acetate.]
[C03CA02, bumetanide, The excretion of Dexamethasone acetate can be decreased when combined with Bumetanide.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be increased when combined with Dexamethasone acetate.]
[N05BE01, buspirone, The metabolism of Buspirone can be increased when combined with Dexamethasone acetate.]
[L01AB01, busulfan, The metabolism of Busulfan can be increased when combined with Dexamethasone acetate.]
[N06DA03, rivastigmine, The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Dexamethasone acetate.]
[P01BE02, artemether, The metabolism of Artemether can be increased when combined with Dexamethasone acetate.]
[J01MA09, sparfloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Sparfloxacin.]
[S01GX07, azelastine, The metabolism of Azelastine can be increased when combined with Dexamethasone acetate.]
[L01XK03, rucaparib, Dexamethasone acetate may decrease the excretion rate of Rucaparib which could result in a higher serum level.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be increased when combined with Dexamethasone acetate.]
[L01EF02, ribociclib, The metabolism of Dexamethasone acetate can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Balsalazide.]
[R03CC12, bambuterol, The therapeutic efficacy of Bambuterol can be decreased when used in combination with Dexamethasone acetate.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be increased when combined with Dexamethasone acetate.]
[A10BX06, benfluorex, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Benfluorex.]
[H05BX05, calcifediol, The therapeutic efficacy of Calcifediol can be decreased when used in combination with Dexamethasone acetate.]
[D05AX03, calcitriol, The therapeutic efficacy of Calcitriol can be decreased when used in combination with Dexamethasone acetate.]
[J01XX08, linezolid, The excretion of Dexamethasone acetate can be decreased when combined with Linezolid.]
[J05AE09, tipranavir, The metabolism of Dexamethasone acetate can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be increased when combined with Dexamethasone acetate.]
[L04AB02, infliximab, The metabolism of Dexamethasone acetate can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Dexamethasone acetate can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be increased when combined with Dexamethasone acetate.]
[J01MA23, delafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Delafloxacin.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be increased when combined with Dexamethasone acetate.]
[L01EH02, neratinib, The metabolism of Neratinib can be increased when combined with Dexamethasone acetate.]
[L01FB01, inotuzumab ozogamicin, The serum concentration of Inotuzumab ozogamicin can be decreased when it is combined with Dexamethasone acetate.]
[L01EM02, copanlisib, The serum concentration of Copanlisib can be decreased when it is combined with Dexamethasone acetate.]
[L01EF03, abemaciclib, The serum concentration of Abemaciclib can be decreased when it is combined with Dexamethasone acetate.]
[R03AC17, bitolterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Bitolterol.]
[J05AG03, efavirenz, The metabolism of Dexamethasone acetate can be decreased when combined with Efavirenz.]
[R03BA02, budesonide, Dexamethasone acetate may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AB07, bumadizone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be increased when combined with Dexamethasone acetate.]
[J05AX18, letermovir, The excretion of Dexamethasone acetate can be decreased when combined with Letermovir.]
[C01AA02, acetyldigoxins, Dexamethasone acetate may increase the excretion rate of Acetyldigoxin which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BJ06, semaglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Semaglutide.]
[N01BX04, capsaicin, The therapeutic efficacy of Capsaicin can be decreased when used in combination with Dexamethasone acetate.]
[A10BK04, ertugliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Ertugliflozin.]
[L02BB05, apalutamide, The metabolism of Dexamethasone acetate can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be increased when combined with Dexamethasone acetate.]
[N03AX24, cannabidiol, The metabolism of Dexamethasone acetate can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The excretion of Dexamethasone acetate can be decreased when combined with Avatrombopag.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be decreased when it is combined with Dexamethasone acetate.]
[J01DD14, ceftibuten, The excretion of Dexamethasone acetate can be decreased when combined with Ceftibuten.]
[C07AB08, celiprolol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Celiprolol.]
[L01XX62, ivosidenib, The metabolism of Dexamethasone acetate can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Dexamethasone acetate can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, Dexamethasone acetate may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.]
[J05AG06, doravirine, The metabolism of Doravirine can be increased when combined with Dexamethasone acetate.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be increased when combined with Dexamethasone acetate.]
[L01EB07, dacomitinib, The serum concentration of Dacomitinib can be decreased when it is combined with Dexamethasone acetate.]
[A10BB06, carbutamide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Carbutamide.]
[M01AC05, lornoxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Lornoxicam.]
[L01XK04, talazoparib, The serum concentration of Talazoparib can be decreased when it is combined with Dexamethasone acetate.]
[R03BB08, revefenacin, Dexamethasone acetate may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be increased when combined with Dexamethasone acetate.]
[L04AA39, emapalumab, The metabolism of Dexamethasone acetate can be increased when combined with Emapalumab.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be increased when combined with Dexamethasone acetate.]
[L01XJ03, glasdegib, Dexamethasone acetate may decrease the excretion rate of Glasdegib which could result in a higher serum level.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be increased when combined with Dexamethasone acetate.]
[L04AA42, siponimod, The metabolism of Siponimod can be increased when combined with Dexamethasone acetate.]
[J01FA09, clarithromycin, The metabolism of Dexamethasone acetate can be decreased when combined with Clarithromycin.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be increased when combined with Dexamethasone acetate.]
[H02AB14, cloprednol, The metabolism of Dexamethasone acetate can be increased when combined with Cloprednol.]
[L04AB01, etanercept, The metabolism of Dexamethasone acetate can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Dexamethasone acetate can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be increased when it is combined with Dexamethasone acetate.]
[J01DC04, cefaclor, The excretion of Dexamethasone acetate can be decreased when combined with Cefaclor.]
[J01DB05, cefadroxil, The excretion of Dexamethasone acetate can be decreased when combined with Cefadroxil.]
[J01DC03, cefamandole, The excretion of Dexamethasone acetate can be decreased when combined with Cefamandole.]
[J01DB04, cefazolin, The excretion of Dexamethasone acetate can be decreased when combined with Cefazolin.]
[L02BB06, darolutamide, The serum concentration of Darolutamide can be decreased when it is combined with Dexamethasone acetate.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be increased when combined with Dexamethasone acetate.]
[J01DD12, cefoperazone, The excretion of Dexamethasone acetate can be decreased when combined with Cefoperazone.]
[J01DD01, cefotaxime, The excretion of Dexamethasone acetate can be decreased when combined with Cefotaxime.]
[J01DC07, cefotiam, The excretion of Dexamethasone acetate can be decreased when combined with Cefotiam.]
[J01DD07, ceftizoxime, The excretion of Dexamethasone acetate can be decreased when combined with Ceftizoxime.]
[J01DD04, ceftriaxone, The excretion of Dexamethasone acetate can be decreased when combined with Ceftriaxone.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be increased when combined with Dexamethasone acetate.]
[N07XX11, pitolisant, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be increased when combined with Dexamethasone acetate.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be increased when combined with Dexamethasone acetate.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be increased when combined with Dexamethasone acetate.]
[C03AA09, cyclothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Cyclothiazide.]
[A10AE03, insulin, regular, pork, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin pork.]
[J01DB01, cephalexin, The excretion of Dexamethasone acetate can be decreased when combined with Cephalexin.]
[J01DB02, cephaloridine, The excretion of Dexamethasone acetate can be decreased when combined with Cefaloridine.]
[J01DB03, cephalothin, The excretion of Dexamethasone acetate can be decreased when combined with Cefalotin.]
[H02AB13, deflazacort, The serum concentration of Deflazacort can be decreased when it is combined with Dexamethasone acetate.]
[G03DB05, demegestone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Demegestone.]
[L01FD03, ado-trastuzumab emtansine, The serum concentration of Trastuzumab emtansine can be decreased when it is combined with Dexamethasone acetate.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be increased when combined with Dexamethasone acetate.]
[G03AC09, desogestrel, The serum concentration of Dexamethasone acetate can be increased when it is combined with Desogestrel.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be decreased when it is combined with Dexamethasone acetate.]
[N03AX25, cenobamate, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Cenobamate.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be decreased when it is combined with Dexamethasone acetate.]
[S01AA13, fusidic acid, The metabolism of Dexamethasone acetate can be decreased when combined with Fusidic acid.]
[J01MB04, pipemidic acid, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Pipemidic acid.]
[S01XA12, dexpanthenol, The therapeutic efficacy of Dexpanthenol can be decreased when used in combination with Dexamethasone acetate.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be decreased when it is combined with Dexamethasone acetate.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be increased when combined with Dexamethasone acetate.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be decreased when it is combined with Dexamethasone acetate.]
[N02CD06, rimegepant, The metabolism of Rimegepant can be increased when combined with Dexamethasone acetate.]
[S01AE06, gatifloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Dexamethasone acetate can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Dexamethasone acetate can be decreased when combined with Amprenavir.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be increased when combined with Dexamethasone acetate.]
[L04AA38, ozanimod, Dexamethasone acetate may decrease the excretion rate of Ozanimod which could result in a higher serum level.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be decreased when it is combined with Dexamethasone acetate.]
[G03DB08, dienogest, The serum concentration of Dexamethasone acetate can be increased when it is combined with Dienogest.]
[M01AH02, rofecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Rofecoxib.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be increased when combined with Dexamethasone acetate.]
[S03AA08, chloramphenicol, The metabolism of Dexamethasone acetate can be decreased when combined with Chloramphenicol.]
[L01EN02, pemigatinib, The metabolism of Pemigatinib can be increased when combined with Dexamethasone acetate.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Dexamethasone acetate.]
[L01EX17, capmatinib, The serum concentration of Capmatinib can be decreased when it is combined with Dexamethasone acetate.]
[D07XB03, fluprednidene, The metabolism of Dexamethasone acetate can be increased when combined with Fluprednidene.]
[M01AC04, droxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Droxicam.]
[L01EX19, ripretinib, Dexamethasone acetate may decrease the excretion rate of Ripretinib which could result in a higher serum level.]
[L01EX22, selpercatinib, The serum concentration of Selpercatinib can be decreased when it is combined with Dexamethasone acetate.]
[M02AA27, dexketoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Dexketoprofen.]
[L01XX69, lurbinectedin, The serum concentration of Lurbinectedin can be decreased when it is combined with Dexamethasone acetate.]
[C08CA17, levamlodipine, The metabolism of Levamlodipine can be increased when combined with Dexamethasone acetate.]
[R06AX22, ebastine, The metabolism of Ebastine can be increased when combined with Dexamethasone acetate.]
[J05AX29, fostemsavir, Dexamethasone acetate may decrease the excretion rate of Fostemsavir which could result in a higher serum level.]
[L01FX15, belantamab mafodotin, Dexamethasone acetate may increase the excretion rate of Belantamab mafodotin which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AC19, satralizumab, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be decreased when it is combined with Dexamethasone acetate.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be increased when combined with Dexamethasone acetate.]
[L01EX23, pralsetinib, Dexamethasone acetate may decrease the excretion rate of Pralsetinib which could result in a higher serum level.]
[C03AA04, chlorothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Chlorothiazide.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be increased when combined with Dexamethasone acetate.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Dexamethasone acetate.]
[A10BB02, chlorpropamide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Chlorpropamide.]
[C03BA04, chlorthalidone, Dexamethasone acetate may increase the hypokalemic activities of Chlorthalidone.]
[A11CC05, cholecalciferol, The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Dexamethasone acetate.]
[N02BA07, ethenzamide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Ethenzamide.]
[C10AC01, cholestyramine resin, Cholestyramine may increase the excretion rate of Dexamethasone acetate which could result in a lower serum level and potentially a reduction in efficacy.]
[G03DC06, ethynodiol, The serum concentration of Dexamethasone acetate can be increased when it is combined with Etynodiol.]
[M01AB08, etodolac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Etofenamate.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be decreased when it is combined with Dexamethasone acetate.]
[A16AX20, lonafarnib, The metabolism of Dexamethasone acetate can be decreased when combined with Lonafarnib.]
[L02BX04, relugolix, The serum concentration of Relugolix can be decreased when it is combined with Dexamethasone acetate.]
[J05AJ04, cabotegravir, The excretion of Dexamethasone acetate can be decreased when combined with Cabotegravir.]
[L04AD03, voclosporin, The metabolism of Voclosporin can be increased when combined with Dexamethasone acetate.]
[P03AX07, abametapir, The serum concentration of Dexamethasone acetate can be increased when it is combined with Abametapir.]
[V03AF12, trilaciclib, Dexamethasone acetate may decrease the excretion rate of Trilaciclib which could result in a higher serum level.]
[M01AE05, fenbufen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Fenbufen.]
[G04CB01, finasteride, The metabolism of Finasteride can be increased when combined with Dexamethasone acetate.]
[J01MB07, flumequine, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Flumequine.]
[S01JA01, fluorescein, Dexamethasone acetate may increase the excretion rate of Fluorescein which could result in a lower serum level and potentially a reduction in efficacy.]
[R03CC15, formoterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Formoterol.]
[A10AF01, insulin, regular, human, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin human.]
[L04AA50, ponesimod, The metabolism of Ponesimod can be increased when combined with Dexamethasone acetate.]
[L01EK03, tivozanib, The metabolism of Tivozanib can be increased when combined with Dexamethasone acetate.]
[A02BA01, cimetidine, The excretion of Dexamethasone acetate can be decreased when combined with Cimetidine.]
[J01MB06, cinoxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be increased when combined with Dexamethasone acetate.]
[S03AA07, ciprofloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Ciprofloxacin.]
[L01XA01, cisplatin, The therapeutic efficacy of Cisplatin can be decreased when used in combination with Dexamethasone acetate.]
[J02AX07, ibrexafungerp, The serum concentration of Ibrexafungerp can be decreased when it is combined with Dexamethasone acetate.]
[C03DA05, finerenone, The therapeutic efficacy of Finerenone can be decreased when used in combination with Dexamethasone acetate.]
[P01CA03, fexinidazole, The excretion of Dexamethasone acetate can be decreased when combined with Fexinidazole.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be increased when combined with Dexamethasone acetate.]
[N02CD07, atogepant, The serum concentration of Atogepant can be decreased when it is combined with Dexamethasone acetate.]
[M01AG01, mefenamic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Mefenamic acid.]
[A10BB12, glimepiride, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Gliquidone.]
[R03CC13, clenbuterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Clenbuterol.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be increased when combined with Dexamethasone acetate.]
[N06AX25, St. John's wort extract, The metabolism of Dexamethasone acetate can be increased when combined with St. John's Wort.]
[J04BA01, clofazimine, The metabolism of Dexamethasone acetate can be decreased when combined with Clofazimine.]
[B06AX04, mitapivat, The metabolism of Mitapivat can be increased when combined with Dexamethasone acetate.]
[L01EJ03, pacritinib, The serum concentration of Pacritinib can be decreased when it is combined with Dexamethasone acetate.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be increased when combined with Dexamethasone acetate.]
[N03AE01, clonazepam, The metabolism of Clonazepam can be increased when combined with Dexamethasone acetate.]
[S01EA04, clonidine, The metabolism of Clonidine can be increased when combined with Dexamethasone acetate.]
[C01EB24, mavacamten, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Mavacamten.]
[A10BX16, tirzepatide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Tirzepatide.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be increased when combined with Dexamethasone acetate.]
[N03AX27, ganaxolone, The metabolism of Ganaxolone can be increased when combined with Dexamethasone acetate.]
[A05BA08, glycyrrhizic acid, Dexamethasone acetate may increase the excretion rate of Glycyrrhizic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be increased when combined with Dexamethasone acetate.]
[J05AX31, lenacapavir, The serum concentration of Lenacapavir can be decreased when it is combined with Dexamethasone acetate.]
[N05AH02, clozapine, The metabolism of Dexamethasone acetate can be decreased when combined with Clozapine.]
[L01EN04, futibatinib, The serum concentration of Futibatinib can be decreased when it is combined with Dexamethasone acetate.]
[A10BX01, guar gum, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Guar gum.]
[A10BK06, sotagliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Sotagliflozin.]
[H01AC08, somatrogon, The metabolism of Dexamethasone acetate can be increased when combined with Somatrogon.]
[L04AC21, bimekizumab, The metabolism of Dexamethasone acetate can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Proquazone.]
[M03AC05, hexafluorenium, The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Dexamethasone acetate.]
[L04AA13, leflunomide, Dexamethasone acetate may decrease the excretion rate of Leflunomide which could result in a higher serum level.]
[A10BX03, nateglinide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Imidazole salicylate.]
[H01AC03, mecasermin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Mecasermin.]
[A10AE04, insulin glargine, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin glargine.]
[J01FA15, telithromycin, The metabolism of Dexamethasone acetate can be decreased when combined with Telithromycin.]
[B01AC10, indobufen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Indobufen.]
[M01AH03, valdecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Valdecoxib.]
[H01AX01, pegvisomant, The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Dexamethasone acetate.]
[C01AA06, lanatoside C, The risk or severity of adverse effects can be increased when Dexamethasone acetate is combined with Lanatoside C.]
[M01AH04, parecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Dexamethasone acetate can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, The excretion of Dexamethasone acetate can be decreased when combined with Acyclovir.]
[M01AA06, kebuzone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Kebuzone.]
[L01EA01, imatinib, Dexamethasone acetate may decrease the excretion rate of Imatinib which could result in a higher serum level.]
[J02AC04, posaconazole, The metabolism of Dexamethasone acetate can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, The excretion of Dexamethasone acetate can be decreased when combined with Esomeprazole.]
[S01BA03, cortisone, The metabolism of Dexamethasone acetate can be increased when combined with Cortisone.]
[S01AE04, lomefloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Lomefloxacin.]
[M01AB09, lonazolac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Lonazolac.]
[R06AX13, loratadine, Dexamethasone acetate may increase the excretion rate of Loratadine which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA31, loxoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Loxoprofen.]
[H02AB15, meprednisone, The metabolism of Dexamethasone acetate can be increased when combined with Meprednisone.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be increased when combined with Dexamethasone acetate.]
[C03AA07, cyclopenthiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Cyclopenthiazide.]
[A10BF02, miglitol, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Miglitol.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be increased when combined with Dexamethasone acetate.]
[N06AX07, minaprine, The therapeutic efficacy of Minaprine can be decreased when used in combination with Dexamethasone acetate.]
[S01XA18, cyclosporine, The risk or severity of adverse effects can be increased when Dexamethasone acetate is combined with Cyclosporine.]
[N06BA07, modafinil, The metabolism of Dexamethasone acetate can be increased when combined with Modafinil.]
[C10AA07, rosuvastatin, The excretion of Dexamethasone acetate can be decreased when combined with Rosuvastatin.]
[M02AA02, mofebutazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Dexamethasone acetate can be decreased when combined with Conivaptan.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be increased when combined with Dexamethasone acetate.]
[M01AH05, etoricoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Etoricoxib.]
[L01DA01, dactinomycin, The serum concentration of Dactinomycin can be decreased when it is combined with Dexamethasone acetate.]
[G03XA01, danazol, The metabolism of Dexamethasone acetate can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Dapsone can be increased when combined with Dexamethasone acetate.]
[L01DB02, daunorubicin, Dexamethasone acetate may increase the excretion rate of Daunorubicin which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AX01, nabumetone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Nabumetone.]
[N06AX06, nefazodone, The metabolism of Dexamethasone acetate can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, The risk or severity of ulceration can be increased when Dexamethasone acetate is combined with Nicorandil.]
[G03DB04, nomegestrol, The serum concentration of Dexamethasone acetate can be increased when it is combined with Nomegestrol.]
[M03AC11, cisatracurium, The risk or severity of myopathy and weakness can be increased when Cisatracurium is combined with Dexamethasone acetate.]
[A07EC03, olsalazine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Olsalazine.]
[C01AA07, deslanoside, The risk or severity of adverse effects can be increased when Dexamethasone acetate is combined with Deslanoside.]
[L01XA03, oxaliplatin, Dexamethasone acetate may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.]
[M01AE12, oxaprozin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Oxaprozin.]
[N03AF02, oxcarbazepine, The metabolism of Dexamethasone acetate can be increased when combined with Oxcarbazepine.]
[G04BD04, oxybutynin, The metabolism of Oxybutynin can be increased when combined with Dexamethasone acetate.]
[L04AB04, adalimumab, The metabolism of Dexamethasone acetate can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, Dexamethasone acetate may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be increased when combined with Dexamethasone acetate.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be increased when combined with Dexamethasone acetate.]
[N05BA01, diazepam, The metabolism of Diazepam can be increased when combined with Dexamethasone acetate.]
[S02DA04, dibucaine, The therapeutic efficacy of Cinchocaine can be decreased when used in combination with Dexamethasone acetate.]
[S01BC03, diclofenac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Diclofenac.]
[A10BG03, pioglitazone, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Pioglitazone.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be increased when combined with Dexamethasone acetate.]
[L01EB02, erlotinib, The serum concentration of Erlotinib can be decreased when it is combined with Dexamethasone acetate.]
[R03CC07, pirbuterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Pirbuterol.]
[C03CA03, piretanide, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Piretanide.]
[P02CB02, diethylcarbamazine, The therapeutic efficacy of Diethylcarbamazine can be decreased when used in combination with Dexamethasone acetate.]
[L02AA01, diethylstilbestrol, The serum concentration of Dexamethasone acetate can be increased when it is combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Dexamethasone acetate can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Dexamethasone acetate can be increased when combined with Difluocortolone.]
[N02BA11, diflunisal, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Diflunisal.]
[C01AA04, digitoxin, The risk or severity of adverse effects can be increased when Dexamethasone acetate is combined with Digitoxin.]
[C01AA05, digoxin, Dexamethasone acetate may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.]
[C10AX09, ezetimibe, Dexamethasone acetate may decrease the excretion rate of Ezetimibe which could result in a higher serum level.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be increased when combined with Dexamethasone acetate.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be increased when combined with Dexamethasone acetate.]
[A11CC02, dihydrotachysterol, The therapeutic efficacy of Dihydrotachysterol can be decreased when used in combination with Dexamethasone acetate.]
[J05AE08, atazanavir, The metabolism of Dexamethasone acetate can be decreased when combined with Atazanavir.]
[C08DB01, diltiazem, The metabolism of Dexamethasone acetate can be decreased when combined with Diltiazem.]
[R03CC08, procaterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Procaterol.]
[N02BB04, propyphenazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Proglumetacin.]
[G02AD02, dinoprostone, The excretion of Dexamethasone acetate can be decreased when combined with Dinoprostone.]
[B01AC07, dipyridamole, Dexamethasone acetate may increase the excretion rate of Dipyridamole which could result in a lower serum level and potentially a reduction in efficacy.]
[A03FA02, cisapride, The metabolism of Cisapride can be increased when combined with Dexamethasone acetate.]
[S01XA23, sirolimus, The serum concentration of Sirolimus can be decreased when it is combined with Dexamethasone acetate.]
[C01BA03, disopyramide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Disopyramide.]
[N07AA03, distigmine, The therapeutic efficacy of Distigmine can be decreased when used in combination with Dexamethasone acetate.]
[P03AA04, disulfiram, Dexamethasone acetate may increase the excretion rate of Disulfiram which could result in a lower serum level and potentially a reduction in efficacy.]
[S02AA12, rifamycin SV, The metabolism of Dexamethasone acetate can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Dexamethasone acetate can be increased when combined with Rifapentine.]
[N07XX02, riluzole, Dexamethasone acetate may decrease the excretion rate of Riluzole which could result in a higher serum level.]
[N05AX08, risperidone, The metabolism of Risperidone can be increased when combined with Dexamethasone acetate.]
[J01MB01, rosoxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Rosoxacin.]
[L01EX01, sunitinib, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Sunitinib.]
[A04AD12, aprepitant, The metabolism of Dexamethasone acetate can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The serum concentration of Tolvaptan can be decreased when it is combined with Dexamethasone acetate.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be decreased when it is combined with Dexamethasone acetate.]
[G04BE08, tadalafil, The metabolism of Tadalafil can be increased when combined with Dexamethasone acetate.]
[S01BC05, ketorolac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Ketorolac.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be increased when combined with Dexamethasone acetate.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be increased when combined with Dexamethasone acetate.]
[N02BA06, salsalate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Salsalate.]
[R03AC12, salmeterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Salmeterol.]
[C01CA07, dobutamine, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Dobutamine.]
[A03FA03, domperidone, The metabolism of Domperidone can be increased when combined with Dexamethasone acetate.]
[L01DB01, doxorubicin, The serum concentration of Doxorubicin can be decreased when it is combined with Dexamethasone acetate.]
[C10AA01, simvastatin, Dexamethasone acetate may increase the excretion rate of Simvastatin which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CC01, sumatriptan, Dexamethasone acetate may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[V04CX07, edrophonium, The therapeutic efficacy of Edrophonium can be decreased when used in combination with Dexamethasone acetate.]
[J01CG02, tazobactam, The excretion of Dexamethasone acetate can be decreased when combined with Tazobactam.]
[J01MA05, temafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Temafloxacin.]
[M01AC02, tenoxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Tenoxicam.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be increased when combined with Dexamethasone acetate.]
[C09AA02, enalapril, The excretion of Dexamethasone acetate can be decreased when combined with Enalapril.]
[M01AG02, tolfenamic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Tolfenamic acid.]
[C03CA04, torsemide, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Torasemide.]
[H02CA01, trilostane, The risk or severity of edema formation can be increased when Trilostane is combined with Dexamethasone acetate.]
[J01MA04, enoxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Enoxacin.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be increased when combined with Dexamethasone acetate.]
[S01FB02, ephedrine, Ephedrine may increase the excretion rate of Dexamethasone acetate which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA12, mepirodipine, The metabolism of Dexamethasone acetate can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Epinephrine.]
[M01AB04, zomepirac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Zomepirac.]
[N03AX15, zonisamide, The metabolism of Zonisamide can be increased when combined with Dexamethasone acetate.]
[A10AB06, insulin glulisine, human, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin glulisine.]
[A11CC01, ergocalciferol, The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Dexamethasone acetate.]
[N02CA02, ergotamine, The metabolism of Dexamethasone acetate can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Dexamethasone acetate can be decreased when combined with Erythromycin.]
[A02BC02, pantoprazole, The excretion of Dexamethasone acetate can be decreased when combined with Pantoprazole.]
[G03CA03, estradiol, The serum concentration of Dexamethasone acetate can be increased when it is combined with Estradiol.]
[G03CA57, estrogens, conjugated (USP), The excretion of Dexamethasone acetate can be decreased when combined with Conjugated estrogens.]
[R03BA09, fluticasone furoate, The metabolism of Dexamethasone acetate can be decreased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Dexamethasone acetate can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be increased when combined with Dexamethasone acetate.]
[L02AA03, ethinyl estradiol, The serum concentration of Dexamethasone acetate can be increased when it is combined with Ethinylestradiol.]
[N04AA05, profenamine, The therapeutic efficacy of Profenamine can be decreased when used in combination with Dexamethasone acetate.]
[M01AC06, meloxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Meloxicam.]
[L01CB01, etoposide, The serum concentration of Etoposide can be decreased when it is combined with Dexamethasone acetate.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be increased when combined with Dexamethasone acetate.]
[A02BA04, nizatidine, The therapeutic efficacy of Nizatidine can be decreased when used in combination with Dexamethasone acetate.]
[J01MA08, fleroxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Fleroxacin.]
[R06AX11, astemizole, The metabolism of Astemizole can be increased when combined with Dexamethasone acetate.]
[R06AX12, terfenadine, The metabolism of Dexamethasone acetate can be decreased when combined with Terfenadine.]
[N06AB08, fluvoxamine, The metabolism of Dexamethasone acetate can be decreased when combined with Fluvoxamine.]
[C10AA03, pravastatin, The excretion of Dexamethasone acetate can be decreased when combined with Pravastatin.]
[A02BA03, famotidine, The excretion of Dexamethasone acetate can be decreased when combined with Famotidine.]
[P02CA03, albendazole, The metabolism of Albendazole can be increased when combined with Dexamethasone acetate.]
[C08CA02, felodipine, Dexamethasone acetate may increase the excretion rate of Felodipine which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AE04, fenoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Fenoprofen.]
[R03CC04, fenoterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Fenoterol.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be increased when combined with Dexamethasone acetate.]
[R03CC02, albuterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Salbutamol.]
[L01BB06, clofarabine, Dexamethasone acetate may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA40, cladribine, Dexamethasone acetate may decrease the excretion rate of Cladribine which could result in a higher serum level.]
[N02BG04, floctafenine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Floctafenine.]
[J01CF05, floxacillin, Dexamethasone acetate may increase the excretion rate of Flucloxacillin which could result in a lower serum level and potentially a reduction in efficacy.]
[J02AC01, fluconazole, The metabolism of Dexamethasone acetate can be decreased when combined with Fluconazole.]
[D07AC08, fluocinonide, The metabolism of Dexamethasone acetate can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Dexamethasone acetate can be increased when combined with Fluocortolone.]
[L01BC02, fluorouracil, Dexamethasone acetate may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[G03BA01, fluoxymesterone, The risk or severity of fluid retention can be increased when Dexamethasone acetate is combined with Fluoxymesterone.]
[S01BC04, flurbiprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Flurbiprofen.]
[L02BB01, flutamide, The metabolism of Flutamide can be increased when combined with Dexamethasone acetate.]
[V04CX02, folic acid, Dexamethasone acetate may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be increased when combined with Dexamethasone acetate.]
[M03AA01, alcuronium, The risk or severity of myopathy and weakness can be increased when Alcuronium is combined with Dexamethasone acetate.]
[J05AE10, darunavir, The metabolism of Dexamethasone acetate can be decreased when combined with Darunavir.]
[C03CA01, furosemide, The excretion of Dexamethasone acetate can be decreased when combined with Furosemide.]
[N05CF04, eszopiclone, The serum concentration of Eszopiclone can be decreased when it is combined with Dexamethasone acetate.]
[N06DA04, galantamine, The therapeutic efficacy of Galantamine can be decreased when used in combination with Dexamethasone acetate.]
[M03AC02, gallamine, The risk or severity of myopathy and weakness can be increased when Gallamine is combined with Dexamethasone acetate.]
[S01AD09, ganciclovir, The excretion of Dexamethasone acetate can be decreased when combined with Ganciclovir.]
[C10AB04, gemfibrozil, The excretion of Dexamethasone acetate can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The serum concentration of Dasatinib can be decreased when it is combined with Dexamethasone acetate.]
[N04BC06, cabergoline, The serum concentration of Cabergoline can be decreased when it is combined with Dexamethasone acetate.]
[A10BJ02, liraglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Liraglutide.]
[G03XA02, gestrinone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Gestrinone.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be increased when combined with Dexamethasone acetate.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be increased when combined with Dexamethasone acetate.]
[A10BB01, glyburide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Glyburide.]
[A10BB09, gliclazide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Gliclazide.]
[A10BB07, glipizide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Glipizide.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be increased when combined with Dexamethasone acetate.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be increased when combined with Dexamethasone acetate.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be increased when combined with Dexamethasone acetate.]
[B01AA12, fluindione, Dexamethasone acetate may increase the anticoagulant activities of Fluindione.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be increased when combined with Dexamethasone acetate.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Dexamethasone acetate.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be increased when combined with Dexamethasone acetate.]
[A10AD05, insulin aspart, human, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin aspart.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be increased when combined with Dexamethasone acetate.]
[M04AA01, allopurinol, Dexamethasone acetate may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C09CA01, losartan, Dexamethasone acetate may increase the excretion rate of Losartan which could result in a lower serum level and potentially a reduction in efficacy.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be increased when combined with Dexamethasone acetate.]
[A07EC02, mesalamine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Mesalazine.]
[R03CC05, hexoprenaline, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be increased when combined with Dexamethasone acetate.]
[C08CA10, nilvadipine, The metabolism of Dexamethasone acetate can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Nimesulide.]
[C03AA03, hydrochlorothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Hydrochlorothiazide.]
[S02BA01, hydrocortisone, The metabolism of Hydrocortisone can be increased when combined with Dexamethasone acetate.]
[C03AA02, hydroflumethiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Hydroflumethiazide.]
[N05BB01, hydroxyzine, The metabolism of Hydroxyzine can be increased when combined with Dexamethasone acetate.]
[R02AX02, ibuprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Ibuprofen.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be increased when combined with Dexamethasone acetate.]
[N06AA02, imipramine, The serum concentration of Imipramine can be decreased when it is combined with Dexamethasone acetate.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be increased when combined with Dexamethasone acetate.]
[L01CE01, topotecan, The serum concentration of Topotecan can be decreased when it is combined with Dexamethasone acetate.]
[C03BA11, indapamide, Dexamethasone acetate may increase the hypokalemic activities of Indapamide.]
[S01BC01, indomethacin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Indomethacin.]
[N06AX17, milnacipran, The metabolism of Milnacipran can be increased when combined with Dexamethasone acetate.]
[A10BH01, sitagliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Sitagliptin.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be increased when combined with Dexamethasone acetate.]
[A10BH02, vildagliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Vildagliptin.]
[C10AA06, cerivastatin, Dexamethasone acetate may decrease the excretion rate of Cerivastatin which could result in a higher serum level.]
[C03BA02, quinethazone, Dexamethasone acetate may increase the hypokalemic activities of Quinethazone.]
[R03CC06, isoetharine, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Isoetharine.]
[S01EB07, isoflurophate, The therapeutic efficacy of Isoflurophate can be decreased when used in combination with Dexamethasone acetate.]
[J04AC01, isoniazid, The serum concentration of Isoniazid can be decreased when it is combined with Dexamethasone acetate.]
[R03CB01, isoproterenol, The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Dexamethasone acetate.]
[A10BJ01, exenatide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Exenatide.]
[P02CF01, ivermectin, Dexamethasone acetate may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L04AC07, tocilizumab, The metabolism of Dexamethasone acetate can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The therapeutic efficacy of Ketamine can be decreased when used in combination with Dexamethasone acetate.]
[J02AB02, ketoconazole, The metabolism of Dexamethasone acetate can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Dexamethasone acetate can be decreased when combined with Levoketoconazole.]
[M02AA10, ketoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Ketoprofen.]
[V03AC03, deferasirox, The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Dexamethasone acetate can be increased when combined with Abatacept.]
[C01CA22, arbutamine, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Arbutamine.]
[J01MB02, nalidixic acid, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Tiaprofenic acid.]
[N07AA30, ambenonium, The therapeutic efficacy of Ambenonium can be decreased when used in combination with Dexamethasone acetate.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be increased when combined with Dexamethasone acetate.]
[C03CC01, ethacrynic acid, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Etacrynic acid.]
[G03AD01, levonorgestrel, The serum concentration of Dexamethasone acetate can be increased when it is combined with Levonorgestrel.]
[S02DA01, lidocaine, The metabolism of Lidocaine can be increased when combined with Dexamethasone acetate.]
[N06BA13, armodafinil, The metabolism of Dexamethasone acetate can be increased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be increased when combined with Dexamethasone acetate.]
[C10AA02, lovastatin, The metabolism of Dexamethasone acetate can be decreased when combined with Lovastatin.]
[G03DC03, lynestrenol, The serum concentration of Dexamethasone acetate can be increased when it is combined with Lynestrenol.]
[L01EG01, temsirolimus, The serum concentration of Temsirolimus can be decreased when it is combined with Dexamethasone acetate.]
[L01BA05, pralatrexate, Dexamethasone acetate may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Dexamethasone acetate can be decreased when combined with Nilotinib.]
[L01AA05, mechlorethamine, The therapeutic efficacy of Mechlorethamine can be decreased when used in combination with Dexamethasone acetate.]
[M02AA18, meclofenamic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Meclofenamic acid.]
[C01AA08, medigoxin, Dexamethasone acetate may increase the excretion rate of Metildigoxin which could result in a lower serum level and potentially a reduction in efficacy.]
[P01BC02, mefloquine, The therapeutic efficacy of Mefloquine can be decreased when used in combination with Dexamethasone acetate.]
[N05CH01, melatonin, The excretion of Dexamethasone acetate can be decreased when combined with Melatonin.]
[N06DX01, memantine, The therapeutic efficacy of Memantine can be decreased when used in combination with Dexamethasone acetate.]
[N02AB02, meperidine, The metabolism of Meperidine can be increased when combined with Dexamethasone acetate.]
[L02BG01, aminoglutethimide, The therapeutic efficacy of Dexamethasone acetate can be decreased when used in combination with Aminoglutethimide.]
[G03BB01, mesterolone, The risk or severity of edema formation can be increased when Mesterolone is combined with Dexamethasone acetate.]
[N05AX13, paliperidone, The serum concentration of Paliperidone can be decreased when it is combined with Dexamethasone acetate.]
[A10BA02, metformin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Metformin.]
[J05AF05, lamivudine, Dexamethasone acetate may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A14AA04, methenolone, The risk or severity of edema formation can be increased when Metenolone is combined with Dexamethasone acetate.]
[H03BB02, methimazole, The metabolism of Dexamethasone acetate can be decreased when combined with Methimazole.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be increased when combined with Dexamethasone acetate.]
[C03AA08, methyclothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Methyclothiazide.]
[V04CG05, methylene blue, The metabolism of Dexamethasone acetate can be decreased when combined with Methylene blue.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be increased when combined with Dexamethasone acetate.]
[G03EK01, methyltestosterone, The risk or severity of edema formation can be increased when Methyltestosterone is combined with Dexamethasone acetate.]
[N02CA04, methysergide, The metabolism of Methysergide can be increased when combined with Dexamethasone acetate.]
[A03FA01, metoclopramide, The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Dexamethasone acetate.]
[C03BA08, metolazone, Dexamethasone acetate may increase the hypokalemic activities of Metolazone.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be increased when combined with Dexamethasone acetate.]
[S02AA13, miconazole, The metabolism of Dexamethasone acetate can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Aminophenazone.]
[N05CD08, midazolam, The metabolism of Midazolam can be increased when combined with Dexamethasone acetate.]
[G03XB01, mifepristone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Mifepristone.]
[J01AA08, minocycline, The excretion of Dexamethasone acetate can be decreased when combined with Minocycline.]
[L01XX23, mitotane, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Mitotane.]
[L01DB07, mitoxantrone, Dexamethasone acetate may decrease the excretion rate of Mitoxantrone which could result in a higher serum level.]
[C01BD01, amiodarone, The metabolism of Dexamethasone acetate can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be increased when combined with Dexamethasone acetate.]
[L04AB05, certolizumab pegol, The metabolism of Dexamethasone acetate can be increased when combined with Certolizumab pegol.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be decreased when it is combined with Dexamethasone acetate.]
[M03AC03, vecuronium, The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Dexamethasone acetate.]
[G03XC01, raloxifene, Dexamethasone acetate may decrease the excretion rate of Raloxifene which could result in a higher serum level.]
[N03AB05, fosphenytoin, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Fosphenytoin.]
[V03AB15, naloxone, The metabolism of Dexamethasone acetate can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Dexamethasone acetate can be increased when combined with Anakinra.]
[S01XA11, nandrolone, The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Dexamethasone acetate.]
[M02AA12, naproxen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Naproxen.]
[A10BG01, troglitazone, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Troglitazone.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be increased when combined with Dexamethasone acetate.]
[A10BX02, repaglinide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Repaglinide.]
[S01EB06, neostigmine, The therapeutic efficacy of Neostigmine can be decreased when used in combination with Dexamethasone acetate.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be increased when combined with Dexamethasone acetate.]
[J02AA01, amphotericin B, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Amphotericin B.]
[N06AX23, desvenlafaxine, The metabolism of Dexamethasone acetate can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, Dexamethasone acetate may increase the excretion rate of Telmisartan which could result in a lower serum level and potentially a reduction in efficacy.]
[H05BX02, paricalcitol, The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Dexamethasone acetate.]
[C08CA04, nicardipine, The metabolism of Dexamethasone acetate can be decreased when combined with Nicardipine.]
[C08CA05, nifedipine, Dexamethasone acetate may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA17, niflumic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Niflumic acid.]
[C08CA07, nisoldipine, The metabolism of Nisoldipine can be increased when combined with Dexamethasone acetate.]
[C08CA08, nitrendipine, Dexamethasone acetate may increase the excretion rate of Nitrendipine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XE01, nitrofurantoin, Dexamethasone acetate may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be increased when combined with Dexamethasone acetate.]
[C01CA03, norepinephrine, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Norepinephrine.]
[G03DC02, norethindrone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Norethisterone.]
[S01AE02, norfloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Norfloxacin.]
[G03AC07, norgestrienone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Norgestrienone.]
[N06AA10, nortriptyline, The serum concentration of Nortriptyline can be decreased when it is combined with Dexamethasone acetate.]
[S02AA16, ofloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Ofloxacin.]
[L04AC04, rilonacept, The metabolism of Dexamethasone acetate can be increased when combined with Rilonacept.]
[R03CB03, metaproterenol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Orciprenaline.]
[C01AC01, ouabain, The excretion of Dexamethasone acetate can be decreased when combined with Ouabain.]
[A14AA08, oxandrolone, The risk or severity of fluid retention can be increased when Dexamethasone acetate is combined with Oxandrolone.]
[J01MB05, oxolinic acid, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Oxolinic acid.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be increased when combined with Dexamethasone acetate.]
[A14AA05, oxymetholone, The risk or severity of fluid retention can be increased when Dexamethasone acetate is combined with Oxymetholone.]
[S01BC02, oxyphenbutazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Oxyphenbutazone.]
[S01AA04, oxytetracycline, The excretion of Dexamethasone acetate can be decreased when combined with Oxytetracycline.]
[V04CH30, 4-aminohippuric acid, The excretion of Dexamethasone acetate can be decreased when combined with Aminohippuric acid.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be decreased when used in combination with Dexamethasone acetate.]
[G03DB06, chlormadinone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Chlormadinone.]
[H02AB05, paramethasone, The metabolism of Dexamethasone acetate can be increased when combined with Paramethasone.]
[J01MA03, pefloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Pefloxacin.]
[S01AA14, penicillin G, The excretion of Dexamethasone acetate can be decreased when combined with Benzylpenicillin.]
[N05CA01, pentobarbital, The metabolism of Dexamethasone acetate can be increased when combined with Pentobarbital.]
[A10BA01, phenformin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Phenformin.]
[B01AA02, phenindione, Dexamethasone acetate may increase the anticoagulant activities of Phenindione.]
[N03AA02, phenobarbital, The metabolism of Dexamethasone acetate can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, Dexamethasone acetate may increase the anticoagulant activities of Phenprocoumon.]
[M02AA01, phenylbutazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Phenylbutazone.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be increased when Dexamethasone acetate is combined with Phenylephrine.]
[R01BA01, phenylpropanolamine, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Phenylpropanolamine.]
[N03AB02, phenytoin, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Dexamethasone acetate can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Levofloxacin.]
[V03AB19, physostigmine, The therapeutic efficacy of Physostigmine can be decreased when used in combination with Dexamethasone acetate.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be increased when combined with Dexamethasone acetate.]
[C08CX01, mibefradil, The metabolism of Dexamethasone acetate can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be increased when combined with Dexamethasone acetate.]
[C10AA05, atorvastatin, Dexamethasone acetate may increase the excretion rate of Atorvastatin which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE01, saquinavir, The metabolism of Dexamethasone acetate can be decreased when combined with Saquinavir.]
[S01BC06, piroxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Piroxicam.]
[J01MA11, grepafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Grepafloxacin.]
[J05AG02, delavirdine, The metabolism of Dexamethasone acetate can be decreased when combined with Delavirdine.]
[A10BG02, rosiglitazone, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Rosiglitazone.]
[L04AC08, canakinumab, The metabolism of Dexamethasone acetate can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Polythiazide.]
[J05AE03, ritonavir, The serum concentration of Dexamethasone acetate can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Saxagliptin.]
[A10AD04, insulin lispro, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin lispro.]
[C10AA08, pitavastatin, Dexamethasone acetate may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be increased when combined with Dexamethasone acetate.]
[C02CA01, prazosin, Dexamethasone acetate may decrease the excretion rate of Prazosin which could result in a higher serum level.]
[P01BA03, primaquine, The metabolism of Dexamethasone acetate can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Dexamethasone acetate can be increased when combined with Primidone.]
[M04AB01, probenecid, The excretion of Dexamethasone acetate can be decreased when combined with Probenecid.]
[C01BA02, procainamide, The therapeutic efficacy of Procainamide can be decreased when used in combination with Dexamethasone acetate.]
[S01HA05, procaine, The therapeutic efficacy of Procaine can be decreased when used in combination with Dexamethasone acetate.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be increased when combined with Dexamethasone acetate.]
[G03DA04, progesterone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Progesterone.]
[L01XH02, romidepsin, The serum concentration of Romidepsin can be decreased when it is combined with Dexamethasone acetate.]
[C07AA05, propranolol, The metabolism of Propranolol can be increased when combined with Dexamethasone acetate.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be increased when combined with Dexamethasone acetate.]
[P02CC01, pyrantel, The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Dexamethasone acetate.]
[N07AA02, pyridostigmine, The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Dexamethasone acetate.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be increased when combined with Dexamethasone acetate.]
[C01BA01, quinidine, The serum concentration of Quinidine can be decreased when it is combined with Dexamethasone acetate.]
[P01BC01, quinine, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Quinine.]
[C02AA02, reserpine, The metabolism of Dexamethasone acetate can be increased when combined with Reserpine.]
[J04AB02, rifampin, The metabolism of Dexamethasone acetate can be increased when combined with Rifampicin.]
[G02CA01, ritodrine, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Ritodrine.]
[N02BA05, salicylamide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Salicylic acid.]
[L01CD04, cabazitaxel, The serum concentration of Cabazitaxel can be decreased when it is combined with Dexamethasone acetate.]
[C03DA01, spironolactone, Dexamethasone acetate may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AG01, valproic acid, The excretion of Dexamethasone acetate can be decreased when combined with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be increased when combined with Dexamethasone acetate.]
[A05AA02, ursodiol, Dexamethasone acetate may increase the excretion rate of Ursodeoxycholic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[P02BB01, trichlorfon, The therapeutic efficacy of Metrifonate can be decreased when used in combination with Dexamethasone acetate.]
[S02DA03, antipyrine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Antipyrine.]
[A14AA02, stanozolol, The risk or severity of fluid retention can be increased when Dexamethasone acetate is combined with Stanozolol.]
[G03XB02, ulipristal, The serum concentration of Dexamethasone acetate can be increased when it is combined with Ulipristal.]
[M03AB01, succinylcholine, The risk or severity of myopathy and weakness can be increased when Succinylcholine is combined with Dexamethasone acetate.]
[J01EC02, sulfadiazine, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Sulfadiazine.]
[J01EC01, sulfamethoxazole, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Sulfamethoxazole.]
[M04AB02, sulfinpyrazone, Dexamethasone acetate may increase the excretion rate of Sulfinpyrazone which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AB02, sulfisoxazole, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Sulfisoxazole.]
[M01AB02, sulindac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Sulindac.]
[N05AL01, sulpiride, The therapeutic efficacy of Sulpiride can be decreased when used in combination with Dexamethasone acetate.]
[A10BB04, glibornuride, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Glibornuride.]
[A10BC01, glymidine, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Glymidine.]
[M01AX04, apazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Azapropazone.]
[L01BB02, mercaptopurine, The excretion of Dexamethasone acetate can be decreased when combined with Mercaptopurine.]
[N06DA01, tacrine, The therapeutic efficacy of Tacrine can be decreased when used in combination with Dexamethasone acetate.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be increased when combined with Dexamethasone acetate.]
[L01CB02, teniposide, The metabolism of Teniposide can be increased when combined with Dexamethasone acetate.]
[R03CC03, terbutaline, The therapeutic efficacy of Terbutaline can be decreased when used in combination with Dexamethasone acetate.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabigatran etexilate can be decreased when it is combined with Dexamethasone acetate.]
[G03BA03, testosterone, The risk or severity of edema formation can be increased when Testosterone is combined with Dexamethasone acetate.]
[S03AA02, tetracycline, The excretion of Dexamethasone acetate can be decreased when combined with Tetracycline.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be increased when combined with Dexamethasone acetate.]
[L04AX02, thalidomide, The metabolism of Dexamethasone acetate can be increased when combined with Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be increased when combined with Dexamethasone acetate.]
[L01AC01, thiotepa, The therapeutic efficacy of Thiotepa can be decreased when used in combination with Dexamethasone acetate.]
[B02AB01, aprotinin, The therapeutic efficacy of Aprotinin can be decreased when used in combination with Dexamethasone acetate.]
[P01AB02, tinidazole, Dexamethasone acetate may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BB05, tolazamide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Tolazamide.]
[V04CA01, tolbutamide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Tolbutamide.]
[M02AA21, tolmetin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Tolmetin.]
[N02AX02, tramadol, The metabolism of Tramadol can be increased when combined with Dexamethasone acetate.]
[N06AX05, trazodone, The metabolism of Trazodone can be increased when combined with Dexamethasone acetate.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be increased when combined with Dexamethasone acetate.]
[S01BA05, triamcinolone, The metabolism of Triamcinolone can be increased when combined with Dexamethasone acetate.]
[N05CD05, triazolam, The metabolism of Triazolam can be increased when combined with Dexamethasone acetate.]
[C03AA06, trichlormethiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Trichlormethiazide.]
[S01EB04, demecarium, The therapeutic efficacy of Demecarium can be decreased when used in combination with Dexamethasone acetate.]
[N05AA05, triflupromazine, The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Dexamethasone acetate.]
[R03BA07, mometasone, The metabolism of Dexamethasone acetate can be increased when combined with Mometasone.]
[N06AA06, trimipramine, The serum concentration of Trimipramine can be decreased when it is combined with Dexamethasone acetate.]
[J01FA08, troleandomycin, The metabolism of Dexamethasone acetate can be decreased when combined with Troleandomycin.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be decreased when used in combination with Dexamethasone acetate.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be increased when combined with Dexamethasone acetate.]
[S01AA05, tyrothricin, The therapeutic efficacy of Tyrothricin can be decreased when used in combination with Dexamethasone acetate.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be increased when combined with Dexamethasone acetate.]
[A10BH05, linagliptin, The serum concentration of Linagliptin can be decreased when it is combined with Dexamethasone acetate.]
[J05AP03, boceprevir, The metabolism of Dexamethasone acetate can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Dexamethasone acetate can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be decreased when it is combined with Dexamethasone acetate.]
[B01AF01, rivaroxaban, Dexamethasone acetate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Indacaterol.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be increased when combined with Dexamethasone acetate.]
[C08DA01, verapamil, The metabolism of Dexamethasone acetate can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Dexamethasone acetate can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The serum concentration of Vinblastine can be decreased when it is combined with Dexamethasone acetate.]
[L01CA02, vincristine, The serum concentration of Vincristine can be decreased when it is combined with Dexamethasone acetate.]
[L01CA03, vindesine, The metabolism of Vindesine can be increased when combined with Dexamethasone acetate.]
[B01AA03, warfarin, Dexamethasone acetate may increase the anticoagulant activities of Warfarin.]
[J05AF01, zidovudine, The excretion of Dexamethasone acetate can be decreased when combined with Zidovudine.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be increased when combined with Dexamethasone acetate.]
[J05AE02, indinavir, The metabolism of Dexamethasone acetate can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The serum concentration of Vemurafenib can be decreased when it is combined with Dexamethasone acetate.]
[L01FX05, brentuximab vedotin, The serum concentration of Brentuximab vedotin can be decreased when it is combined with Dexamethasone acetate.]
[L01ED01, crizotinib, The serum concentration of Crizotinib can be decreased when it is combined with Dexamethasone acetate.]
[H05BX03, doxercalciferol, The therapeutic efficacy of Doxercalciferol can be decreased when used in combination with Dexamethasone acetate.]
[J01MA13, trovafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The metabolism of Ziprasidone can be increased when combined with Dexamethasone acetate.]
[G03AC10, drospirenone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Drospirenone.]
[N02BA01, aspirin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be increased when combined with Dexamethasone acetate.]
[C07AB03, atenolol, Dexamethasone acetate may increase the excretion rate of Atenolol which could result in a lower serum level and potentially a reduction in efficacy.]
[A11CC03, alfacalcidol, The therapeutic efficacy of Alfacalcidol can be decreased when used in combination with Dexamethasone acetate.]
[J02AC03, voriconazole, The serum concentration of Dexamethasone acetate can be increased when it is combined with Voriconazole.]
[M03AC04, atracurium, The risk or severity of myopathy and weakness can be increased when Atracurium is combined with Dexamethasone acetate.]
[S01FA01, atropine, Dexamethasone acetate may increase the excretion rate of Atropine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EK01, axitinib, The serum concentration of Axitinib can be decreased when it is combined with Dexamethasone acetate.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be increased when combined with Dexamethasone acetate.]
[H02AB11, prednylidene, The metabolism of Dexamethasone acetate can be increased when combined with Prednylidene.]
[L01BC05, gemcitabine, The serum concentration of Gemcitabine can be decreased when it is combined with Dexamethasone acetate.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Dexamethasone acetate.]
[L01XG02, carfilzomib, The serum concentration of Carfilzomib can be decreased when it is combined with Dexamethasone acetate.]
[V03AX03, cobicistat, The metabolism of Dexamethasone acetate can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Dexamethasone acetate can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be decreased when it is combined with Dexamethasone acetate.]
[L04AA31, teriflunomide, The excretion of Dexamethasone acetate can be decreased when combined with Teriflunomide.]
[L01EX05, regorafenib, The serum concentration of Regorafenib can be decreased when it is combined with Dexamethasone acetate.]
[C01AA01, acetyldigitoxin, The risk or severity of adverse effects can be increased when Dexamethasone acetate is combined with Acetyldigitoxin.]
[J05AE04, nelfinavir, The metabolism of Dexamethasone acetate can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be decreased when it is combined with Dexamethasone acetate.]
[C08CA13, lercanidipine, The metabolism of Lercanidipine can be increased when combined with Dexamethasone acetate.]
[N06DA02, donepezil, The therapeutic efficacy of Donepezil can be decreased when used in combination with Dexamethasone acetate.]
[N03AX22, perampanel, The metabolism of Perampanel can be increased when combined with Dexamethasone acetate.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be increased when combined with Dexamethasone acetate.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be increased when combined with Dexamethasone acetate.]
[B01AF02, apixaban, Dexamethasone acetate may decrease the excretion rate of Apixaban which could result in a higher serum level.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be increased when combined with Dexamethasone acetate.]
[A10BH04, alogliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Alogliptin.]
[A16AX09, glycerol phenylbutyrate, The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Dexamethasone acetate.]
[C03AA01, bendroflumethiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Bendroflumethiazide.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be decreased when it is combined with Dexamethasone acetate.]
[N02BA10, benorilate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Benorilate.]
[A10BK02, canagliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Canagliflozin.]
[J01MA15, gemifloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Gemifloxacin.]
[M04AB03, benzbromarone, Dexamethasone acetate may increase the excretion rate of Benzbromarone which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AE07, moxifloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Moxifloxacin.]
[A06AX06, tegaserod, Dexamethasone acetate may decrease the excretion rate of Tegaserod which could result in a higher serum level.]
[A10AE05, insulin detemir, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin detemir.]
[A10BX05, pramlintide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Pramlintide.]
[M01AH01, celecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Celecoxib.]
[L04AA18, everolimus, The serum concentration of Everolimus can be decreased when it is combined with Dexamethasone acetate.]
[L01EC02, dabrafenib, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Benzydamine.]
[L01EB03, afatinib, The serum concentration of Afatinib can be decreased when it is combined with Dexamethasone acetate.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be increased when combined with Dexamethasone acetate.]
[J05AJ03, dolutegravir, The excretion of Dexamethasone acetate can be decreased when combined with Dolutegravir.]
[C02KX05, riociguat, Dexamethasone acetate may decrease the excretion rate of Riociguat which could result in a higher serum level.]
[A10BJ03, lixisenatide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Lixisenatide.]
[A05AA03, cholic acid, The excretion of Dexamethasone acetate can be decreased when combined with Cholic Acid.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be increased when combined with Dexamethasone acetate.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be increased when combined with Dexamethasone acetate.]
[G03AC08, etonogestrel, The serum concentration of Dexamethasone acetate can be increased when it is combined with Etonogestrel.]
[J05AP05, simeprevir, The metabolism of Dexamethasone acetate can be decreased when combined with Simeprevir.]
[J05AP08, sofosbuvir, The serum concentration of Sofosbuvir can be decreased when it is combined with Dexamethasone acetate.]
[A10BK01, dapagliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Dapagliflozin.]
[C01CA27, droxidopa, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Droxidopa.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be increased when combined with Dexamethasone acetate.]
[A16AA07, metreleptin, The metabolism of Dexamethasone acetate can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Dexamethasone acetate can be increased when combined with Apremilast.]
[L02BG02, formestane, The risk or severity of edema formation can be increased when Formestane is combined with Dexamethasone acetate.]
[A16AA06, betaine, The therapeutic efficacy of Betaine can be decreased when used in combination with Dexamethasone acetate.]
[S03BA03, betamethasone, The metabolism of Dexamethasone acetate can be increased when combined with Betamethasone.]
[A10BJ04, albiglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Albiglutide.]
[L04AC11, siltuximab, The metabolism of Dexamethasone acetate can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Ceritinib.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be increased when combined with Dexamethasone acetate.]
[B01AA07, acenocoumarol, Dexamethasone acetate may increase the anticoagulant activities of Acenocoumarol.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be increased when combined with Dexamethasone acetate.]
[N07XX08, tafamidis, The excretion of Dexamethasone acetate can be decreased when combined with Tafamidis.]
[A10BK03, empagliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Empagliflozin.]
[R03AC19, olodaterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Olodaterol.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be increased when combined with Dexamethasone acetate.]
[A10BJ05, dulaglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Dulaglutide.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be increased when combined with Dexamethasone acetate.]
[L01XK01, olaparib, The metabolism of Olaparib can be increased when combined with Dexamethasone acetate.]
[B01AA01, dicumarol, Dexamethasone acetate may increase the anticoagulant activities of Dicoumarol.]
[L04AC10, secukinumab, The metabolism of Dexamethasone acetate can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be increased when combined with Dexamethasone acetate.]
[L01EX08, lenvatinib, The excretion of Dexamethasone acetate can be decreased when combined with Lenvatinib.]
[L01XH03, panobinostat, The serum concentration of Panobinostat can be decreased when it is combined with Dexamethasone acetate.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be increased when combined with Dexamethasone acetate.]
[B01AA11, tioclomarol, Dexamethasone acetate may increase the anticoagulant activities of Tioclomarol.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be increased when combined with Dexamethasone acetate.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be increased when combined with Dexamethasone acetate.]
[A04AD14, rolapitant, The metabolism of Rolapitant can be increased when combined with Dexamethasone acetate.]
[N05AX15, cariprazine, The metabolism of Cariprazine can be increased when combined with Dexamethasone acetate.]
[A10BF01, acarbose, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Acarbose.]
[M02AA25, aceclofenac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Acemetacin.]
[A10AE06, insulin degludec, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin degludec.]
[A02BC03, lansoprazole, The excretion of Dexamethasone acetate can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be increased when combined with Dexamethasone acetate.]
[J02AC05, isavuconazole, The metabolism of Isavuconazole can be increased when combined with Dexamethasone acetate.]
[L01EB04, osimertinib, The serum concentration of Osimertinib can be decreased when it is combined with Dexamethasone acetate.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Dexamethasone acetate.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be decreased when it is combined with Dexamethasone acetate.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be increased when combined with Dexamethasone acetate.]
[L01ED03, alectinib, The metabolism of Alectinib can be increased when combined with Dexamethasone acetate.]
[A10BB31, acetohexamide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Acetohexamide.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be increased when combined with Dexamethasone acetate.]
[M01AE16, alminoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Alminoprofen.]
[L01XX52, venetoclax, The serum concentration of Venetoclax can be decreased when it is combined with Dexamethasone acetate.]
[N04BC01, bromocriptine, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Bromocriptine.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be increased when combined with Dexamethasone acetate.]
[C03CA02, bumetanide, The excretion of Dexamethasone acetate can be decreased when combined with Bumetanide.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be increased when combined with Dexamethasone acetate.]
[N05BE01, buspirone, The metabolism of Buspirone can be increased when combined with Dexamethasone acetate.]
[L01AB01, busulfan, The metabolism of Busulfan can be increased when combined with Dexamethasone acetate.]
[N06DA03, rivastigmine, The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Dexamethasone acetate.]
[P01BE02, artemether, The metabolism of Artemether can be increased when combined with Dexamethasone acetate.]
[J01MA09, sparfloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Sparfloxacin.]
[S01GX07, azelastine, The metabolism of Azelastine can be increased when combined with Dexamethasone acetate.]
[L01XK03, rucaparib, Dexamethasone acetate may decrease the excretion rate of Rucaparib which could result in a higher serum level.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be increased when combined with Dexamethasone acetate.]
[L01EF02, ribociclib, The metabolism of Dexamethasone acetate can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Balsalazide.]
[R03CC12, bambuterol, The therapeutic efficacy of Bambuterol can be decreased when used in combination with Dexamethasone acetate.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be increased when combined with Dexamethasone acetate.]
[A10BX06, benfluorex, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Benfluorex.]
[H05BX05, calcifediol, The therapeutic efficacy of Calcifediol can be decreased when used in combination with Dexamethasone acetate.]
[D05AX03, calcitriol, The therapeutic efficacy of Calcitriol can be decreased when used in combination with Dexamethasone acetate.]
[J01XX08, linezolid, The excretion of Dexamethasone acetate can be decreased when combined with Linezolid.]
[J05AE09, tipranavir, The metabolism of Dexamethasone acetate can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be increased when combined with Dexamethasone acetate.]
[L04AB02, infliximab, The metabolism of Dexamethasone acetate can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Dexamethasone acetate can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be increased when combined with Dexamethasone acetate.]
[J01MA23, delafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Delafloxacin.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be increased when combined with Dexamethasone acetate.]
[L01EH02, neratinib, The metabolism of Neratinib can be increased when combined with Dexamethasone acetate.]
[L01FB01, inotuzumab ozogamicin, The serum concentration of Inotuzumab ozogamicin can be decreased when it is combined with Dexamethasone acetate.]
[L01EM02, copanlisib, The serum concentration of Copanlisib can be decreased when it is combined with Dexamethasone acetate.]
[L01EF03, abemaciclib, The serum concentration of Abemaciclib can be decreased when it is combined with Dexamethasone acetate.]
[R03AC17, bitolterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Bitolterol.]
[J05AG03, efavirenz, The metabolism of Dexamethasone acetate can be decreased when combined with Efavirenz.]
[R03BA02, budesonide, Dexamethasone acetate may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AB07, bumadizone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be increased when combined with Dexamethasone acetate.]
[J05AX18, letermovir, The excretion of Dexamethasone acetate can be decreased when combined with Letermovir.]
[C01AA02, acetyldigoxins, Dexamethasone acetate may increase the excretion rate of Acetyldigoxin which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BJ06, semaglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Semaglutide.]
[N01BX04, capsaicin, The therapeutic efficacy of Capsaicin can be decreased when used in combination with Dexamethasone acetate.]
[A10BK04, ertugliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Ertugliflozin.]
[L02BB05, apalutamide, The metabolism of Dexamethasone acetate can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be increased when combined with Dexamethasone acetate.]
[N03AX24, cannabidiol, The metabolism of Dexamethasone acetate can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The excretion of Dexamethasone acetate can be decreased when combined with Avatrombopag.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be decreased when it is combined with Dexamethasone acetate.]
[J01DD14, ceftibuten, The excretion of Dexamethasone acetate can be decreased when combined with Ceftibuten.]
[C07AB08, celiprolol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Celiprolol.]
[L01XX62, ivosidenib, The metabolism of Dexamethasone acetate can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Dexamethasone acetate can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, Dexamethasone acetate may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.]
[J05AG06, doravirine, The metabolism of Doravirine can be increased when combined with Dexamethasone acetate.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be increased when combined with Dexamethasone acetate.]
[L01EB07, dacomitinib, The serum concentration of Dacomitinib can be decreased when it is combined with Dexamethasone acetate.]
[A10BB06, carbutamide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Carbutamide.]
[M01AC05, lornoxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Lornoxicam.]
[L01XK04, talazoparib, The serum concentration of Talazoparib can be decreased when it is combined with Dexamethasone acetate.]
[R03BB08, revefenacin, Dexamethasone acetate may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be increased when combined with Dexamethasone acetate.]
[L04AA39, emapalumab, The metabolism of Dexamethasone acetate can be increased when combined with Emapalumab.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be increased when combined with Dexamethasone acetate.]
[L01XJ03, glasdegib, Dexamethasone acetate may decrease the excretion rate of Glasdegib which could result in a higher serum level.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be increased when combined with Dexamethasone acetate.]
[L04AA42, siponimod, The metabolism of Siponimod can be increased when combined with Dexamethasone acetate.]
[J01FA09, clarithromycin, The metabolism of Dexamethasone acetate can be decreased when combined with Clarithromycin.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be increased when combined with Dexamethasone acetate.]
[H02AB14, cloprednol, The metabolism of Dexamethasone acetate can be increased when combined with Cloprednol.]
[L04AB01, etanercept, The metabolism of Dexamethasone acetate can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Dexamethasone acetate can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be increased when it is combined with Dexamethasone acetate.]
[J01DC04, cefaclor, The excretion of Dexamethasone acetate can be decreased when combined with Cefaclor.]
[J01DB05, cefadroxil, The excretion of Dexamethasone acetate can be decreased when combined with Cefadroxil.]
[J01DC03, cefamandole, The excretion of Dexamethasone acetate can be decreased when combined with Cefamandole.]
[J01DB04, cefazolin, The excretion of Dexamethasone acetate can be decreased when combined with Cefazolin.]
[L02BB06, darolutamide, The serum concentration of Darolutamide can be decreased when it is combined with Dexamethasone acetate.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be increased when combined with Dexamethasone acetate.]
[J01DD12, cefoperazone, The excretion of Dexamethasone acetate can be decreased when combined with Cefoperazone.]
[J01DD01, cefotaxime, The excretion of Dexamethasone acetate can be decreased when combined with Cefotaxime.]
[J01DC07, cefotiam, The excretion of Dexamethasone acetate can be decreased when combined with Cefotiam.]
[J01DD07, ceftizoxime, The excretion of Dexamethasone acetate can be decreased when combined with Ceftizoxime.]
[J01DD04, ceftriaxone, The excretion of Dexamethasone acetate can be decreased when combined with Ceftriaxone.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be increased when combined with Dexamethasone acetate.]
[N07XX11, pitolisant, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be increased when combined with Dexamethasone acetate.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be increased when combined with Dexamethasone acetate.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be increased when combined with Dexamethasone acetate.]
[C03AA09, cyclothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Cyclothiazide.]
[A10AE03, insulin, regular, pork, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin pork.]
[J01DB01, cephalexin, The excretion of Dexamethasone acetate can be decreased when combined with Cephalexin.]
[J01DB02, cephaloridine, The excretion of Dexamethasone acetate can be decreased when combined with Cefaloridine.]
[J01DB03, cephalothin, The excretion of Dexamethasone acetate can be decreased when combined with Cefalotin.]
[H02AB13, deflazacort, The serum concentration of Deflazacort can be decreased when it is combined with Dexamethasone acetate.]
[G03DB05, demegestone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Demegestone.]
[L01FD03, ado-trastuzumab emtansine, The serum concentration of Trastuzumab emtansine can be decreased when it is combined with Dexamethasone acetate.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be increased when combined with Dexamethasone acetate.]
[G03AC09, desogestrel, The serum concentration of Dexamethasone acetate can be increased when it is combined with Desogestrel.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be decreased when it is combined with Dexamethasone acetate.]
[N03AX25, cenobamate, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Cenobamate.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be decreased when it is combined with Dexamethasone acetate.]
[S01XA12, dexpanthenol, The therapeutic efficacy of Dexpanthenol can be decreased when used in combination with Dexamethasone acetate.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be decreased when it is combined with Dexamethasone acetate.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be increased when combined with Dexamethasone acetate.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be decreased when it is combined with Dexamethasone acetate.]
[N02CD06, rimegepant, The metabolism of Rimegepant can be increased when combined with Dexamethasone acetate.]
[S01AE06, gatifloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Dexamethasone acetate can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Dexamethasone acetate can be decreased when combined with Amprenavir.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be increased when combined with Dexamethasone acetate.]
[L04AA38, ozanimod, Dexamethasone acetate may decrease the excretion rate of Ozanimod which could result in a higher serum level.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be decreased when it is combined with Dexamethasone acetate.]
[G03DB08, dienogest, The serum concentration of Dexamethasone acetate can be increased when it is combined with Dienogest.]
[M01AH02, rofecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Rofecoxib.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be increased when combined with Dexamethasone acetate.]
[S03AA08, chloramphenicol, The metabolism of Dexamethasone acetate can be decreased when combined with Chloramphenicol.]
[L01EN02, pemigatinib, The metabolism of Pemigatinib can be increased when combined with Dexamethasone acetate.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Dexamethasone acetate.]
[L01EX17, capmatinib, The serum concentration of Capmatinib can be decreased when it is combined with Dexamethasone acetate.]
[D07XB03, fluprednidene, The metabolism of Dexamethasone acetate can be increased when combined with Fluprednidene.]
[M01AC04, droxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Droxicam.]
[L01EX19, ripretinib, Dexamethasone acetate may decrease the excretion rate of Ripretinib which could result in a higher serum level.]
[L01EX22, selpercatinib, The serum concentration of Selpercatinib can be decreased when it is combined with Dexamethasone acetate.]
[M02AA27, dexketoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Dexketoprofen.]
[L01XX69, lurbinectedin, The serum concentration of Lurbinectedin can be decreased when it is combined with Dexamethasone acetate.]
[C08CA17, levamlodipine, The metabolism of Levamlodipine can be increased when combined with Dexamethasone acetate.]
[S01AA13, fusidic acid, The metabolism of Dexamethasone acetate can be decreased when combined with Fusidic acid.]
[J01MB04, pipemidic acid, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Pipemidic acid.]
[R06AX22, ebastine, The metabolism of Ebastine can be increased when combined with Dexamethasone acetate.]
[J05AX29, fostemsavir, Dexamethasone acetate may decrease the excretion rate of Fostemsavir which could result in a higher serum level.]
[L01FX15, belantamab mafodotin, Dexamethasone acetate may increase the excretion rate of Belantamab mafodotin which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AC19, satralizumab, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be decreased when it is combined with Dexamethasone acetate.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be increased when combined with Dexamethasone acetate.]
[L01EX23, pralsetinib, Dexamethasone acetate may decrease the excretion rate of Pralsetinib which could result in a higher serum level.]
[C03AA04, chlorothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Chlorothiazide.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be increased when combined with Dexamethasone acetate.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Dexamethasone acetate.]
[A10BB02, chlorpropamide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Chlorpropamide.]
[C03BA04, chlorthalidone, Dexamethasone acetate may increase the hypokalemic activities of Chlorthalidone.]
[A11CC05, cholecalciferol, The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Dexamethasone acetate.]
[N02BA07, ethenzamide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Ethenzamide.]
[C10AC01, cholestyramine resin, Cholestyramine may increase the excretion rate of Dexamethasone acetate which could result in a lower serum level and potentially a reduction in efficacy.]
[G03DC06, ethynodiol, The serum concentration of Dexamethasone acetate can be increased when it is combined with Etynodiol.]
[M01AB08, etodolac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Etofenamate.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be decreased when it is combined with Dexamethasone acetate.]
[A16AX20, lonafarnib, The metabolism of Dexamethasone acetate can be decreased when combined with Lonafarnib.]
[L02BX04, relugolix, The serum concentration of Relugolix can be decreased when it is combined with Dexamethasone acetate.]
[J05AJ04, cabotegravir, The excretion of Dexamethasone acetate can be decreased when combined with Cabotegravir.]
[L04AD03, voclosporin, The metabolism of Voclosporin can be increased when combined with Dexamethasone acetate.]
[P03AX07, abametapir, The serum concentration of Dexamethasone acetate can be increased when it is combined with Abametapir.]
[V03AF12, trilaciclib, Dexamethasone acetate may decrease the excretion rate of Trilaciclib which could result in a higher serum level.]
[M01AE05, fenbufen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Fenbufen.]
[G04CB01, finasteride, The metabolism of Finasteride can be increased when combined with Dexamethasone acetate.]
[J01MB07, flumequine, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Flumequine.]
[S01JA01, fluorescein, Dexamethasone acetate may increase the excretion rate of Fluorescein which could result in a lower serum level and potentially a reduction in efficacy.]
[R03CC15, formoterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Formoterol.]
[A10AF01, insulin, regular, human, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin human.]
[L04AA50, ponesimod, The metabolism of Ponesimod can be increased when combined with Dexamethasone acetate.]
[L01EK03, tivozanib, The metabolism of Tivozanib can be increased when combined with Dexamethasone acetate.]
[A02BA01, cimetidine, The excretion of Dexamethasone acetate can be decreased when combined with Cimetidine.]
[J01MB06, cinoxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be increased when combined with Dexamethasone acetate.]
[S03AA07, ciprofloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Ciprofloxacin.]
[L01XA01, cisplatin, The therapeutic efficacy of Cisplatin can be decreased when used in combination with Dexamethasone acetate.]
[J02AX07, ibrexafungerp, The serum concentration of Ibrexafungerp can be decreased when it is combined with Dexamethasone acetate.]
[C03DA05, finerenone, The therapeutic efficacy of Finerenone can be decreased when used in combination with Dexamethasone acetate.]
[P01CA03, fexinidazole, The excretion of Dexamethasone acetate can be decreased when combined with Fexinidazole.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be increased when combined with Dexamethasone acetate.]
[N02CD07, atogepant, The serum concentration of Atogepant can be decreased when it is combined with Dexamethasone acetate.]
[M01AG01, mefenamic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Mefenamic acid.]
[A10BB12, glimepiride, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Gliquidone.]
[R03CC13, clenbuterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Clenbuterol.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be increased when combined with Dexamethasone acetate.]
[N06AX25, St. John's wort extract, The metabolism of Dexamethasone acetate can be increased when combined with St. John's Wort.]
[J04BA01, clofazimine, The metabolism of Dexamethasone acetate can be decreased when combined with Clofazimine.]
[B06AX04, mitapivat, The metabolism of Mitapivat can be increased when combined with Dexamethasone acetate.]
[L01EJ03, pacritinib, The serum concentration of Pacritinib can be decreased when it is combined with Dexamethasone acetate.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be increased when combined with Dexamethasone acetate.]
[N03AE01, clonazepam, The metabolism of Clonazepam can be increased when combined with Dexamethasone acetate.]
[S01EA04, clonidine, The metabolism of Clonidine can be increased when combined with Dexamethasone acetate.]
[C01EB24, mavacamten, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Mavacamten.]
[A10BX16, tirzepatide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Tirzepatide.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be increased when combined with Dexamethasone acetate.]
[N03AX27, ganaxolone, The metabolism of Ganaxolone can be increased when combined with Dexamethasone acetate.]
[A05BA08, glycyrrhizic acid, Dexamethasone acetate may increase the excretion rate of Glycyrrhizic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be increased when combined with Dexamethasone acetate.]
[J05AX31, lenacapavir, The serum concentration of Lenacapavir can be decreased when it is combined with Dexamethasone acetate.]
[N05AH02, clozapine, The metabolism of Dexamethasone acetate can be decreased when combined with Clozapine.]
[L01EN04, futibatinib, The serum concentration of Futibatinib can be decreased when it is combined with Dexamethasone acetate.]
[A10BX01, guar gum, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Guar gum.]
[A10BK06, sotagliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Sotagliflozin.]
[H01AC08, somatrogon, The metabolism of Dexamethasone acetate can be increased when combined with Somatrogon.]
[L04AC21, bimekizumab, The metabolism of Dexamethasone acetate can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Proquazone.]
[M03AC05, hexafluorenium, The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Dexamethasone acetate.]
[L04AA13, leflunomide, Dexamethasone acetate may decrease the excretion rate of Leflunomide which could result in a higher serum level.]
[A10BX03, nateglinide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Imidazole salicylate.]
[H01AC03, mecasermin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Mecasermin.]
[A10AE04, insulin glargine, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin glargine.]
[J01FA15, telithromycin, The metabolism of Dexamethasone acetate can be decreased when combined with Telithromycin.]
[B01AC10, indobufen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Indobufen.]
[M01AH03, valdecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Valdecoxib.]
[H01AX01, pegvisomant, The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Dexamethasone acetate.]
[C01AA06, lanatoside C, The risk or severity of adverse effects can be increased when Dexamethasone acetate is combined with Lanatoside C.]
[M01AH04, parecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Dexamethasone acetate can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, The excretion of Dexamethasone acetate can be decreased when combined with Acyclovir.]
[M01AA06, kebuzone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Kebuzone.]
[L01EA01, imatinib, Dexamethasone acetate may decrease the excretion rate of Imatinib which could result in a higher serum level.]
[J02AC04, posaconazole, The metabolism of Dexamethasone acetate can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, The excretion of Dexamethasone acetate can be decreased when combined with Esomeprazole.]
[S01BA03, cortisone, The metabolism of Dexamethasone acetate can be increased when combined with Cortisone.]
[S01AE04, lomefloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Lomefloxacin.]
[M01AB09, lonazolac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Lonazolac.]
[R06AX13, loratadine, Dexamethasone acetate may increase the excretion rate of Loratadine which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA31, loxoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Loxoprofen.]
[H02AB15, meprednisone, The metabolism of Dexamethasone acetate can be increased when combined with Meprednisone.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be increased when combined with Dexamethasone acetate.]
[C03AA07, cyclopenthiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Cyclopenthiazide.]
[A10BF02, miglitol, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Miglitol.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be increased when combined with Dexamethasone acetate.]
[N06AX07, minaprine, The therapeutic efficacy of Minaprine can be decreased when used in combination with Dexamethasone acetate.]
[S01XA18, cyclosporine, The risk or severity of adverse effects can be increased when Dexamethasone acetate is combined with Cyclosporine.]
[N06BA07, modafinil, The metabolism of Dexamethasone acetate can be increased when combined with Modafinil.]
[C10AA07, rosuvastatin, The excretion of Dexamethasone acetate can be decreased when combined with Rosuvastatin.]
[M02AA02, mofebutazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Dexamethasone acetate can be decreased when combined with Conivaptan.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be increased when combined with Dexamethasone acetate.]
[M01AH05, etoricoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Etoricoxib.]
[L01DA01, dactinomycin, The serum concentration of Dactinomycin can be decreased when it is combined with Dexamethasone acetate.]
[G03XA01, danazol, The metabolism of Dexamethasone acetate can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Dapsone can be increased when combined with Dexamethasone acetate.]
[L01DB02, daunorubicin, Dexamethasone acetate may increase the excretion rate of Daunorubicin which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AX01, nabumetone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Nabumetone.]
[N06AX06, nefazodone, The metabolism of Dexamethasone acetate can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, The risk or severity of ulceration can be increased when Dexamethasone acetate is combined with Nicorandil.]
[G03DB04, nomegestrol, The serum concentration of Dexamethasone acetate can be increased when it is combined with Nomegestrol.]
[M03AC11, cisatracurium, The risk or severity of myopathy and weakness can be increased when Cisatracurium is combined with Dexamethasone acetate.]
[A07EC03, olsalazine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Olsalazine.]
[C01AA07, deslanoside, The risk or severity of adverse effects can be increased when Dexamethasone acetate is combined with Deslanoside.]
[L01XA03, oxaliplatin, Dexamethasone acetate may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.]
[M01AE12, oxaprozin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Oxaprozin.]
[N03AF02, oxcarbazepine, The metabolism of Dexamethasone acetate can be increased when combined with Oxcarbazepine.]
[G04BD04, oxybutynin, The metabolism of Oxybutynin can be increased when combined with Dexamethasone acetate.]
[L04AB04, adalimumab, The metabolism of Dexamethasone acetate can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, Dexamethasone acetate may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be increased when combined with Dexamethasone acetate.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be increased when combined with Dexamethasone acetate.]
[N05BA01, diazepam, The metabolism of Diazepam can be increased when combined with Dexamethasone acetate.]
[S02DA04, dibucaine, The therapeutic efficacy of Cinchocaine can be decreased when used in combination with Dexamethasone acetate.]
[S01BC03, diclofenac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Diclofenac.]
[A10BG03, pioglitazone, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Pioglitazone.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be increased when combined with Dexamethasone acetate.]
[L01EB02, erlotinib, The serum concentration of Erlotinib can be decreased when it is combined with Dexamethasone acetate.]
[R03CC07, pirbuterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Pirbuterol.]
[C03CA03, piretanide, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Piretanide.]
[P02CB02, diethylcarbamazine, The therapeutic efficacy of Diethylcarbamazine can be decreased when used in combination with Dexamethasone acetate.]
[L02AA01, diethylstilbestrol, The serum concentration of Dexamethasone acetate can be increased when it is combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Dexamethasone acetate can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Dexamethasone acetate can be increased when combined with Difluocortolone.]
[N02BA11, diflunisal, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Diflunisal.]
[C01AA04, digitoxin, The risk or severity of adverse effects can be increased when Dexamethasone acetate is combined with Digitoxin.]
[C01AA05, digoxin, Dexamethasone acetate may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.]
[C10AX09, ezetimibe, Dexamethasone acetate may decrease the excretion rate of Ezetimibe which could result in a higher serum level.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be increased when combined with Dexamethasone acetate.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be increased when combined with Dexamethasone acetate.]
[A11CC02, dihydrotachysterol, The therapeutic efficacy of Dihydrotachysterol can be decreased when used in combination with Dexamethasone acetate.]
[J05AE08, atazanavir, The metabolism of Dexamethasone acetate can be decreased when combined with Atazanavir.]
[C08DB01, diltiazem, The metabolism of Dexamethasone acetate can be decreased when combined with Diltiazem.]
[R03CC08, procaterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Procaterol.]
[N02BB04, propyphenazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Proglumetacin.]
[G02AD02, dinoprostone, The excretion of Dexamethasone acetate can be decreased when combined with Dinoprostone.]
[B01AC07, dipyridamole, Dexamethasone acetate may increase the excretion rate of Dipyridamole which could result in a lower serum level and potentially a reduction in efficacy.]
[A03FA02, cisapride, The metabolism of Cisapride can be increased when combined with Dexamethasone acetate.]
[S01XA23, sirolimus, The serum concentration of Sirolimus can be decreased when it is combined with Dexamethasone acetate.]
[C01BA03, disopyramide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Disopyramide.]
[N07AA03, distigmine, The therapeutic efficacy of Distigmine can be decreased when used in combination with Dexamethasone acetate.]
[P03AA04, disulfiram, Dexamethasone acetate may increase the excretion rate of Disulfiram which could result in a lower serum level and potentially a reduction in efficacy.]
[S02AA12, rifamycin SV, The metabolism of Dexamethasone acetate can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Dexamethasone acetate can be increased when combined with Rifapentine.]
[N07XX02, riluzole, Dexamethasone acetate may decrease the excretion rate of Riluzole which could result in a higher serum level.]
[N05AX08, risperidone, The metabolism of Risperidone can be increased when combined with Dexamethasone acetate.]
[J01MB01, rosoxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Rosoxacin.]
[L01EX01, sunitinib, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Sunitinib.]
[A04AD12, aprepitant, The metabolism of Dexamethasone acetate can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The serum concentration of Tolvaptan can be decreased when it is combined with Dexamethasone acetate.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be decreased when it is combined with Dexamethasone acetate.]
[G04BE08, tadalafil, The metabolism of Tadalafil can be increased when combined with Dexamethasone acetate.]
[S01BC05, ketorolac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Ketorolac.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be increased when combined with Dexamethasone acetate.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be increased when combined with Dexamethasone acetate.]
[N02BA06, salsalate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Salsalate.]
[R03AC12, salmeterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Salmeterol.]
[C01CA07, dobutamine, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Dobutamine.]
[A03FA03, domperidone, The metabolism of Domperidone can be increased when combined with Dexamethasone acetate.]
[L01DB01, doxorubicin, The serum concentration of Doxorubicin can be decreased when it is combined with Dexamethasone acetate.]
[C10AA01, simvastatin, Dexamethasone acetate may increase the excretion rate of Simvastatin which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CC01, sumatriptan, Dexamethasone acetate may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[V04CX07, edrophonium, The therapeutic efficacy of Edrophonium can be decreased when used in combination with Dexamethasone acetate.]
[J01CG02, tazobactam, The excretion of Dexamethasone acetate can be decreased when combined with Tazobactam.]
[J01MA05, temafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Temafloxacin.]
[M01AC02, tenoxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Tenoxicam.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be increased when combined with Dexamethasone acetate.]
[C09AA02, enalapril, The excretion of Dexamethasone acetate can be decreased when combined with Enalapril.]
[M01AG02, tolfenamic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Tolfenamic acid.]
[C03CA04, torsemide, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Torasemide.]
[H02CA01, trilostane, The risk or severity of edema formation can be increased when Trilostane is combined with Dexamethasone acetate.]
[J01MA04, enoxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Enoxacin.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be increased when combined with Dexamethasone acetate.]
[S01FB02, ephedrine, Ephedrine may increase the excretion rate of Dexamethasone acetate which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA12, mepirodipine, The metabolism of Dexamethasone acetate can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Epinephrine.]
[M01AB04, zomepirac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Zomepirac.]
[N03AX15, zonisamide, The metabolism of Zonisamide can be increased when combined with Dexamethasone acetate.]
[A10AB06, insulin glulisine, human, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin glulisine.]
[A11CC01, ergocalciferol, The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Dexamethasone acetate.]
[N02CA02, ergotamine, The metabolism of Dexamethasone acetate can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Dexamethasone acetate can be decreased when combined with Erythromycin.]
[A02BC02, pantoprazole, The excretion of Dexamethasone acetate can be decreased when combined with Pantoprazole.]
[G03CA03, estradiol, The serum concentration of Dexamethasone acetate can be increased when it is combined with Estradiol.]
[G03CA57, estrogens, conjugated (USP), The excretion of Dexamethasone acetate can be decreased when combined with Conjugated estrogens.]
[R03BA09, fluticasone furoate, The metabolism of Dexamethasone acetate can be decreased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Dexamethasone acetate can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be increased when combined with Dexamethasone acetate.]
[L02AA03, ethinyl estradiol, The serum concentration of Dexamethasone acetate can be increased when it is combined with Ethinylestradiol.]
[N04AA05, profenamine, The therapeutic efficacy of Profenamine can be decreased when used in combination with Dexamethasone acetate.]
[M01AC06, meloxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Meloxicam.]
[L01CB01, etoposide, The serum concentration of Etoposide can be decreased when it is combined with Dexamethasone acetate.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be increased when combined with Dexamethasone acetate.]
[A02BA04, nizatidine, The therapeutic efficacy of Nizatidine can be decreased when used in combination with Dexamethasone acetate.]
[J01MA08, fleroxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Fleroxacin.]
[R06AX11, astemizole, The metabolism of Astemizole can be increased when combined with Dexamethasone acetate.]
[R06AX12, terfenadine, The metabolism of Dexamethasone acetate can be decreased when combined with Terfenadine.]
[N06AB08, fluvoxamine, The metabolism of Dexamethasone acetate can be decreased when combined with Fluvoxamine.]
[C10AA03, pravastatin, The excretion of Dexamethasone acetate can be decreased when combined with Pravastatin.]
[A02BA03, famotidine, The excretion of Dexamethasone acetate can be decreased when combined with Famotidine.]
[P02CA03, albendazole, The metabolism of Albendazole can be increased when combined with Dexamethasone acetate.]
[C08CA02, felodipine, Dexamethasone acetate may increase the excretion rate of Felodipine which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AE04, fenoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Fenoprofen.]
[R03CC04, fenoterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Fenoterol.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be increased when combined with Dexamethasone acetate.]
[R03CC02, albuterol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Salbutamol.]
[L01BB06, clofarabine, Dexamethasone acetate may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA40, cladribine, Dexamethasone acetate may decrease the excretion rate of Cladribine which could result in a higher serum level.]
[N02BG04, floctafenine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Floctafenine.]
[J01CF05, floxacillin, Dexamethasone acetate may increase the excretion rate of Flucloxacillin which could result in a lower serum level and potentially a reduction in efficacy.]
[J02AC01, fluconazole, The metabolism of Dexamethasone acetate can be decreased when combined with Fluconazole.]
[D07AC08, fluocinonide, The metabolism of Dexamethasone acetate can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Dexamethasone acetate can be increased when combined with Fluocortolone.]
[L01BC02, fluorouracil, Dexamethasone acetate may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[G03BA01, fluoxymesterone, The risk or severity of fluid retention can be increased when Dexamethasone acetate is combined with Fluoxymesterone.]
[S01BC04, flurbiprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Flurbiprofen.]
[L02BB01, flutamide, The metabolism of Flutamide can be increased when combined with Dexamethasone acetate.]
[V04CX02, folic acid, Dexamethasone acetate may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be increased when combined with Dexamethasone acetate.]
[M03AA01, alcuronium, The risk or severity of myopathy and weakness can be increased when Alcuronium is combined with Dexamethasone acetate.]
[J05AE10, darunavir, The metabolism of Dexamethasone acetate can be decreased when combined with Darunavir.]
[C03CA01, furosemide, The excretion of Dexamethasone acetate can be decreased when combined with Furosemide.]
[N05CF04, eszopiclone, The serum concentration of Eszopiclone can be decreased when it is combined with Dexamethasone acetate.]
[N06DA04, galantamine, The therapeutic efficacy of Galantamine can be decreased when used in combination with Dexamethasone acetate.]
[M03AC02, gallamine, The risk or severity of myopathy and weakness can be increased when Gallamine is combined with Dexamethasone acetate.]
[S01AD09, ganciclovir, The excretion of Dexamethasone acetate can be decreased when combined with Ganciclovir.]
[C10AB04, gemfibrozil, The excretion of Dexamethasone acetate can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The serum concentration of Dasatinib can be decreased when it is combined with Dexamethasone acetate.]
[N04BC06, cabergoline, The serum concentration of Cabergoline can be decreased when it is combined with Dexamethasone acetate.]
[A10BJ02, liraglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Liraglutide.]
[G03XA02, gestrinone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Gestrinone.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be increased when combined with Dexamethasone acetate.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be increased when combined with Dexamethasone acetate.]
[A10BB01, glyburide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Glyburide.]
[A10BB09, gliclazide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Gliclazide.]
[A10BB07, glipizide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Glipizide.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be increased when combined with Dexamethasone acetate.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be increased when combined with Dexamethasone acetate.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be increased when combined with Dexamethasone acetate.]
[B01AA12, fluindione, Dexamethasone acetate may increase the anticoagulant activities of Fluindione.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be increased when combined with Dexamethasone acetate.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Dexamethasone acetate.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be increased when combined with Dexamethasone acetate.]
[A10AD05, insulin aspart, human, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin aspart.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be increased when combined with Dexamethasone acetate.]
[M04AA01, allopurinol, Dexamethasone acetate may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C09CA01, losartan, Dexamethasone acetate may increase the excretion rate of Losartan which could result in a lower serum level and potentially a reduction in efficacy.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be increased when combined with Dexamethasone acetate.]
[A07EC02, mesalamine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Mesalazine.]
[R03CC05, hexoprenaline, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be increased when combined with Dexamethasone acetate.]
[C08CA10, nilvadipine, The metabolism of Dexamethasone acetate can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Nimesulide.]
[C03AA03, hydrochlorothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Hydrochlorothiazide.]
[S02BA01, hydrocortisone, The metabolism of Hydrocortisone can be increased when combined with Dexamethasone acetate.]
[C03AA02, hydroflumethiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Hydroflumethiazide.]
[N05BB01, hydroxyzine, The metabolism of Hydroxyzine can be increased when combined with Dexamethasone acetate.]
[R02AX02, ibuprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Ibuprofen.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be increased when combined with Dexamethasone acetate.]
[N06AA02, imipramine, The serum concentration of Imipramine can be decreased when it is combined with Dexamethasone acetate.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be increased when combined with Dexamethasone acetate.]
[L01CE01, topotecan, The serum concentration of Topotecan can be decreased when it is combined with Dexamethasone acetate.]
[C03BA11, indapamide, Dexamethasone acetate may increase the hypokalemic activities of Indapamide.]
[S01BC01, indomethacin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Indomethacin.]
[N06AX17, milnacipran, The metabolism of Milnacipran can be increased when combined with Dexamethasone acetate.]
[A10BH01, sitagliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Sitagliptin.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be increased when combined with Dexamethasone acetate.]
[A10BH02, vildagliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Vildagliptin.]
[C10AA06, cerivastatin, Dexamethasone acetate may decrease the excretion rate of Cerivastatin which could result in a higher serum level.]
[C03BA02, quinethazone, Dexamethasone acetate may increase the hypokalemic activities of Quinethazone.]
[R03CC06, isoetharine, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Isoetharine.]
[S01EB07, isoflurophate, The therapeutic efficacy of Isoflurophate can be decreased when used in combination with Dexamethasone acetate.]
[J04AC01, isoniazid, The serum concentration of Isoniazid can be decreased when it is combined with Dexamethasone acetate.]
[R03CB01, isoproterenol, The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Dexamethasone acetate.]
[A10BJ01, exenatide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Exenatide.]
[P02CF01, ivermectin, Dexamethasone acetate may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L04AC07, tocilizumab, The metabolism of Dexamethasone acetate can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The therapeutic efficacy of Ketamine can be decreased when used in combination with Dexamethasone acetate.]
[J02AB02, ketoconazole, The metabolism of Dexamethasone acetate can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Dexamethasone acetate can be decreased when combined with Levoketoconazole.]
[M02AA10, ketoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Ketoprofen.]
[V03AC03, deferasirox, The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Dexamethasone acetate can be increased when combined with Abatacept.]
[C01CA22, arbutamine, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Arbutamine.]
[J01MB02, nalidixic acid, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Tiaprofenic acid.]
[N07AA30, ambenonium, The therapeutic efficacy of Ambenonium can be decreased when used in combination with Dexamethasone acetate.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be increased when combined with Dexamethasone acetate.]
[C03CC01, ethacrynic acid, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Etacrynic acid.]
[G03AD01, levonorgestrel, The serum concentration of Dexamethasone acetate can be increased when it is combined with Levonorgestrel.]
[S02DA01, lidocaine, The metabolism of Lidocaine can be increased when combined with Dexamethasone acetate.]
[N06BA13, armodafinil, The metabolism of Dexamethasone acetate can be increased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be increased when combined with Dexamethasone acetate.]
[C10AA02, lovastatin, The metabolism of Dexamethasone acetate can be decreased when combined with Lovastatin.]
[G03DC03, lynestrenol, The serum concentration of Dexamethasone acetate can be increased when it is combined with Lynestrenol.]
[L01EG01, temsirolimus, The serum concentration of Temsirolimus can be decreased when it is combined with Dexamethasone acetate.]
[L01BA05, pralatrexate, Dexamethasone acetate may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Dexamethasone acetate can be decreased when combined with Nilotinib.]
[L01AA05, mechlorethamine, The therapeutic efficacy of Mechlorethamine can be decreased when used in combination with Dexamethasone acetate.]
[M02AA18, meclofenamic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Meclofenamic acid.]
[C01AA08, medigoxin, Dexamethasone acetate may increase the excretion rate of Metildigoxin which could result in a lower serum level and potentially a reduction in efficacy.]
[P01BC02, mefloquine, The therapeutic efficacy of Mefloquine can be decreased when used in combination with Dexamethasone acetate.]
[N05CH01, melatonin, The excretion of Dexamethasone acetate can be decreased when combined with Melatonin.]
[N06DX01, memantine, The therapeutic efficacy of Memantine can be decreased when used in combination with Dexamethasone acetate.]
[N02AB02, meperidine, The metabolism of Meperidine can be increased when combined with Dexamethasone acetate.]
[L02BG01, aminoglutethimide, The therapeutic efficacy of Dexamethasone acetate can be decreased when used in combination with Aminoglutethimide.]
[G03BB01, mesterolone, The risk or severity of edema formation can be increased when Mesterolone is combined with Dexamethasone acetate.]
[N05AX13, paliperidone, The serum concentration of Paliperidone can be decreased when it is combined with Dexamethasone acetate.]
[A10BA02, metformin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Metformin.]
[J05AF05, lamivudine, Dexamethasone acetate may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A14AA04, methenolone, The risk or severity of edema formation can be increased when Metenolone is combined with Dexamethasone acetate.]
[H03BB02, methimazole, The metabolism of Dexamethasone acetate can be decreased when combined with Methimazole.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be increased when combined with Dexamethasone acetate.]
[C03AA08, methyclothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Methyclothiazide.]
[V04CG05, methylene blue, The metabolism of Dexamethasone acetate can be decreased when combined with Methylene blue.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be increased when combined with Dexamethasone acetate.]
[G03EK01, methyltestosterone, The risk or severity of edema formation can be increased when Methyltestosterone is combined with Dexamethasone acetate.]
[N02CA04, methysergide, The metabolism of Methysergide can be increased when combined with Dexamethasone acetate.]
[A03FA01, metoclopramide, The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Dexamethasone acetate.]
[C03BA08, metolazone, Dexamethasone acetate may increase the hypokalemic activities of Metolazone.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be increased when combined with Dexamethasone acetate.]
[S02AA13, miconazole, The metabolism of Dexamethasone acetate can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Aminophenazone.]
[N05CD08, midazolam, The metabolism of Midazolam can be increased when combined with Dexamethasone acetate.]
[G03XB01, mifepristone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Mifepristone.]
[J01AA08, minocycline, The excretion of Dexamethasone acetate can be decreased when combined with Minocycline.]
[L01XX23, mitotane, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Mitotane.]
[L01DB07, mitoxantrone, Dexamethasone acetate may decrease the excretion rate of Mitoxantrone which could result in a higher serum level.]
[C01BD01, amiodarone, The metabolism of Dexamethasone acetate can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be increased when combined with Dexamethasone acetate.]
[L04AB05, certolizumab pegol, The metabolism of Dexamethasone acetate can be increased when combined with Certolizumab pegol.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be decreased when it is combined with Dexamethasone acetate.]
[M03AC03, vecuronium, The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Dexamethasone acetate.]
[G03XC01, raloxifene, Dexamethasone acetate may decrease the excretion rate of Raloxifene which could result in a higher serum level.]
[N03AB05, fosphenytoin, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Fosphenytoin.]
[V03AB15, naloxone, The metabolism of Dexamethasone acetate can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Dexamethasone acetate can be increased when combined with Anakinra.]
[S01XA11, nandrolone, The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Dexamethasone acetate.]
[M02AA12, naproxen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Naproxen.]
[A10BG01, troglitazone, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Troglitazone.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be increased when combined with Dexamethasone acetate.]
[A10BX02, repaglinide, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Repaglinide.]
[S01EB06, neostigmine, The therapeutic efficacy of Neostigmine can be decreased when used in combination with Dexamethasone acetate.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be increased when combined with Dexamethasone acetate.]
[J02AA01, amphotericin B, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Amphotericin B.]
[N06AX23, desvenlafaxine, The metabolism of Dexamethasone acetate can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, Dexamethasone acetate may increase the excretion rate of Telmisartan which could result in a lower serum level and potentially a reduction in efficacy.]
[H05BX02, paricalcitol, The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Dexamethasone acetate.]
[C08CA04, nicardipine, The metabolism of Dexamethasone acetate can be decreased when combined with Nicardipine.]
[C08CA05, nifedipine, Dexamethasone acetate may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA17, niflumic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Niflumic acid.]
[C08CA07, nisoldipine, The metabolism of Nisoldipine can be increased when combined with Dexamethasone acetate.]
[C08CA08, nitrendipine, Dexamethasone acetate may increase the excretion rate of Nitrendipine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XE01, nitrofurantoin, Dexamethasone acetate may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be increased when combined with Dexamethasone acetate.]
[C01CA03, norepinephrine, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Norepinephrine.]
[G03DC02, norethindrone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Norethisterone.]
[S01AE02, norfloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Norfloxacin.]
[G03AC07, norgestrienone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Norgestrienone.]
[N06AA10, nortriptyline, The serum concentration of Nortriptyline can be decreased when it is combined with Dexamethasone acetate.]
[S02AA16, ofloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Ofloxacin.]
[L04AC04, rilonacept, The metabolism of Dexamethasone acetate can be increased when combined with Rilonacept.]
[R03CB03, metaproterenol, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Orciprenaline.]
[C01AC01, ouabain, The excretion of Dexamethasone acetate can be decreased when combined with Ouabain.]
[A14AA08, oxandrolone, The risk or severity of fluid retention can be increased when Dexamethasone acetate is combined with Oxandrolone.]
[J01MB05, oxolinic acid, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Oxolinic acid.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be increased when combined with Dexamethasone acetate.]
[A14AA05, oxymetholone, The risk or severity of fluid retention can be increased when Dexamethasone acetate is combined with Oxymetholone.]
[S01BC02, oxyphenbutazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Oxyphenbutazone.]
[S01AA04, oxytetracycline, The excretion of Dexamethasone acetate can be decreased when combined with Oxytetracycline.]
[V04CH30, 4-aminohippuric acid, The excretion of Dexamethasone acetate can be decreased when combined with Aminohippuric acid.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be decreased when used in combination with Dexamethasone acetate.]
[G03DB06, chlormadinone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Chlormadinone.]
[H02AB05, paramethasone, The metabolism of Dexamethasone acetate can be increased when combined with Paramethasone.]
[J01MA03, pefloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Pefloxacin.]
[S01AA14, penicillin G, The excretion of Dexamethasone acetate can be decreased when combined with Benzylpenicillin.]
[N05CA01, pentobarbital, The metabolism of Dexamethasone acetate can be increased when combined with Pentobarbital.]
[A10BA01, phenformin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Phenformin.]
[B01AA02, phenindione, Dexamethasone acetate may increase the anticoagulant activities of Phenindione.]
[N03AA02, phenobarbital, The metabolism of Dexamethasone acetate can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, Dexamethasone acetate may increase the anticoagulant activities of Phenprocoumon.]
[M02AA01, phenylbutazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Phenylbutazone.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be increased when Dexamethasone acetate is combined with Phenylephrine.]
[R01BA01, phenylpropanolamine, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Phenylpropanolamine.]
[N03AB02, phenytoin, The serum concentration of Dexamethasone acetate can be decreased when it is combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Dexamethasone acetate can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Levofloxacin.]
[V03AB19, physostigmine, The therapeutic efficacy of Physostigmine can be decreased when used in combination with Dexamethasone acetate.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be increased when combined with Dexamethasone acetate.]
[C08CX01, mibefradil, The metabolism of Dexamethasone acetate can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be increased when combined with Dexamethasone acetate.]
[C10AA05, atorvastatin, Dexamethasone acetate may increase the excretion rate of Atorvastatin which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE01, saquinavir, The metabolism of Dexamethasone acetate can be decreased when combined with Saquinavir.]
[S01BC06, piroxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Piroxicam.]
[J01MA11, grepafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone acetate is combined with Grepafloxacin.]
[J05AG02, delavirdine, The metabolism of Dexamethasone acetate can be decreased when combined with Delavirdine.]
[A10BG02, rosiglitazone, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Rosiglitazone.]
[L04AC08, canakinumab, The metabolism of Dexamethasone acetate can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone acetate is combined with Polythiazide.]
[J05AE03, ritonavir, The serum concentration of Dexamethasone acetate can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Saxagliptin.]
[A10AD04, insulin lispro, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Insulin lispro.]
[C10AA08, pitavastatin, Dexamethasone acetate may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be increased when combined with Dexamethasone acetate.]
[C02CA01, prazosin, Dexamethasone acetate may decrease the excretion rate of Prazosin which could result in a higher serum level.]
[P01BA03, primaquine, The metabolism of Dexamethasone acetate can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Dexamethasone acetate can be increased when combined with Primidone.]
[M04AB01, probenecid, The excretion of Dexamethasone acetate can be decreased when combined with Probenecid.]
[C01BA02, procainamide, The therapeutic efficacy of Procainamide can be decreased when used in combination with Dexamethasone acetate.]
[S01HA05, procaine, The therapeutic efficacy of Procaine can be decreased when used in combination with Dexamethasone acetate.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be increased when combined with Dexamethasone acetate.]
[G03DA04, progesterone, The serum concentration of Dexamethasone acetate can be increased when it is combined with Progesterone.]
[L01XH02, romidepsin, The serum concentration of Romidepsin can be decreased when it is combined with Dexamethasone acetate.]
[C07AA05, propranolol, The metabolism of Propranolol can be increased when combined with Dexamethasone acetate.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be increased when combined with Dexamethasone acetate.]
[P02CC01, pyrantel, The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Dexamethasone acetate.]
[N07AA02, pyridostigmine, The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Dexamethasone acetate.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be increased when combined with Dexamethasone acetate.]
[C01BA01, quinidine, The serum concentration of Quinidine can be decreased when it is combined with Dexamethasone acetate.]
[P01BC01, quinine, The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Quinine.]
[C02AA02, reserpine, The metabolism of Dexamethasone acetate can be increased when combined with Reserpine.]
[J04AB02, rifampin, The metabolism of Dexamethasone acetate can be increased when combined with Rifampicin.]
[G02CA01, ritodrine, The risk or severity of hypokalemia can be increased when Dexamethasone acetate is combined with Ritodrine.]
[N02BA05, salicylamide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone acetate is combined with Salicylic acid.]
[L01CD04, cabazitaxel, The serum concentration of Cabazitaxel can be decreased when it is combined with Dexamethasone acetate.]
[C03DA01, spironolactone, Dexamethasone acetate may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AG01, valproic acid, The excretion of Dexamethasone acetate can be decreased when combined with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be increased when combined with Dexamethasone acetate.]
[A05AA02, ursodiol, Dexamethasone acetate may increase the excretion rate of Ursodeoxycholic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[P02BB01, trichlorfon, The therapeutic efficacy of Metrifonate can be decreased when used in combination with Dexamethasone.]
[S02DA03, antipyrine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Antipyrine.]
[A14AA02, stanozolol, The risk or severity of fluid retention can be increased when Dexamethasone is combined with Stanozolol.]
[G03XB02, ulipristal, The metabolism of Ulipristal can be increased when combined with Dexamethasone.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Dexamethasone.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Dexamethasone.]
[L04AA27, fingolimod, Dexamethasone may increase the immunosuppressive activities of Fingolimod.]
[M03AB01, succinylcholine, The risk or severity of myopathy and weakness can be increased when Succinylcholine is combined with Dexamethasone.]
[J01EC02, sulfadiazine, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Sulfadiazine.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Dexamethasone.]
[M04AB02, sulfinpyrazone, The metabolism of Sulfinpyrazone can be increased when combined with Dexamethasone.]
[S01AB02, sulfisoxazole, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Sulfisoxazole.]
[M01AB02, sulindac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Sulindac.]
[N05AL01, sulpiride, The therapeutic efficacy of Sulpiride can be decreased when used in combination with Dexamethasone.]
[A10BB04, glibornuride, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Glibornuride.]
[A10BC01, glymidine, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Glymidine.]
[M01AX04, apazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Azapropazone.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Dexamethasone.]
[N06DA01, tacrine, The therapeutic efficacy of Tacrine can be decreased when used in combination with Dexamethasone.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be increased when combined with Dexamethasone.]
[L01CB02, teniposide, The metabolism of Teniposide can be increased when combined with Dexamethasone.]
[R03CC03, terbutaline, The therapeutic efficacy of Terbutaline can be decreased when used in combination with Dexamethasone.]
[G03BA03, testosterone, The risk or severity of edema formation can be increased when Testosterone is combined with Dexamethasone.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Tetracaine.]
[S03AA02, tetracycline, The metabolism of Tetracycline can be increased when combined with Dexamethasone.]
[N05AE05, lurasidone, The metabolism of Lurasidone can be increased when combined with Dexamethasone.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Dexamethasone.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be increased when combined with Dexamethasone.]
[L04AX02, thalidomide, The risk or severity of thromboembolism can be increased when Dexamethasone is combined with Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be increased when combined with Dexamethasone.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Eribulin.]
[L01AC01, thiotepa, The therapeutic efficacy of Thiotepa can be decreased when used in combination with Dexamethasone.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Dexamethasone.]
[N05CA19, thiopental, The metabolism of Thiopental can be increased when combined with Dexamethasone.]
[B02AB01, aprotinin, The therapeutic efficacy of Aprotinin can be decreased when used in combination with Dexamethasone.]
[P01AB02, tinidazole, The metabolism of Tinidazole can be increased when combined with Dexamethasone.]
[A10BB05, tolazamide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Tolazamide.]
[V04CA01, tolbutamide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Tolbutamide.]
[M02AA21, tolmetin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Tolmetin.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Dexamethasone.]
[N06AX05, trazodone, The serum concentration of Trazodone can be decreased when it is combined with Dexamethasone.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Dexamethasone.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Triamcinolone is combined with Dexamethasone.]
[N05CD05, triazolam, The metabolism of Triazolam can be increased when combined with Dexamethasone.]
[C03AA06, trichlormethiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Trichlormethiazide.]
[S01EB04, demecarium, The therapeutic efficacy of Demecarium can be decreased when used in combination with Dexamethasone.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Dexamethasone.]
[N05AA05, triflupromazine, The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Dexamethasone.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Fluclorolone.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Mometasone is combined with Dexamethasone.]
[A03AA05, trimebutine, The metabolism of Trimebutine can be increased when combined with Dexamethasone.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be increased when combined with Dexamethasone.]
[J01EA01, trimethoprim, The metabolism of Trimethoprim can be increased when combined with Dexamethasone.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be increased when combined with Dexamethasone.]
[J01FA08, troleandomycin, The metabolism of Dexamethasone can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be increased when combined with Dexamethasone.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be decreased when used in combination with Dexamethasone.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Dexamethasone.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Belimumab.]
[S01AA05, tyrothricin, The therapeutic efficacy of Tyrothricin can be decreased when used in combination with Dexamethasone.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be increased when combined with Dexamethasone.]
[L02BX03, abiraterone, The metabolism of Abiraterone can be increased when combined with Dexamethasone.]
[A10BH05, linagliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Dexamethasone can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Dexamethasone can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be decreased when it is combined with Dexamethasone.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Belatacept.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be increased when combined with Dexamethasone.]
[R03AC18, indacaterol, The metabolism of Indacaterol can be increased when combined with Dexamethasone.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be increased when combined with Dexamethasone.]
[C08DA01, verapamil, The metabolism of Verapamil can be increased when combined with Dexamethasone.]
[N06AX09, viloxazine, The metabolism of Dexamethasone can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be increased when combined with Dexamethasone.]
[L01CA02, vincristine, The metabolism of Vincristine can be increased when combined with Dexamethasone.]
[L01CA03, vindesine, The metabolism of Vindesine can be increased when combined with Dexamethasone.]
[A11HA03, vitamin E, The metabolism of Vitamin E can be increased when combined with Dexamethasone.]
[B01AA03, warfarin, Dexamethasone may increase the anticoagulant activities of Warfarin.]
[J05AF01, zidovudine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Dexamethasone.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be increased when combined with Dexamethasone.]
[J05AE02, indinavir, The metabolism of Dexamethasone can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be increased when combined with Dexamethasone.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Dexamethasone.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be increased when combined with Dexamethasone.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be increased when combined with Dexamethasone.]
[H05BX03, doxercalciferol, The therapeutic efficacy of Doxercalciferol can be decreased when used in combination with Dexamethasone.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ibandronate is combined with Dexamethasone.]
[J01MA13, trovafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Trovafloxacin.]
[L01XX02, asparaginase, The serum concentration of Dexamethasone can be increased when it is combined with Asparaginase Escherichia coli.]
[N05AE04, ziprasidone, The metabolism of Ziprasidone can be increased when combined with Dexamethasone.]
[G03AC10, drospirenone, The serum concentration of Dexamethasone can be increased when it is combined with Drospirenone.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Dexamethasone.]
[N02BA01, aspirin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be increased when combined with Dexamethasone.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be increased when combined with Dexamethasone.]
[C07AB03, atenolol, Dexamethasone may increase the excretion rate of Atenolol which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dexamethasone.]
[A11CC03, alfacalcidol, The therapeutic efficacy of Alfacalcidol can be decreased when used in combination with Dexamethasone.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Dexamethasone.]
[J02AC03, voriconazole, The serum concentration of Dexamethasone can be increased when it is combined with Voriconazole.]
[M03AC04, atracurium, The risk or severity of myopathy and weakness can be increased when Atracurium is combined with Dexamethasone.]
[S01FA01, atropine, Dexamethasone may increase the excretion rate of Atropine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be increased when combined with Dexamethasone.]
[L01EK01, axitinib, The metabolism of Axitinib can be increased when combined with Dexamethasone.]
[R07AX02, ivacaftor, The serum concentration of Ivacaftor can be decreased when it is combined with Dexamethasone.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Prednylidene.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Dexamethasone.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Azacitidine is combined with Dexamethasone.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Azathioprine is combined with Dexamethasone.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dexamethasone.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Dexamethasone.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Dexamethasone.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Dexamethasone.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dexamethasone.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be increased when combined with Dexamethasone.]
[G04BD12, mirabegron, The metabolism of Mirabegron can be increased when combined with Dexamethasone.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Carfilzomib.]
[V03AX03, cobicistat, The serum concentration of Cobicistat can be decreased when it is combined with Dexamethasone.]
[J05AJ02, elvitegravir, The serum concentration of Elvitegravir can be decreased when it is combined with Dexamethasone.]
[L02BB04, enzalutamide, The serum concentration of Dexamethasone can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be increased when combined with Dexamethasone.]
[L04AA31, teriflunomide, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Teriflunomide.]
[A02AA05, magnesium silicate, The bioavailability of Dexamethasone can be decreased when combined with Magnesium silicate.]
[A02AC02, calcium silicate, The bioavailability of Dexamethasone can be decreased when combined with Calcium silicate.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Abetimus.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Aldosterone.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be increased when combined with Dexamethasone.]
[C01AA01, acetyldigitoxin, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Acetyldigitoxin.]
[J05AE04, nelfinavir, The metabolism of Dexamethasone can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Bendamustine.]
[C08CA13, lercanidipine, The metabolism of Lercanidipine can be increased when combined with Dexamethasone.]
[N06DA02, donepezil, The therapeutic efficacy of Donepezil can be decreased when used in combination with Dexamethasone.]
[N03AX22, perampanel, The metabolism of Perampanel can be increased when combined with Dexamethasone.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Dexamethasone.]
[G04BD10, darifenacin, The metabolism of Darifenacin can be increased when combined with Dexamethasone.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be increased when combined with Dexamethasone.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be increased when combined with Dexamethasone.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be increased when combined with Dexamethasone.]
[B01AF02, apixaban, The metabolism of Apixaban can be increased when combined with Dexamethasone.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Dexamethasone.]
[J04AK05, bedaquiline, The metabolism of Bedaquiline can be increased when combined with Dexamethasone.]
[C04AX11, bencyclane, The metabolism of Bencyclane can be increased when combined with Dexamethasone.]
[A10BH04, alogliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Alogliptin.]
[A16AX09, glycerol phenylbutyrate, The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Dexamethasone.]
[C03AA01, bendroflumethiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Bendroflumethiazide.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be increased when combined with Dexamethasone.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be increased when combined with Dexamethasone.]
[N02BA10, benorilate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Benorilate.]
[A10BK02, canagliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Canagliflozin.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Dimethyl fumarate.]
[J01MA15, gemifloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Gemifloxacin.]
[M04AB03, benzbromarone, Dexamethasone may increase the excretion rate of Benzbromarone which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AE07, moxifloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Moxifloxacin.]
[A06AX06, tegaserod, Dexamethasone may decrease the excretion rate of Tegaserod which could result in a higher serum level.]
[A10AE05, insulin detemir, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin detemir.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Benzocaine.]
[A10BX05, pramlintide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Pramlintide.]
[M01AH01, celecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Celecoxib.]
[L04AA18, everolimus, The metabolism of Everolimus can be increased when combined with Dexamethasone.]
[L01EC02, dabrafenib, The serum concentration of Dexamethasone can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Benzydamine.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Benzyl alcohol.]
[L01EB03, afatinib, Dexamethasone may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be increased when combined with Dexamethasone.]
[J05AJ03, dolutegravir, The excretion of Dexamethasone can be decreased when combined with Dolutegravir.]
[C08EA02, bepridil, The metabolism of Bepridil can be increased when combined with Dexamethasone.]
[C02KX05, riociguat, The metabolism of Riociguat can be increased when combined with Dexamethasone.]
[A10BJ03, lixisenatide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Lixisenatide.]
[A05AA03, cholic acid, The excretion of Dexamethasone can be decreased when combined with Cholic Acid.]
[C02KX04, macitentan, The metabolism of Macitentan can be increased when combined with Dexamethasone.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Dexamethasone.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be increased when combined with Dexamethasone.]
[G03AC08, etonogestrel, The serum concentration of Dexamethasone can be increased when it is combined with Etonogestrel.]
[J05AP05, simeprevir, The metabolism of Simeprevir can be increased when combined with Dexamethasone.]
[J05AP08, sofosbuvir, Dexamethasone may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Dapagliflozin.]
[C01CA27, droxidopa, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Droxidopa.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be increased when combined with Dexamethasone.]
[A16AA07, metreleptin, The metabolism of Dexamethasone can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Dexamethasone can be increased when combined with Apremilast.]
[L02BG02, formestane, The risk or severity of edema formation can be increased when Formestane is combined with Dexamethasone.]
[A16AA06, betaine, The therapeutic efficacy of Betaine can be decreased when used in combination with Dexamethasone.]
[S03BA03, betamethasone, The risk or severity of adverse effects can be increased when Betamethasone is combined with Dexamethasone.]
[C10AB02, bezafibrate, The metabolism of Bezafibrate can be increased when combined with Dexamethasone.]
[A10BJ04, albiglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Albiglutide.]
[L04AC11, siltuximab, The metabolism of Dexamethasone can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Ceritinib.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be increased when combined with Dexamethasone.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Vedolizumab.]
[B01AA07, acenocoumarol, Dexamethasone may increase the anticoagulant activities of Acenocoumarol.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Belinostat.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be increased when combined with Dexamethasone.]
[N07XX08, tafamidis, The excretion of Dexamethasone can be decreased when combined with Tafamidis.]
[A10BK03, empagliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Empagliflozin.]
[R03AC19, olodaterol, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Olodaterol.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Peginterferon beta-1a.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be increased when combined with Dexamethasone.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Dexamethasone.]
[V04CX03, methacholine, Dexamethasone may decrease effectiveness of Methacholine as a diagnostic agent.]
[A10BJ05, dulaglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Dulaglutide.]
[A06AH03, naloxegol, The metabolism of Naloxegol can be increased when combined with Dexamethasone.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Decitabine.]
[A11HA08, tocophersolan, The metabolism of Tocofersolan can be increased when combined with Dexamethasone.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Pirfenidone.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be increased when combined with Dexamethasone.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Blinatumomab.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be increased when combined with Dexamethasone.]
[L01XK01, olaparib, The metabolism of Olaparib can be increased when combined with Dexamethasone.]
[B01AA01, dicumarol, Dexamethasone may increase the anticoagulant activities of Dicoumarol.]
[N06AX11, mirtazapine, The metabolism of Mirtazapine can be increased when combined with Dexamethasone.]
[L04AC10, secukinumab, The metabolism of Dexamethasone can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be increased when combined with Dexamethasone.]
[L01EX08, lenvatinib, The excretion of Dexamethasone can be decreased when combined with Lenvatinib.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be increased when combined with Dexamethasone.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be increased when combined with Dexamethasone.]
[N02BE01, acetaminophen, Dexamethasone may increase the hepatotoxic activities of Acetaminophen.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Dexamethasone.]
[B01AA11, tioclomarol, Dexamethasone may increase the anticoagulant activities of Tioclomarol.]
[C01EB17, ivabradine, The metabolism of Ivabradine can be increased when combined with Dexamethasone.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be increased when combined with Dexamethasone.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be increased when combined with Dexamethasone.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be increased when combined with Dexamethasone.]
[A04AD14, rolapitant, The metabolism of Rolapitant can be increased when combined with Dexamethasone.]
[G02CX02, flibanserin, The metabolism of Flibanserin can be increased when combined with Dexamethasone.]
[A06AD03, magnesium peroxide, The bioavailability of Dexamethasone can be decreased when combined with Magnesium peroxide.]
[N05AX15, cariprazine, The metabolism of Cariprazine can be increased when combined with Dexamethasone.]
[A10BF01, acarbose, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Acarbose.]
[M02AA25, aceclofenac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Acemetacin.]
[A10AE06, insulin degludec, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin degludec.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Acipimox.]
[A02BC03, lansoprazole, The metabolism of Lansoprazole can be increased when combined with Dexamethasone.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be increased when combined with Dexamethasone.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Mepolizumab.]
[J02AC05, isavuconazole, The metabolism of Isavuconazole can be increased when combined with Dexamethasone.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be increased when combined with Dexamethasone.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Dexamethasone.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be decreased when it is combined with Dexamethasone.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be increased when combined with Dexamethasone.]
[L01ED03, alectinib, The metabolism of Alectinib can be increased when combined with Dexamethasone.]
[B01AC27, selexipag, The metabolism of Selexipag can be increased when combined with Dexamethasone.]
[A10BB31, acetohexamide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Acetohexamide.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be decreased when combined with Dexamethasone.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be increased when combined with Dexamethasone.]
[J05AP11, grazoprevir, The metabolism of Grazoprevir can be increased when combined with Dexamethasone.]
[M01AE16, alminoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Alminoprofen.]
[A02AB06, aloglutamol, The bioavailability of Dexamethasone can be decreased when combined with Aloglutamol.]
[N02BA02, aloxiprin, The serum concentration of Aloxiprin can be decreased when it is combined with Dexamethasone.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be increased when combined with Dexamethasone.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ixekizumab.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be increased when combined with Dexamethasone.]
[N04BC01, bromocriptine, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Bromocriptine.]
[A02AD05, aluminum magnesium silicate, The bioavailability of Dexamethasone can be decreased when combined with Almasilate.]
[A02AB03, aluminum phosphate, The bioavailability of Dexamethasone can be decreased when combined with Aluminium phosphate.]
[R06AB01, brompheniramine, The metabolism of Brompheniramine can be increased when combined with Dexamethasone.]
[C08CA01, amlodipine, The metabolism of Amlodipine can be increased when combined with Dexamethasone.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be increased when combined with Dexamethasone.]
[C03CA02, bumetanide, The excretion of Dexamethasone can be decreased when combined with Bumetanide.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Bupivacaine.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be increased when combined with Dexamethasone.]
[N05BE01, buspirone, The metabolism of Buspirone can be increased when combined with Dexamethasone.]
[L01AB01, busulfan, The metabolism of Busulfan can be increased when combined with Dexamethasone.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Dexamethasone.]
[N06DA03, rivastigmine, The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Dexamethasone.]
[P01BE02, artemether, The metabolism of Artemether can be increased when combined with Dexamethasone.]
[J01MA09, sparfloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Sparfloxacin.]
[S01GX07, azelastine, The metabolism of Azelastine can be increased when combined with Dexamethasone.]
[L01XK03, rucaparib, The metabolism of Rucaparib can be increased when combined with Dexamethasone.]
[S01AA26, azithromycin, The serum concentration of Dexamethasone can be increased when it is combined with Azithromycin.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Brodalumab.]
[L01EF02, ribociclib, The metabolism of Dexamethasone can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Balsalazide.]
[R03CC12, bambuterol, The therapeutic efficacy of Bambuterol can be decreased when used in combination with Dexamethasone.]
[L04AA36, ocrelizumab, Ocrelizumab may increase the immunosuppressive activities of Dexamethasone.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be increased when combined with Dexamethasone.]
[A10BX06, benfluorex, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Benfluorex.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Oxybuprocaine.]
[H05BX05, calcifediol, The therapeutic efficacy of Calcifediol can be decreased when used in combination with Dexamethasone.]
[D05AX03, calcitriol, The therapeutic efficacy of Calcitriol can be decreased when used in combination with Dexamethasone.]
[A12AA04, calcium carbonate, The bioavailability of Dexamethasone can be decreased when combined with Calcium carbonate.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Dexamethasone.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Linezolid is combined with Dexamethasone.]
[J05AE09, tipranavir, The metabolism of Dexamethasone can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be increased when combined with Dexamethasone.]
[L04AB02, infliximab, The metabolism of Dexamethasone can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Dexamethasone can be decreased when combined with Midostaurin.]
[L01FF03, durvalumab, The therapeutic efficacy of Durvalumab can be decreased when used in combination with Dexamethasone.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be increased when combined with Dexamethasone.]
[N04BD03, safinamide, The metabolism of Safinamide can be increased when combined with Dexamethasone.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Sarilumab.]
[J01MA23, delafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Delafloxacin.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Guselkumab.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Capecitabine is combined with Dexamethasone.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be increased when combined with Dexamethasone.]
[L01EH02, neratinib, The metabolism of Neratinib can be increased when combined with Dexamethasone.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Vorinostat.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be increased when combined with Dexamethasone.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be increased when combined with Dexamethasone.]
[C07AB07, bisoprolol, The metabolism of Bisoprolol can be increased when combined with Dexamethasone.]
[R03AC17, bitolterol, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Bitolterol.]
[J05AG03, efavirenz, The metabolism of Dexamethasone can be decreased when combined with Efavirenz.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Dexamethasone.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Dexamethasone.]
[N05CD09, brotizolam, The metabolism of Brotizolam can be increased when combined with Dexamethasone.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Budesonide is combined with Dexamethasone.]
[M01AB07, bumadizone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be increased when combined with Dexamethasone.]
[J05AX18, letermovir, The excretion of Dexamethasone can be decreased when combined with Letermovir.]
[C01AA02, acetyldigoxins, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Acetyldigoxin.]
[A10BJ06, semaglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Semaglutide.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Capsaicin.]
[A10BK04, ertugliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Ertugliflozin.]
[C09AA01, captopril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Dexamethasone.]
[V04CD06, macimorelin, The metabolism of Macimorelin can be increased when combined with Dexamethasone.]
[L02BB05, apalutamide, The metabolism of Apalutamide can be increased when combined with Dexamethasone.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be increased when combined with Dexamethasone.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Dexamethasone.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dexamethasone.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be increased when combined with Dexamethasone.]
[B02BX09, fostamatinib, The metabolism of Fostamatinib can be increased when combined with Dexamethasone.]
[N03AX24, cannabidiol, The metabolism of Cannabidiol can be increased when combined with Dexamethasone.]
[B02BX08, avatrombopag, The excretion of Dexamethasone can be decreased when combined with Avatrombopag.]
[L04AA37, baricitinib, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Baricitinib.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be increased when combined with Dexamethasone.]
[J01DD14, ceftibuten, The excretion of Dexamethasone can be decreased when combined with Ceftibuten.]
[C07AB08, celiprolol, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Celiprolol.]
[H01CC03, elagolix, The metabolism of Elagolix can be increased when combined with Dexamethasone.]
[L01XX62, ivosidenib, The metabolism of Ivosidenib can be increased when combined with Dexamethasone.]
[N03AX17, stiripentol, The metabolism of Dexamethasone can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, Dexamethasone may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.]
[J05AG06, doravirine, The metabolism of Doravirine can be increased when combined with Dexamethasone.]
[J01AA13, eravacycline, The metabolism of Eravacycline can be increased when combined with Dexamethasone.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be increased when combined with Dexamethasone.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be increased when combined with Dexamethasone.]
[A10BB06, carbutamide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Carbutamide.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Chloroprocaine.]
[M01AC05, lornoxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Lornoxicam.]
[L01XK04, talazoparib, Dexamethasone may decrease the excretion rate of Talazoparib which could result in a higher serum level.]
[R03BB08, revefenacin, Dexamethasone may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be increased when combined with Dexamethasone.]
[L04AA39, emapalumab, The metabolism of Dexamethasone can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Dexamethasone.]
[L01EX12, larotrectinib, The metabolism of Larotrectinib can be increased when combined with Dexamethasone.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be increased when combined with Dexamethasone.]
[L01XJ03, glasdegib, The metabolism of Glasdegib can be increased when combined with Dexamethasone.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ravulizumab.]
[A06AX05, prucalopride, The metabolism of Prucalopride can be decreased when combined with Dexamethasone.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Dexamethasone.]
[C10AB08, ciprofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Ciprofibrate.]
[P02BX04, triclabendazole, The metabolism of Triclabendazole can be increased when combined with Dexamethasone.]
[N06AX27, esketamine, The metabolism of Esketamine can be increased when combined with Dexamethasone.]
[L04AA42, siponimod, The therapeutic efficacy of Siponimod can be decreased when used in combination with Dexamethasone.]
[J01FA09, clarithromycin, The metabolism of Dexamethasone can be decreased when combined with Clarithromycin.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be increased when combined with Dexamethasone.]
[N05BA09, clobazam, The metabolism of Clobazam can be increased when combined with Dexamethasone.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Cloprednol.]
[C01EB09, ubidecarenone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Ubidecarenone.]
[L04AB01, etanercept, The metabolism of Dexamethasone can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Risankizumab.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be decreased when it is combined with Dexamethasone.]
[L01FX14, polatuzumab vedotin, The risk or severity of adverse effects can be decreased when Dexamethasone is combined with Polatuzumab vedotin.]
[J01DC04, cefaclor, The excretion of Dexamethasone can be decreased when combined with Cefaclor.]
[J01DB05, cefadroxil, The excretion of Dexamethasone can be decreased when combined with Cefadroxil.]
[J01DC03, cefamandole, The excretion of Dexamethasone can be decreased when combined with Cefamandole.]
[L01XX66, selinexor, The metabolism of Selinexor can be increased when combined with Dexamethasone.]
[J01DB04, cefazolin, The excretion of Dexamethasone can be decreased when combined with Cefazolin.]
[L02BB06, darolutamide, The serum concentration of Darolutamide can be decreased when it is combined with Dexamethasone.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be increased when combined with Dexamethasone.]
[J01DD12, cefoperazone, The excretion of Dexamethasone can be decreased when combined with Cefoperazone.]
[J01DD01, cefotaxime, The excretion of Dexamethasone can be decreased when combined with Cefotaxime.]
[J01DC07, cefotiam, The excretion of Dexamethasone can be decreased when combined with Cefotiam.]
[J01DD07, ceftizoxime, The excretion of Dexamethasone can be decreased when combined with Ceftizoxime.]
[J01DD04, ceftriaxone, The excretion of Dexamethasone can be decreased when combined with Ceftriaxone.]
[M03BX08, cyclobenzaprine, The metabolism of Cyclobenzaprine can be increased when combined with Dexamethasone.]
[L04AA44, upadacitinib, The metabolism of Upadacitinib can be increased when combined with Dexamethasone.]
[L01EJ02, fedratinib, The metabolism of Fedratinib can be increased when combined with Dexamethasone.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be increased when combined with Dexamethasone.]
[N07XX11, pitolisant, The metabolism of Pitolisant can be increased when combined with Dexamethasone.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be increased when combined with Dexamethasone.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be increased when combined with Dexamethasone.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be increased when combined with Dexamethasone.]
[C03AA09, cyclothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Cyclothiazide.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be increased when combined with Dexamethasone.]
[A10AE03, insulin, regular, pork, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin pork.]
[J01XX09, daptomycin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Dexamethasone.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be increased when combined with Dexamethasone.]
[J01DB02, cephaloridine, The excretion of Dexamethasone can be decreased when combined with Cefaloridine.]
[J01DB03, cephalothin, The excretion of Dexamethasone can be decreased when combined with Cefalotin.]
[H02AB13, deflazacort, The serum concentration of Deflazacort can be decreased when it is combined with Dexamethasone.]
[G03DB05, demegestone, The serum concentration of Dexamethasone can be increased when it is combined with Demegestone.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Dexamethasone.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be increased when combined with Dexamethasone.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Diroximel fumarate.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be increased when combined with Dexamethasone.]
[G03AC09, desogestrel, The serum concentration of Dexamethasone can be increased when it is combined with Desogestrel.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be increased when it is combined with Dexamethasone.]
[N03AX25, cenobamate, The serum concentration of Dexamethasone can be decreased when it is combined with Cenobamate.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be decreased when it is combined with Dexamethasone.]
[L01FX13, enfortumab vedotin, The metabolism of Enfortumab vedotin can be increased when combined with Dexamethasone.]
[S01XA12, dexpanthenol, The therapeutic efficacy of Dexpanthenol can be decreased when used in combination with Dexamethasone.]
[L01EX18, avapritinib, The metabolism of Avapritinib can be increased when combined with Dexamethasone.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be decreased when it is combined with Dexamethasone.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be increased when combined with Dexamethasone.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Teprotumumab.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be decreased when it is combined with Dexamethasone.]
[N02CD06, rimegepant, The metabolism of Rimegepant can be increased when combined with Dexamethasone.]
[S01AE06, gatifloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Gatifloxacin.]
[H02CA02, osilodrostat, The serum concentration of Osilodrostat can be decreased when it is combined with Dexamethasone.]
[J05AE05, amprenavir, The metabolism of Dexamethasone can be decreased when combined with Amprenavir.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be increased when combined with Dexamethasone.]
[L04AA38, ozanimod, Dexamethasone may decrease the excretion rate of Ozanimod which could result in a higher serum level.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be decreased when it is combined with Dexamethasone.]
[G03DB08, dienogest, The metabolism of Dienogest can be increased when combined with Dexamethasone.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be increased when combined with Dexamethasone.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be increased when combined with Dexamethasone.]
[M01AH02, rofecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Rofecoxib.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Bexarotene is combined with Dexamethasone.]
[C08CA16, clevidipine, The metabolism of Clevidipine can be increased when combined with Dexamethasone.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be increased when combined with Dexamethasone.]
[J01FA13, dirithromycin, The serum concentration of Dexamethasone can be increased when it is combined with Dirithromycin.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Dexamethasone.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Dexamethasone.]
[L01EN02, pemigatinib, The metabolism of Pemigatinib can be increased when combined with Dexamethasone.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be increased when combined with Dexamethasone.]
[L01EX17, capmatinib, The serum concentration of Capmatinib can be decreased when it is combined with Dexamethasone.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Fluprednidene.]
[P01BE01, artemisinin, The metabolism of Artemisinin can be increased when combined with Dexamethasone.]
[M01AC04, droxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Droxicam.]
[L01EX19, ripretinib, The serum concentration of Ripretinib can be decreased when it is combined with Dexamethasone.]
[L01EX22, selpercatinib, The serum concentration of Selpercatinib can be decreased when it is combined with Dexamethasone.]
[M02AA27, dexketoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Dexketoprofen.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be increased when combined with Dexamethasone.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Dexamethasone is combined with Inebilizumab.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Dyclonine.]
[L01XX69, lurbinectedin, The serum concentration of Lurbinectedin can be decreased when it is combined with Dexamethasone.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Stepronin.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Dexamethasone.]
[R06AX22, ebastine, The metabolism of Ebastine can be increased when combined with Dexamethasone.]
[J05AX29, fostemsavir, The serum concentration of Fostemsavir can be decreased when it is combined with Dexamethasone.]
[L01FX15, belantamab mafodotin, Dexamethasone may increase the excretion rate of Belantamab mafodotin which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AC19, satralizumab, The serum concentration of Dexamethasone can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be decreased when it is combined with Dexamethasone.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be increased when combined with Dexamethasone.]
[L01EX23, pralsetinib, The serum concentration of Pralsetinib can be decreased when it is combined with Dexamethasone.]
[C03AA04, chlorothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Chlorothiazide.]
[G03CA06, chlorotrianisene, The serum concentration of Dexamethasone can be increased when it is combined with Chlorotrianisene.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be increased when combined with Dexamethasone.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Dexamethasone.]
[A10BB02, chlorpropamide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Chlorpropamide.]
[C03BA04, chlorthalidone, Dexamethasone may increase the hypokalemic activities of Chlorthalidone.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be increased when combined with Dexamethasone.]
[A11CC05, cholecalciferol, The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Dexamethasone.]
[N02BA07, ethenzamide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Ethenzamide.]
[C10AC01, cholestyramine resin, Cholestyramine may increase the excretion rate of Dexamethasone which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA03, choline salicylate, The serum concentration of Choline salicylate can be decreased when it is combined with Dexamethasone.]
[N06BX18, vinpocetine, The metabolism of Vinpocetine can be increased when combined with Dexamethasone.]
[G03DC06, ethynodiol, The serum concentration of Dexamethasone can be increased when it is combined with Etynodiol.]
[M01AB08, etodolac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Etofenamate.]
[C10AB09, etofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Etofibrate.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Dexamethasone.]
[A16AX20, lonafarnib, The metabolism of Dexamethasone can be decreased when combined with Lonafarnib.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Fludarabine is combined with Dexamethasone.]
[L02BX04, relugolix, The serum concentration of Relugolix can be decreased when it is combined with Dexamethasone.]
[J05AJ04, cabotegravir, The excretion of Dexamethasone can be decreased when combined with Cabotegravir.]
[L04AD03, voclosporin, The metabolism of Voclosporin can be increased when combined with Dexamethasone.]
[P03AX07, abametapir, The serum concentration of Dexamethasone can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The serum concentration of Tepotinib can be decreased when it is combined with Dexamethasone.]
[V03AF12, trilaciclib, Dexamethasone may decrease the excretion rate of Trilaciclib which could result in a higher serum level.]
[N03AX10, felbamate, The metabolism of Felbamate can be increased when combined with Dexamethasone.]
[M01AE05, fenbufen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Fenbufen.]
[G04CB01, finasteride, The metabolism of Finasteride can be increased when combined with Dexamethasone.]
[J01MB07, flumequine, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Flumequine.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Dexamethasone.]
[S01JA01, fluorescein, Dexamethasone may increase the excretion rate of Fluorescein which could result in a lower serum level and potentially a reduction in efficacy.]
[R03CC15, formoterol, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Formoterol.]
[A10AF01, insulin, regular, human, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin human.]
[L04AA50, ponesimod, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ponesimod.]
[L01EK03, tivozanib, The metabolism of Tivozanib can be increased when combined with Dexamethasone.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dexamethasone.]
[A02BA01, cimetidine, The excretion of Dexamethasone can be decreased when combined with Cimetidine.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be increased when combined with Dexamethasone.]
[J01MB06, cinoxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Sotorasib can be decreased when it is combined with Dexamethasone.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be increased when combined with Dexamethasone.]
[S03AA07, ciprofloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Ciprofloxacin.]
[L01XA01, cisplatin, The therapeutic efficacy of Cisplatin can be decreased when used in combination with Dexamethasone.]
[N06AB04, citalopram, The metabolism of Citalopram can be increased when combined with Dexamethasone.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Pegcetacoplan.]
[J02AX07, ibrexafungerp, The serum concentration of Ibrexafungerp can be decreased when it is combined with Dexamethasone.]
[C03DA05, finerenone, The therapeutic efficacy of Finerenone can be decreased when used in combination with Dexamethasone.]
[L04AA48, belumosudil, The serum concentration of Belumosudil can be decreased when it is combined with Dexamethasone.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be increased when combined with Dexamethasone.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Anifrolumab.]
[L01EB10, mobocertinib, The serum concentration of Mobocertinib can be decreased when it is combined with Dexamethasone.]
[L01FX23, tisotumab vedotin, The metabolism of Tisotumab vedotin can be increased when combined with Dexamethasone.]
[N02CD07, atogepant, The serum concentration of Atogepant can be decreased when it is combined with Dexamethasone.]
[L04AA59, avacopan, The metabolism of Avacopan can be increased when combined with Dexamethasone.]
[A10BB12, glimepiride, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Gliquidone.]
[R03CC13, clenbuterol, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Clenbuterol.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be increased when combined with Dexamethasone.]
[N06AX25, St. John's wort extract, The metabolism of St. John's Wort can be increased when combined with Dexamethasone.]
[L01EA06, asciminib, The metabolism of Asciminib can be increased when combined with Dexamethasone.]
[L02BG06, exemestane, The metabolism of Exemestane can be increased when combined with Dexamethasone.]
[J05AX10, maribavir, The serum concentration of Maribavir can be decreased when it is combined with Dexamethasone.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ropeginterferon alfa-2b.]
[J04BA01, clofazimine, The metabolism of Dexamethasone can be decreased when combined with Clofazimine.]
[C10AB01, clofibrate, The metabolism of Clofibrate can be increased when combined with Dexamethasone.]
[B06AX04, mitapivat, The metabolism of Mitapivat can be increased when combined with Dexamethasone.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Pacritinib can be decreased when it is combined with Dexamethasone.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be increased when combined with Dexamethasone.]
[N03AE01, clonazepam, The metabolism of Clonazepam can be increased when combined with Dexamethasone.]
[S01EA04, clonidine, The metabolism of Clonidine can be increased when combined with Dexamethasone.]
[C01EB24, mavacamten, The serum concentration of Mavacamten can be decreased when it is combined with Dexamethasone.]
[A10BX16, tirzepatide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Tirzepatide.]
[A02BC08, vonoprazan, The therapeutic efficacy of Vonoprazan can be decreased when used in combination with Dexamethasone.]
[N03AX27, ganaxolone, The metabolism of Ganaxolone can be increased when combined with Dexamethasone.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Deucravacitinib.]
[A05BA08, glycyrrhizic acid, Dexamethasone may increase the excretion rate of Glycyrrhizic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA21, clotiazepam, The metabolism of Clotiazepam can be increased when combined with Dexamethasone.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be increased when combined with Dexamethasone.]
[A04AA02, granisetron, The metabolism of Granisetron can be increased when combined with Dexamethasone.]
[J05AX31, lenacapavir, The metabolism of Lenacapavir can be increased when combined with Dexamethasone.]
[L01XX77, adagrasib, The serum concentration of Adagrasib can be decreased when it is combined with Dexamethasone.]
[N05AH02, clozapine, The metabolism of Clozapine can be increased when combined with Dexamethasone.]
[L01EN04, futibatinib, The metabolism of Futibatinib can be increased when combined with Dexamethasone.]
[A10BX01, guar gum, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Guar gum.]
[A10BK06, sotagliflozin, The serum concentration of Sotagliflozin can be decreased when it is combined with Dexamethasone.]
[H01AC08, somatrogon, The metabolism of Dexamethasone can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Cocaine.]
[M09AX11, palovarotene, The serum concentration of Palovarotene can be decreased when it is combined with Dexamethasone.]
[L04AC21, bimekizumab, The metabolism of Dexamethasone can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Proquazone.]
[R05DA04, codeine, The metabolism of Codeine can be increased when combined with Dexamethasone.]
[M03AC05, hexafluorenium, The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Dexamethasone.]
[M04AC01, colchicine, The metabolism of Colchicine can be decreased when combined with Dexamethasone.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Leflunomide.]
[A02AD04, hydrotalcite, The bioavailability of Dexamethasone can be decreased when combined with Hydrotalcite.]
[A10BX03, nateglinide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Imidazole salicylate.]
[H01AC03, mecasermin, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Mecasermin.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Nelarabine.]
[A10AE04, insulin glargine, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin glargine.]
[J01FA15, telithromycin, The metabolism of Dexamethasone can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ciclesonide.]
[B01AC10, indobufen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Indobufen.]
[M01AH03, valdecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Valdecoxib.]
[H01AX01, pegvisomant, The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Dexamethasone.]
[C01AA06, lanatoside C, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Lanatoside C.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be increased when combined with Dexamethasone.]
[M01AH04, parecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Dexamethasone can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, The excretion of Dexamethasone can be decreased when combined with Acyclovir.]
[N05BA10, ketazolam, The metabolism of Ketazolam can be increased when combined with Dexamethasone.]
[L01EA01, imatinib, The metabolism of Imatinib can be increased when combined with Dexamethasone.]
[J02AC04, posaconazole, The metabolism of Dexamethasone can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, The metabolism of Esomeprazole can be increased when combined with Dexamethasone.]
[C08CA09, lacidipine, The metabolism of Lacidipine can be increased when combined with Dexamethasone.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dexamethasone.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Dexamethasone.]
[S01BA03, cortisone, The metabolism of Dexamethasone can be increased when combined with Cortisone.]
[S01AE04, lomefloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Lomefloxacin.]
[M01AB09, lonazolac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Lonazolac.]
[R06AX13, loratadine, The metabolism of Loratadine can be increased when combined with Dexamethasone.]
[M02AA31, loxoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Loxoprofen.]
[A02AD02, magaldrate, The bioavailability of Dexamethasone can be decreased when combined with Magaldrate.]
[A06AD01, magnesium carbonate, The bioavailability of Dexamethasone can be decreased when combined with Magnesium carbonate.]
[C08CA11, manidipine, The metabolism of Manidipine can be increased when combined with Dexamethasone.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Mebeverine.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Meprednisone.]
[C04AX01, cyclandelate, The metabolism of Cyclandelate can be increased when combined with Dexamethasone.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be increased when combined with Dexamethasone.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Dexamethasone.]
[C03AA07, cyclopenthiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Cyclopenthiazide.]
[J01FA03, midecamycin, The serum concentration of Dexamethasone can be increased when it is combined with Midecamycin.]
[A10BF02, miglitol, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Miglitol.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be increased when combined with Dexamethasone.]
[N06AX07, minaprine, The therapeutic efficacy of Minaprine can be decreased when used in combination with Dexamethasone.]
[S01XA18, cyclosporine, Dexamethasone may increase the immunosuppressive activities of Cyclosporine.]
[N06BA07, modafinil, The metabolism of Modafinil can be increased when combined with Dexamethasone.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be increased when combined with Dexamethasone.]
[M02AA02, mofebutazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Dexamethasone can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Cytarabine is combined with Dexamethasone.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Dexamethasone.]
[M01AH05, etoricoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Etoricoxib.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Dexamethasone.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Dactinomycin is combined with Dexamethasone.]
[G03XA01, danazol, The metabolism of Dexamethasone can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Dapsone can be increased when combined with Dexamethasone.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Daunorubicin is combined with Dexamethasone.]
[A04AD11, nabilone, The metabolism of Nabilone can be increased when combined with Dexamethasone.]
[M01AX01, nabumetone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Nabumetone.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be increased when combined with Dexamethasone.]
[N06AX06, nefazodone, The metabolism of Dexamethasone can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, The risk or severity of ulceration can be increased when Dexamethasone is combined with Nicorandil.]
[N03AG06, tiagabine, The metabolism of Tiagabine can be increased when combined with Dexamethasone.]
[G03DB04, nomegestrol, The serum concentration of Dexamethasone can be increased when it is combined with Nomegestrol.]
[M03AC11, cisatracurium, The risk or severity of myopathy and weakness can be increased when Cisatracurium is combined with Dexamethasone.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Dexamethasone.]
[N06AB10, escitalopram, The metabolism of Escitalopram can be increased when combined with Dexamethasone.]
[G04BD08, solifenacin, The metabolism of Solifenacin can be increased when combined with Dexamethasone.]
[A07EC03, olsalazine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Olsalazine.]
[C01AA07, deslanoside, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Deslanoside.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Desoximetasone is combined with Dexamethasone.]
[C09XA02, aliskiren, The metabolism of Aliskiren can be increased when combined with Dexamethasone.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Dexamethasone.]
[M01AE12, oxaprozin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Oxaprozin.]
[N03AF02, oxcarbazepine, The metabolism of Dexamethasone can be increased when combined with Oxcarbazepine.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Antilymphocyte immunoglobulin (horse).]
[S01AA13, fusidic acid, The metabolism of Fusidic acid can be increased when combined with Dexamethasone.]
[J01MB04, pipemidic acid, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Pipemidic acid.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Dexamethasone.]
[M01AG01, mefenamic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Mefenamic acid.]
[G04BD04, oxybutynin, The metabolism of Oxybutynin can be increased when combined with Dexamethasone.]
[L04AB04, adalimumab, The metabolism of Dexamethasone can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be increased when combined with Dexamethasone.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be increased when combined with Dexamethasone.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be increased when combined with Dexamethasone.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be increased when combined with Dexamethasone.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be increased when combined with Dexamethasone.]
[N05BA01, diazepam, The metabolism of Diazepam can be increased when combined with Dexamethasone.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Cinchocaine.]
[S01BC03, diclofenac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Diclofenac.]
[G03CC02, dienestrol, The serum concentration of Dexamethasone can be increased when it is combined with Dienestrol.]
[C02DG01, pinacidil, The metabolism of Pinacidil can be increased when combined with Dexamethasone.]
[A03AX04, pinaverium, The metabolism of Pinaverium can be increased when combined with Dexamethasone.]
[A10BG03, pioglitazone, The metabolism of Pioglitazone can be increased when combined with Dexamethasone.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be increased when combined with Dexamethasone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be increased when combined with Dexamethasone.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Pirarubicin.]
[R03CC07, pirbuterol, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Pirbuterol.]
[C03CA03, piretanide, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Piretanide.]
[P02CB02, diethylcarbamazine, The therapeutic efficacy of Diethylcarbamazine can be decreased when used in combination with Dexamethasone.]
[L02AA01, diethylstilbestrol, The serum concentration of Dexamethasone can be increased when it is combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Isradipine can be increased when combined with Dexamethasone.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Difluocortolone.]
[N02BA11, diflunisal, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Diflunisal.]
[C01AA04, digitoxin, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Digitoxin.]
[C01AA05, digoxin, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Digoxin.]
[L02AA02, polyestradiol phosphate, The serum concentration of Dexamethasone can be increased when it is combined with Polyestradiol phosphate.]
[C10AX09, ezetimibe, Dexamethasone may decrease the excretion rate of Ezetimibe which could result in a higher serum level.]
[L01XX24, pegaspargase, The serum concentration of Dexamethasone can be increased when it is combined with Pegaspargase.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be increased when combined with Dexamethasone.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be increased when combined with Dexamethasone.]
[L04AX04, lenalidomide, Dexamethasone may increase the thrombogenic activities of Lenalidomide.]
[A11CC02, dihydrotachysterol, The therapeutic efficacy of Dihydrotachysterol can be decreased when used in combination with Dexamethasone.]
[J05AE08, atazanavir, The metabolism of Dexamethasone can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Treprostinil can be increased when combined with Dexamethasone.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Diltiazem can be increased when combined with Dexamethasone.]
[R03CC08, procaterol, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Procaterol.]
[G03CA09, promestriene, The serum concentration of Dexamethasone can be increased when it is combined with Promestriene.]
[N02BB04, propyphenazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Proglumetacin.]
[G02AD02, dinoprostone, The excretion of Dexamethasone can be decreased when combined with Dinoprostone.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Diphenhydramine.]
[N05CD10, quazepam, The metabolism of Quazepam can be increased when combined with Dexamethasone.]
[B01AC07, dipyridamole, Dexamethasone may increase the excretion rate of Dipyridamole which could result in a lower serum level and potentially a reduction in efficacy.]
[A03FA02, cisapride, The metabolism of Cisapride can be increased when combined with Dexamethasone.]
[S01XA23, sirolimus, The serum concentration of Dexamethasone can be increased when it is combined with Sirolimus.]
[C01BA03, disopyramide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Disopyramide.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Natalizumab.]
[N07AA03, distigmine, The therapeutic efficacy of Distigmine can be decreased when used in combination with Dexamethasone.]
[P03AA04, disulfiram, The metabolism of Disulfiram can be increased when combined with Dexamethasone.]
[S02AA12, rifamycin SV, The metabolism of Dexamethasone can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Dexamethasone can be increased when combined with Rifapentine.]
[N07XX02, riluzole, Dexamethasone may decrease the excretion rate of Riluzole which could result in a higher serum level.]
[N05AX08, risperidone, The metabolism of Risperidone can be increased when combined with Dexamethasone.]
[R06AE09, levocetirizine, The metabolism of Levocetirizine can be increased when combined with Dexamethasone.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Dexamethasone.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Ropivacaine.]
[J01MB01, rosoxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Rosoxacin.]
[L01EX01, sunitinib, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Sunitinib.]
[A04AD12, aprepitant, The metabolism of Aprepitant can be increased when combined with Dexamethasone.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be increased when combined with Dexamethasone.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be increased when combined with Dexamethasone.]
[J05AE07, fosamprenavir, The metabolism of Fosamprenavir can be increased when combined with Dexamethasone.]
[G04BE08, tadalafil, The metabolism of Tadalafil can be increased when combined with Dexamethasone.]
[S01BC05, ketorolac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Ketorolac.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be increased when combined with Dexamethasone.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be increased when combined with Dexamethasone.]
[N02BA06, salsalate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Salsalate.]
[R03AC12, salmeterol, The metabolism of Salmeterol can be increased when combined with Dexamethasone.]
[C01CA07, dobutamine, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Dobutamine.]
[A03FA03, domperidone, The metabolism of Domperidone can be increased when combined with Dexamethasone.]
[N06AA16, dothiepin, The metabolism of Dosulepin can be increased when combined with Dexamethasone.]
[N06AA12, doxepin, The metabolism of Doxepin can be increased when combined with Dexamethasone.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be increased when combined with Dexamethasone.]
[N06AB06, sertraline, The metabolism of Sertraline can be increased when combined with Dexamethasone.]
[N01AB08, sevoflurane, The metabolism of Sevoflurane can be increased when combined with Dexamethasone.]
[A08AA10, sibutramine, The metabolism of Sibutramine can be increased when combined with Dexamethasone.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be increased when combined with Dexamethasone.]
[B05XA02, sodium bicarbonate, The bioavailability of Dexamethasone can be decreased when combined with Sodium bicarbonate.]
[G03DB01, dydrogesterone, The metabolism of Dydrogesterone can be increased when combined with Dexamethasone.]
[N02CC01, sumatriptan, Dexamethasone may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[V04CX07, edrophonium, The therapeutic efficacy of Edrophonium can be decreased when used in combination with Dexamethasone.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Corticotropin.]
[J01CG02, tazobactam, The excretion of Dexamethasone can be decreased when combined with Tazobactam.]
[J01MA05, temafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Temafloxacin.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Temozolomide is combined with Dexamethasone.]
[M01AC02, tenoxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Tenoxicam.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be increased when combined with Dexamethasone.]
[G04BD05, terodiline, The metabolism of Terodiline can be increased when combined with Dexamethasone.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Emetine.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be increased when combined with Dexamethasone.]
[G03CX01, tibolone, The serum concentration of Dexamethasone can be increased when it is combined with Tibolone.]
[C09AA02, enalapril, The excretion of Dexamethasone can be decreased when combined with Enalapril.]
[M01AG02, tolfenamic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Tolfenamic acid.]
[L02BA02, toremifene, The metabolism of Toremifene can be increased when combined with Dexamethasone.]
[C03CA04, torsemide, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Torasemide.]
[H02CA01, trilostane, The risk or severity of edema formation can be increased when Trilostane is combined with Dexamethasone.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Trofosfamide.]
[N01AB04, enflurane, The metabolism of Enflurane can be increased when combined with Dexamethasone.]
[J01MA04, enoxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Enoxacin.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be increased when combined with Dexamethasone.]
[S01FB02, ephedrine, Ephedrine may increase the excretion rate of Dexamethasone which could result in a lower serum level and potentially a reduction in efficacy.]
[S01GX10, epinastine, The metabolism of Epinastine can be increased when combined with Dexamethasone.]
[N06AX16, venlafaxine, The metabolism of Venlafaxine can be increased when combined with Dexamethasone.]
[C08CA12, mepirodipine, The metabolism of Barnidipine can be increased when combined with Dexamethasone.]
[S01EA01, epinephrine, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Epinephrine.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Dexamethasone.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be increased when combined with Dexamethasone.]
[M01AB04, zomepirac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Zomepirac.]
[N03AX15, zonisamide, The metabolism of Zonisamide can be increased when combined with Dexamethasone.]
[A10AB06, insulin glulisine, human, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin glulisine.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Dexamethasone.]
[N05AX11, zotepine, The metabolism of Zotepine can be increased when combined with Dexamethasone.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Carboplatin is combined with Dexamethasone.]
[C02AC02, guanfacine, The metabolism of Guanfacine can be increased when combined with Dexamethasone.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Iloprost is combined with Dexamethasone.]
[A11CC01, ergocalciferol, The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Dexamethasone.]
[G02AB03, ergonovine, The metabolism of Ergometrine can be increased when combined with Dexamethasone.]
[C04AE01, ergoloid mesylates, USP, The metabolism of Ergoloid mesylate can be increased when combined with Dexamethasone.]
[N02CA02, ergotamine, The metabolism of Dexamethasone can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The serum concentration of Dexamethasone can be increased when it is combined with Erythromycin.]
[N05CD04, estazolam, The metabolism of Estazolam can be increased when combined with Dexamethasone.]
[A02BC02, pantoprazole, The metabolism of Pantoprazole can be increased when combined with Dexamethasone.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be increased when combined with Dexamethasone.]
[G03CA03, estradiol, The serum concentration of Dexamethasone can be increased when it is combined with Estradiol.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Estramustine is combined with Dexamethasone.]
[G03CC06, estriol, The serum concentration of Dexamethasone can be increased when it is combined with Estriol.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Dexamethasone can be increased when it is combined with Conjugated estrogens.]
[G03CC04, estrone, The serum concentration of Dexamethasone can be increased when it is combined with Estrone.]
[R03BA09, fluticasone furoate, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Fluticasone furoate.]
[R03BA05, fluticasone, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be increased when combined with Dexamethasone.]
[L02AA03, ethinyl estradiol, The serum concentration of Dexamethasone can be increased when it is combined with Ethinylestradiol.]
[N04AA05, profenamine, The therapeutic efficacy of Profenamine can be decreased when used in combination with Dexamethasone.]
[N03AD01, ethosuximide, The metabolism of Ethosuximide can be increased when combined with Dexamethasone.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Meloxicam.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be increased when combined with Dexamethasone.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Etidocaine.]
[L01CB01, etoposide, The metabolism of Etoposide can be increased when combined with Dexamethasone.]
[N05AE03, sertindole, The metabolism of Sertindole can be increased when combined with Dexamethasone.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Dexamethasone.]
[A02BA04, nizatidine, The therapeutic efficacy of Nizatidine can be decreased when used in combination with Dexamethasone.]
[J01MA08, fleroxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Fleroxacin.]
[R06AX11, astemizole, The metabolism of Astemizole can be increased when combined with Dexamethasone.]
[R06AX12, terfenadine, The metabolism of Dexamethasone can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Bupropion can be increased when combined with Dexamethasone.]
[N06AB08, fluvoxamine, The metabolism of Fluvoxamine can be increased when combined with Dexamethasone.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Dexamethasone.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Dexamethasone.]
[C10AA03, pravastatin, The excretion of Dexamethasone can be decreased when combined with Pravastatin.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Dexamethasone.]
[A02BA03, famotidine, The excretion of Dexamethasone can be decreased when combined with Famotidine.]
[P02CA03, albendazole, The metabolism of Albendazole can be increased when combined with Dexamethasone.]
[C08CA02, felodipine, The metabolism of Felodipine can be increased when combined with Dexamethasone.]
[C08EA01, fendiline, The metabolism of Fendiline can be increased when combined with Dexamethasone.]
[N03AX26, fenfluramine, The metabolism of Fenfluramine can be increased when combined with Dexamethasone.]
[M01AE04, fenoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Fenoprofen.]
[R03CC04, fenoterol, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Fenoterol.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Dexamethasone.]
[R03CC02, albuterol, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Salbutamol.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Dexamethasone.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Dexamethasone.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be increased when combined with Dexamethasone.]
[N02BG04, floctafenine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Floctafenine.]
[J01CF05, floxacillin, Dexamethasone may increase the excretion rate of Flucloxacillin which could result in a lower serum level and potentially a reduction in efficacy.]
[J02AC01, fluconazole, The metabolism of Dexamethasone can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Flucytosine is combined with Dexamethasone.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Dexamethasone.]
[D07XB01, flumethasone, The metabolism of Flumethasone can be increased when combined with Dexamethasone.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be increased when combined with Dexamethasone.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be increased when combined with Dexamethasone.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Fluocinonide is combined with Dexamethasone.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Ethanol can be increased when combined with Dexamethasone.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Dexamethasone.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Dexamethasone.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be increased when combined with Dexamethasone.]
[N06AB03, fluoxetine, The metabolism of Fluoxetine can be increased when combined with Dexamethasone.]
[G03BA01, fluoxymesterone, The risk or severity of fluid retention can be increased when Dexamethasone is combined with Fluoxymesterone.]
[N05CD01, flurazepam, The metabolism of Flurazepam can be increased when combined with Dexamethasone.]
[S01BC04, flurbiprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Flurbiprofen.]
[N05AG01, fluspirilene, The metabolism of Fluspirilene can be increased when combined with Dexamethasone.]
[L02BB01, flutamide, The metabolism of Flutamide can be increased when combined with Dexamethasone.]
[V04CX02, folic acid, Dexamethasone may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be increased when combined with Dexamethasone.]
[M03AA01, alcuronium, The risk or severity of myopathy and weakness can be increased when Alcuronium is combined with Dexamethasone.]
[J05AE10, darunavir, The metabolism of Dexamethasone can be decreased when combined with Darunavir.]
[C03CA01, furosemide, The excretion of Dexamethasone can be decreased when combined with Furosemide.]
[N05CF04, eszopiclone, The serum concentration of Eszopiclone can be decreased when it is combined with Dexamethasone.]
[N06DA04, galantamine, The therapeutic efficacy of Galantamine can be decreased when used in combination with Dexamethasone.]
[M03AC02, gallamine, The risk or severity of myopathy and weakness can be increased when Gallamine is combined with Dexamethasone.]
[C08DA02, gallopamil, The metabolism of Gallopamil can be increased when combined with Dexamethasone.]
[S01AD09, ganciclovir, The excretion of Dexamethasone can be decreased when combined with Ganciclovir.]
[C10AB04, gemfibrozil, The metabolism of Gemfibrozil can be increased when combined with Dexamethasone.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be increased when combined with Dexamethasone.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be increased when combined with Dexamethasone.]
[A10BJ02, liraglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Liraglutide.]
[J05AG04, etravirine, The metabolism of Etravirine can be increased when combined with Dexamethasone.]
[G03XA02, gestrinone, The serum concentration of Dexamethasone can be increased when it is combined with Gestrinone.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be increased when combined with Dexamethasone.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be increased when combined with Dexamethasone.]
[A10BB01, glyburide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Glyburide.]
[A10BB09, gliclazide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Gliclazide.]
[A10BB07, glipizide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Glipizide.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be increased when combined with Dexamethasone.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be increased when combined with Dexamethasone.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be increased when combined with Dexamethasone.]
[B01AA12, fluindione, Dexamethasone may increase the anticoagulant activities of Fluindione.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be increased when combined with Dexamethasone.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Dexamethasone.]
[N01AB01, halothane, The metabolism of Halothane can be increased when combined with Dexamethasone.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be increased when combined with Dexamethasone.]
[A10AD05, insulin aspart, human, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin aspart.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be increased when combined with Dexamethasone.]
[M04AA01, allopurinol, Dexamethasone may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C09CA01, losartan, The metabolism of Losartan can be increased when combined with Dexamethasone.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be increased when combined with Dexamethasone.]
[A07EC02, mesalamine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Mesalazine.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Dexamethasone.]
[R03CC05, hexoprenaline, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be increased when combined with Dexamethasone.]
[C08CA10, nilvadipine, The metabolism of Nilvadipine can be increased when combined with Dexamethasone.]
[M02AA26, nimesulide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Nimesulide.]
[C03AA03, hydrochlorothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Hydrochlorothiazide.]
[R05DA03, hydrocodone, The metabolism of Hydrocodone can be increased when combined with Dexamethasone.]
[S02BA01, hydrocortisone, The metabolism of Hydrocortisone can be increased when combined with Dexamethasone.]
[C03AA02, hydroflumethiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Hydroflumethiazide.]
[G04BD06, propiverine, The metabolism of Propiverine can be increased when combined with Dexamethasone.]
[P01BA02, hydroxychloroquine, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Hydroxychloroquine.]
[G03DA03, 17-alpha-hydroxyprogesterone, The metabolism of Hydroxyprogesterone can be increased when combined with Dexamethasone.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Dexamethasone.]
[N05BB01, hydroxyzine, The metabolism of Hydroxyzine can be increased when combined with Dexamethasone.]
[J04AB04, rifabutin, The metabolism of Rifabutin can be increased when combined with Dexamethasone.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Dexamethasone.]
[R02AX02, ibuprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Ibuprofen.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Idarubicin is combined with Dexamethasone.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be increased when combined with Dexamethasone.]
[N01AH03, sufentanil, The metabolism of Sufentanil can be increased when combined with Dexamethasone.]
[N06AA02, imipramine, The metabolism of Imipramine can be increased when combined with Dexamethasone.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be increased when combined with Dexamethasone.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Tixocortol.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Topotecan is combined with Dexamethasone.]
[C03BA11, indapamide, The metabolism of Indapamide can be increased when combined with Dexamethasone.]
[S01BC01, indomethacin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Indomethacin.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Dexamethasone.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Dexamethasone.]
[N06AX17, milnacipran, The metabolism of Milnacipran can be increased when combined with Dexamethasone.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Eculizumab.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Articaine.]
[A10BH01, sitagliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Sitagliptin.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Dexamethasone.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be increased when combined with Dexamethasone.]
[A10BH02, vildagliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Vildagliptin.]
[C10AA06, cerivastatin, The metabolism of Cerivastatin can be increased when combined with Dexamethasone.]
[C03BA02, quinethazone, Dexamethasone may increase the hypokalemic activities of Quinethazone.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Dexamethasone.]
[V03AB01, ipecac, The metabolism of Ipecac can be increased when combined with Dexamethasone.]
[J05AF04, stavudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Dexamethasone.]
[P01AX06, atovaquone, The metabolism of Atovaquone can be increased when combined with Dexamethasone.]
[R03CC06, isoetharine, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Isoetharine.]
[N01AB06, isoflurane, The metabolism of Isoflurane can be increased when combined with Dexamethasone.]
[S01EB07, isoflurophate, The therapeutic efficacy of Isoflurophate can be decreased when used in combination with Dexamethasone.]
[J04AC01, isoniazid, The serum concentration of Isoniazid can be decreased when it is combined with Dexamethasone.]
[R03CB01, isoproterenol, The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Dexamethasone.]
[A10BJ01, exenatide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Exenatide.]
[D10BA01, isotretinoin, The metabolism of Isotretinoin can be increased when combined with Dexamethasone.]
[P02CF01, ivermectin, The metabolism of Ivermectin can be increased when combined with Dexamethasone.]
[J01FA07, josamycin, The serum concentration of Dexamethasone can be increased when it is combined with Josamycin.]
[N06AX18, reboxetine, The metabolism of Reboxetine can be increased when combined with Dexamethasone.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Dexamethasone.]
[A02AB01, aluminum hydroxide, The bioavailability of Dexamethasone can be decreased when combined with Aluminum hydroxide.]
[L04AC07, tocilizumab, The metabolism of Dexamethasone can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The therapeutic efficacy of Ketamine can be decreased when used in combination with Dexamethasone.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be increased when combined with Dexamethasone.]
[J02AB02, ketoconazole, The metabolism of Dexamethasone can be decreased when combined with Ketoconazole.]
[M02AA10, ketoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Ketoprofen.]
[V03AC03, deferasirox, The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Dexamethasone is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Dexamethasone can be increased when combined with Abatacept.]
[C01CA22, arbutamine, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Arbutamine.]
[N04BC09, rotigotine, The metabolism of Rotigotine can be increased when combined with Dexamethasone.]
[J01MB02, nalidixic acid, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Tiaprofenic acid.]
[J05AX09, maraviroc, The metabolism of Maraviroc can be increased when combined with Dexamethasone.]
[N07AA30, ambenonium, The therapeutic efficacy of Ambenonium can be decreased when used in combination with Dexamethasone.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be increased when combined with Dexamethasone.]
[C03CC01, ethacrynic acid, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Etacrynic acid.]
[R05CB06, ambroxol, The metabolism of Ambroxol can be increased when combined with Dexamethasone.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Dexamethasone.]
[G03AD01, levonorgestrel, The serum concentration of Dexamethasone can be increased when it is combined with Levonorgestrel.]
[C08EX01, lidoflazine, The metabolism of Lidoflazine can be increased when combined with Dexamethasone.]
[N06BA13, armodafinil, The metabolism of Dexamethasone can be increased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Dexamethasone.]
[N02CA07, lisuride, The metabolism of Lisuride can be increased when combined with Dexamethasone.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Lomustine is combined with Dexamethasone.]
[A07DA03, loperamide, The metabolism of Loperamide can be increased when combined with Dexamethasone.]
[N05BA06, lorazepam, The metabolism of Lorazepam can be increased when combined with Dexamethasone.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be decreased when combined with Dexamethasone.]
[G03DC03, lynestrenol, The serum concentration of Dexamethasone can be increased when it is combined with Lynestrenol.]
[L01EG01, temsirolimus, The serum concentration of Dexamethasone can be increased when it is combined with Temsirolimus.]
[G04BX01, magnesium hydroxide, The bioavailability of Dexamethasone can be decreased when combined with Magnesium hydroxide.]
[A12CC10, magnesium oxide, The bioavailability of Dexamethasone can be decreased when combined with Magnesium oxide.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Pralatrexate.]
[L01EA03, nilotinib, The metabolism of Dexamethasone can be decreased when combined with Nilotinib.]
[L01AA05, mechlorethamine, The therapeutic efficacy of Mechlorethamine can be decreased when used in combination with Dexamethasone.]
[M02AA18, meclofenamic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Meclofenamic acid.]
[C01AA08, medigoxin, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Metildigoxin.]
[G03DB03, medrogestone, The metabolism of Medrogestone can be increased when combined with Dexamethasone.]
[P01BC02, mefloquine, The therapeutic efficacy of Mefloquine can be decreased when used in combination with Dexamethasone.]
[N05CH01, melatonin, The excretion of Dexamethasone can be decreased when combined with Melatonin.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Melphalan is combined with Dexamethasone.]
[N06DX01, memantine, The therapeutic efficacy of Memantine can be decreased when used in combination with Dexamethasone.]
[N02AB02, meperidine, The metabolism of Meperidine can be increased when combined with Dexamethasone.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be increased when combined with Dexamethasone.]
[N03AA01, mephobarbital, The metabolism of Methylphenobarbital can be increased when combined with Dexamethasone.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Mepivacaine.]
[L02BG01, aminoglutethimide, The therapeutic efficacy of Dexamethasone can be decreased when used in combination with Aminoglutethimide.]
[G03BB01, mesterolone, The risk or severity of edema formation can be increased when Mesterolone is combined with Dexamethasone.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be increased when combined with Dexamethasone.]
[A10BA02, metformin, The therapeutic efficacy of Metformin can be decreased when used in combination with Dexamethasone.]
[A04AA04, dolasetron, The metabolism of Dolasetron can be increased when combined with Dexamethasone.]
[N07BC02, methadone, The metabolism of Methadone can be increased when combined with Dexamethasone.]
[N05CM01, methaqualone, The metabolism of Methaqualone can be increased when combined with Dexamethasone.]
[J05AF05, lamivudine, Dexamethasone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A14AA04, methenolone, The risk or severity of edema formation can be increased when Metenolone is combined with Dexamethasone.]
[H03BB02, methimazole, The metabolism of Dexamethasone can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Pemetrexed is combined with Dexamethasone.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be increased when combined with Dexamethasone.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be increased when combined with Dexamethasone.]
[C03AA08, methyclothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Methyclothiazide.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Methyldopa is combined with Dexamethasone.]
[V04CG05, methylene blue, The metabolism of Dexamethasone can be decreased when combined with Methylene blue.]
[G02AB01, methylergonovine, The metabolism of Methylergometrine can be increased when combined with Dexamethasone.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be increased when combined with Dexamethasone.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Dexamethasone.]
[G03EK01, methyltestosterone, The risk or severity of edema formation can be increased when Methyltestosterone is combined with Dexamethasone.]
[N02CA04, methysergide, The metabolism of Methysergide can be increased when combined with Dexamethasone.]
[A03FA01, metoclopramide, The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Dexamethasone.]
[C03BA08, metolazone, Dexamethasone may increase the hypokalemic activities of Metolazone.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be increased when combined with Dexamethasone.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be increased when combined with Dexamethasone.]
[N06AX03, mianserin, The metabolism of Mianserin can be increased when combined with Dexamethasone.]
[S02AA13, miconazole, The metabolism of Dexamethasone can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Aminophenazone.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Dexamethasone.]
[G03XB01, mifepristone, The serum concentration of Dexamethasone can be increased when it is combined with Mifepristone.]
[J01AA08, minocycline, The excretion of Dexamethasone can be decreased when combined with Minocycline.]
[J01FA11, miocamycin, The serum concentration of Dexamethasone can be increased when it is combined with Miocamycin.]
[L01XX23, mitotane, The serum concentration of Dexamethasone can be decreased when it is combined with Mitotane.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Dexamethasone.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dexamethasone.]
[C01BD01, amiodarone, The metabolism of Dexamethasone can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be increased when combined with Dexamethasone.]
[N02AA01, morphine, The metabolism of Morphine can be increased when combined with Dexamethasone.]
[A04AA05, palonosetron, The metabolism of Palonosetron can be increased when combined with Dexamethasone.]
[L04AB05, certolizumab pegol, The metabolism of Dexamethasone can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be increased when combined with Dexamethasone.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ofatumumab.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be increased when combined with Dexamethasone.]
[L04AA06, mycophenolic acid, The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Dexamethasone.]
[M03AC03, vecuronium, The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Dexamethasone.]
[J05AJ01, raltegravir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Raltegravir.]
[P01BA06, amodiaquine, The metabolism of Amodiaquine can be increased when combined with Dexamethasone.]
[G04CA04, silodosin, The metabolism of Silodosin can be increased when combined with Dexamethasone.]
[G03XC01, raloxifene, Dexamethasone may decrease the excretion rate of Raloxifene which could result in a higher serum level.]
[N03AB05, fosphenytoin, The serum concentration of Dexamethasone can be decreased when it is combined with Fosphenytoin.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Dexamethasone.]
[V03AB15, naloxone, The metabolism of Dexamethasone can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Dexamethasone.]
[L04AC03, anakinra, The metabolism of Dexamethasone can be increased when combined with Anakinra.]
[S01XA11, nandrolone, The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Dexamethasone.]
[M02AA12, naproxen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Naproxen.]
[A10BG01, troglitazone, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Troglitazone.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Dexamethasone.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be increased when combined with Dexamethasone.]
[L02BG04, letrozole, The metabolism of Letrozole can be increased when combined with Dexamethasone.]
[A10BX02, repaglinide, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Repaglinide.]
[S01EB06, neostigmine, The therapeutic efficacy of Neostigmine can be decreased when used in combination with Dexamethasone.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Dexamethasone.]
[J02AA01, amphotericin B, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Amphotericin B.]
[N06AX23, desvenlafaxine, The metabolism of Desvenlafaxine can be increased when combined with Dexamethasone.]
[C09CA07, telmisartan, Dexamethasone may increase the excretion rate of Telmisartan which could result in a lower serum level and potentially a reduction in efficacy.]
[H05BX02, paricalcitol, The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Dexamethasone.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Dexamethasone.]
[C10AD02, niacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Dexamethasone.]
[C08CA04, nicardipine, The metabolism of Nicardipine can be increased when combined with Dexamethasone.]
[N07BA01, nicotine, The metabolism of Nicotine can be increased when combined with Dexamethasone.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be increased when combined with Dexamethasone.]
[M02AA17, niflumic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Niflumic acid.]
[C08CA06, nimodipine, The metabolism of Nimodipine can be increased when combined with Dexamethasone.]
[C08CA07, nisoldipine, The metabolism of Nisoldipine can be increased when combined with Dexamethasone.]
[N05CD02, nitrazepam, The metabolism of Nitrazepam can be increased when combined with Dexamethasone.]
[C08CA08, nitrendipine, The metabolism of Nitrendipine can be increased when combined with Dexamethasone.]
[J01XE01, nitrofurantoin, Dexamethasone may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be increased when combined with Dexamethasone.]
[C01CA03, norepinephrine, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Norepinephrine.]
[G03DC02, norethindrone, The serum concentration of Dexamethasone can be increased when it is combined with Norethisterone.]
[S01AE02, norfloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Norfloxacin.]
[G03AC07, norgestrienone, The serum concentration of Dexamethasone can be increased when it is combined with Norgestrienone.]
[C02KX01, bosentan, The metabolism of Bosentan can be increased when combined with Dexamethasone.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be increased when combined with Dexamethasone.]
[G02CA02, nylidrin, The metabolism of Nylidrin can be increased when combined with Dexamethasone.]
[S02AA16, ofloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Ofloxacin.]
[J01FA05, oleandomycin, The serum concentration of Dexamethasone can be increased when it is combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Dexamethasone can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Omeprazole can be increased when combined with Dexamethasone.]
[N02AA02, opium, The metabolism of Opium can be increased when combined with Dexamethasone.]
[R03CB03, metaproterenol, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Orciprenaline.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be increased when combined with Dexamethasone.]
[C01AC01, ouabain, The excretion of Dexamethasone can be decreased when combined with Ouabain.]
[A14AA08, oxandrolone, The risk or severity of fluid retention can be increased when Dexamethasone is combined with Oxandrolone.]
[J01MB05, oxolinic acid, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Oxolinic acid.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be increased when combined with Dexamethasone.]
[S01GA04, oxymetazoline, The absorption of Dexamethasone can be decreased when combined with Oxymetazoline.]
[A14AA05, oxymetholone, The risk or severity of fluid retention can be increased when Dexamethasone is combined with Oxymetholone.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be increased when combined with Dexamethasone.]
[S01BC02, oxyphenbutazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Oxyphenbutazone.]
[S01AA04, oxytetracycline, The excretion of Dexamethasone can be decreased when combined with Oxytetracycline.]
[V04CH30, 4-aminohippuric acid, The excretion of Dexamethasone can be decreased when combined with Aminohippuric acid.]
[J04AA01, aminosalicylic acid, The serum concentration of Aminosalicylic acid can be decreased when it is combined with Dexamethasone.]
[N05AH05, asenapine, The metabolism of Asenapine can be increased when combined with Dexamethasone.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be decreased when used in combination with Dexamethasone.]
[G03DB06, chlormadinone, The serum concentration of Dexamethasone can be increased when it is combined with Chlormadinone.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Paramethasone.]
[J01MA03, pefloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Pefloxacin.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be increased when combined with Dexamethasone.]
[N05AG03, penfluridol, The metabolism of Penfluridol can be increased when combined with Dexamethasone.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Penicillamine is combined with Dexamethasone.]
[S01AA14, penicillin G, The excretion of Dexamethasone can be decreased when combined with Benzylpenicillin.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Dexamethasone.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Dexamethasone.]
[N05CA01, pentobarbital, The metabolism of Dexamethasone can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Pentostatin is combined with Dexamethasone.]
[C08EX02, perhexiline, The metabolism of Perhexiline can be increased when combined with Dexamethasone.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Dexamethasone.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be increased when combined with Dexamethasone.]
[A10BA01, phenformin, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Phenformin.]
[B01AA02, phenindione, Dexamethasone may increase the anticoagulant activities of Phenindione.]
[N03AA02, phenobarbital, The metabolism of Phenobarbital can be increased when combined with Dexamethasone.]
[B01AA04, phenprocoumon, Dexamethasone may increase the anticoagulant activities of Phenprocoumon.]
[A08AA01, phentermine, The metabolism of Phentermine can be increased when combined with Dexamethasone.]
[M02AA01, phenylbutazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Phenylbutazone.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be increased when Dexamethasone is combined with Phenylephrine.]
[A02BC06, dexlansoprazole, The metabolism of Dexlansoprazole can be increased when combined with Dexamethasone.]
[R01BA01, phenylpropanolamine, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Phenylpropanolamine.]
[N03AB02, phenytoin, The serum concentration of Dexamethasone can be decreased when it is combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Dexamethasone can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Levofloxacin.]
[V03AB19, physostigmine, The therapeutic efficacy of Physostigmine can be decreased when used in combination with Dexamethasone.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be increased when combined with Dexamethasone.]
[C08CX01, mibefradil, The metabolism of Mibefradil can be increased when combined with Dexamethasone.]
[N05AG02, pimozide, The metabolism of Pimozide can be increased when combined with Dexamethasone.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Dexamethasone.]
[J05AE01, saquinavir, The metabolism of Dexamethasone can be decreased when combined with Saquinavir.]
[N05AC04, pipothiazine, The metabolism of Pipotiazine can be increased when combined with Dexamethasone.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Dexamethasone.]
[S01BC06, piroxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Piroxicam.]
[J01MA11, grepafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Grepafloxacin.]
[J05AG02, delavirdine, The metabolism of Dexamethasone can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Irbesartan can be increased when combined with Dexamethasone.]
[D05AX05, tazarotene, The metabolism of Tazarotene can be increased when combined with Dexamethasone.]
[A10BG02, rosiglitazone, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Rosiglitazone.]
[L02BG03, anastrozole, The metabolism of Anastrozole can be increased when combined with Dexamethasone.]
[A03AE01, alosetron, The metabolism of Alosetron can be increased when combined with Dexamethasone.]
[L04AC08, canakinumab, The metabolism of Dexamethasone can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Polythiazide.]
[J05AE03, ritonavir, The serum concentration of Dexamethasone can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Saxagliptin.]
[A10AD04, insulin lispro, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin lispro.]
[C10AA08, pitavastatin, Dexamethasone may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[N05BA11, prazepam, The metabolism of Prazepam can be increased when combined with Dexamethasone.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be increased when combined with Dexamethasone.]
[C02CA01, prazosin, Dexamethasone may decrease the excretion rate of Prazosin which could result in a higher serum level.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Prednisolone is combined with Dexamethasone.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Prednisone is combined with Dexamethasone.]
[C01DX02, prenylamine, The metabolism of Prenylamine can be increased when combined with Dexamethasone.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Primaquine can be increased when combined with Dexamethasone.]
[N03AA03, primidone, The metabolism of Dexamethasone can be increased when combined with Primidone.]
[M04AB01, probenecid, The excretion of Dexamethasone can be decreased when combined with Probenecid.]
[C01BA02, procainamide, The therapeutic efficacy of Procainamide can be decreased when used in combination with Dexamethasone.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Procarbazine is combined with Dexamethasone.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be increased when combined with Dexamethasone.]
[N05AB04, prochlorperazine, The metabolism of Prochlorperazine can be increased when combined with Dexamethasone.]
[G03DA04, progesterone, The serum concentration of Dexamethasone can be increased when it is combined with Progesterone.]
[N05AA03, promazine, The metabolism of Promazine can be increased when combined with Dexamethasone.]
[G03DB07, promegestone, The metabolism of Promegestone can be increased when combined with Dexamethasone.]
[R06AD02, promethazine, The metabolism of Promethazine can be increased when combined with Dexamethasone.]
[C01BC03, propafenone, The metabolism of Propafenone can be increased when combined with Dexamethasone.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be increased when combined with Dexamethasone.]
[N01AX10, propofol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propofol is combined with Dexamethasone.]
[N02AC04, propoxyphene, The metabolism of Dextropropoxyphene can be increased when combined with Dexamethasone.]
[C07AA05, propranolol, The serum concentration of Propranolol can be decreased when it is combined with Dexamethasone.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Dexamethasone.]
[R03DC03, montelukast, The metabolism of Montelukast can be increased when combined with Dexamethasone.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be increased when combined with Dexamethasone.]
[P02CC01, pyrantel, The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Dexamethasone.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Dexamethasone.]
[N07AA02, pyridostigmine, The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Dexamethasone.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be increased when combined with Dexamethasone.]
[C01BA01, quinidine, The metabolism of Quinidine can be increased when combined with Dexamethasone.]
[P01BC01, quinine, The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Quinine.]
[A02BA02, ranitidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ranitidine is combined with Dexamethasone.]
[C02AA02, reserpine, The metabolism of Dexamethasone can be increased when combined with Reserpine.]
[J04AB02, rifampin, The metabolism of Dexamethasone can be increased when combined with Rifampicin.]
[G02CA01, ritodrine, The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Ritodrine.]
[J01FA06, roxithromycin, The serum concentration of Dexamethasone can be increased when it is combined with Roxithromycin.]
[N02BA05, salicylamide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Salicylic acid.]
[S01FA02, scopolamine, The metabolism of Scopolamine can be increased when combined with Dexamethasone.]
[N04BD01, selegiline, The metabolism of Selegiline can be increased when combined with Dexamethasone.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Obinutuzumab.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Dexamethasone.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be increased when combined with Dexamethasone.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Dexamethasone.]
[J01FA02, spiramycin, The serum concentration of Dexamethasone can be increased when it is combined with Spiramycin.]
[C03DA01, spironolactone, Dexamethasone may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AG01, valproic acid, The excretion of Dexamethasone can be decreased when combined with Valproic acid.]
[A05AA01, chenodeoxycholic acid, The metabolism of Chenodeoxycholic acid can be increased when combined with Dexamethasone.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Dexamethasone.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Dexamethasone is combined with Hydrocortisone butyrate.]
[H02CA04, levoketoconazole, The metabolism of Dexamethasone can be decreased when combined with Levoketoconazole.]
[A05AA02, ursodiol, Dexamethasone may increase the excretion rate of Ursodeoxycholic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[P02BB01, trichlorfon, The therapeutic efficacy of Metrifonate can be decreased when used in combination with Dexamethasone isonicotinate.]
[S02DA03, antipyrine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Antipyrine.]
[A14AA02, stanozolol, The risk or severity of fluid retention can be increased when Dexamethasone isonicotinate is combined with Stanozolol.]
[G03XB02, ulipristal, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Ulipristal.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Dexamethasone isonicotinate.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Dexamethasone isonicotinate.]
[L04AA27, fingolimod, Dexamethasone isonicotinate may increase the immunosuppressive activities of Fingolimod.]
[M03AB01, succinylcholine, The risk or severity of myopathy and weakness can be increased when Succinylcholine is combined with Dexamethasone isonicotinate.]
[J01EC02, sulfadiazine, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Sulfadiazine.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Dexamethasone isonicotinate.]
[S01AB02, sulfisoxazole, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Sulfisoxazole.]
[M01AB02, sulindac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Sulindac.]
[N05AL01, sulpiride, The therapeutic efficacy of Sulpiride can be decreased when used in combination with Dexamethasone isonicotinate.]
[A10BB04, glibornuride, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Glibornuride.]
[A10BC01, glymidine, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Glymidine.]
[M01AX04, apazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Azapropazone.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Dexamethasone isonicotinate.]
[N06DA01, tacrine, The therapeutic efficacy of Tacrine can be decreased when used in combination with Dexamethasone isonicotinate.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be increased when combined with Dexamethasone isonicotinate.]
[L01CB02, teniposide, The metabolism of Teniposide can be increased when combined with Dexamethasone isonicotinate.]
[R03CC03, terbutaline, The therapeutic efficacy of Terbutaline can be decreased when used in combination with Dexamethasone isonicotinate.]
[G03BA03, testosterone, The risk or severity of edema formation can be increased when Testosterone is combined with Dexamethasone isonicotinate.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be increased when combined with Dexamethasone isonicotinate.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Thalidomide is combined with Dexamethasone isonicotinate.]
[R03DA04, theophylline, The metabolism of Theophylline can be increased when combined with Dexamethasone isonicotinate.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Eribulin is combined with Dexamethasone isonicotinate.]
[L01AC01, thiotepa, The therapeutic efficacy of Thiotepa can be decreased when used in combination with Dexamethasone isonicotinate.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Dexamethasone isonicotinate.]
[B02AB01, aprotinin, The therapeutic efficacy of Aprotinin can be decreased when used in combination with Dexamethasone isonicotinate.]
[A10BB05, tolazamide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Tolazamide.]
[V04CA01, tolbutamide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Tolbutamide.]
[M02AA21, tolmetin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Tolmetin.]
[N02AX02, tramadol, The metabolism of Tramadol can be increased when combined with Dexamethasone isonicotinate.]
[N06AX05, trazodone, The metabolism of Trazodone can be increased when combined with Dexamethasone isonicotinate.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Dexamethasone isonicotinate.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Triamcinolone is combined with Dexamethasone isonicotinate.]
[N05CD05, triazolam, The metabolism of Triazolam can be increased when combined with Dexamethasone isonicotinate.]
[C03AA06, trichlormethiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone isonicotinate is combined with Trichlormethiazide.]
[S01EB04, demecarium, The therapeutic efficacy of Demecarium can be decreased when used in combination with Dexamethasone isonicotinate.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Dexamethasone isonicotinate.]
[N05AA05, triflupromazine, The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Dexamethasone isonicotinate.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Fluclorolone.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Mometasone is combined with Dexamethasone isonicotinate.]
[J01FA08, troleandomycin, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Troleandomycin.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be decreased when used in combination with Dexamethasone isonicotinate.]
[R03DX07, roflumilast, Roflumilast may increase the immunosuppressive activities of Dexamethasone isonicotinate.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Belimumab is combined with Dexamethasone isonicotinate.]
[S01AA05, tyrothricin, The therapeutic efficacy of Tyrothricin can be decreased when used in combination with Dexamethasone isonicotinate.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be increased when combined with Dexamethasone isonicotinate.]
[A10BH05, linagliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be decreased when it is combined with Dexamethasone isonicotinate.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Belatacept is combined with Dexamethasone isonicotinate.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be increased when combined with Dexamethasone isonicotinate.]
[R03AC18, indacaterol, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Indacaterol.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be increased when combined with Dexamethasone isonicotinate.]
[C08DA01, verapamil, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be increased when combined with Dexamethasone isonicotinate.]
[L01CA02, vincristine, The metabolism of Vincristine can be increased when combined with Dexamethasone isonicotinate.]
[L01CA03, vindesine, The metabolism of Vindesine can be increased when combined with Dexamethasone isonicotinate.]
[B01AA03, warfarin, Dexamethasone isonicotinate may increase the anticoagulant activities of Warfarin.]
[J05AF01, zidovudine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Dexamethasone isonicotinate.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be increased when combined with Dexamethasone isonicotinate.]
[J05AE02, indinavir, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be increased when combined with Dexamethasone isonicotinate.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be increased when combined with Dexamethasone isonicotinate.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be increased when combined with Dexamethasone isonicotinate.]
[H05BX03, doxercalciferol, The therapeutic efficacy of Doxercalciferol can be decreased when used in combination with Dexamethasone isonicotinate.]
[J01MA13, trovafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Ziprasidone.]
[G03AC10, drospirenone, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Drospirenone.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Dexamethasone isonicotinate.]
[N02BA01, aspirin, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be increased when combined with Dexamethasone isonicotinate.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dexamethasone isonicotinate.]
[A11CC03, alfacalcidol, The therapeutic efficacy of Alfacalcidol can be decreased when used in combination with Dexamethasone isonicotinate.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Dexamethasone isonicotinate.]
[J02AC03, voriconazole, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Voriconazole.]
[M03AC04, atracurium, The risk or severity of myopathy and weakness can be increased when Atracurium is combined with Dexamethasone isonicotinate.]
[L01EK01, axitinib, The metabolism of Axitinib can be increased when combined with Dexamethasone isonicotinate.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be increased when combined with Dexamethasone isonicotinate.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Prednylidene.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Azacitidine is combined with Dexamethasone isonicotinate.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Azathioprine is combined with Dexamethasone isonicotinate.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dexamethasone isonicotinate.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Dexamethasone isonicotinate.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Dexamethasone isonicotinate.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dexamethasone isonicotinate.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Carfilzomib is combined with Dexamethasone isonicotinate.]
[V03AX03, cobicistat, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Dexamethasone isonicotinate can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be increased when combined with Dexamethasone isonicotinate.]
[L04AA31, teriflunomide, The risk or severity of adverse effects can be increased when Teriflunomide is combined with Dexamethasone isonicotinate.]
[A02AA05, magnesium silicate, The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Magnesium silicate.]
[A02AC02, calcium silicate, The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Calcium silicate.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Abetimus is combined with Dexamethasone isonicotinate.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Aldosterone is combined with Dexamethasone isonicotinate.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be increased when combined with Dexamethasone isonicotinate.]
[C01AA01, acetyldigitoxin, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Acetyldigitoxin.]
[J05AE04, nelfinavir, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Bendamustine is combined with Dexamethasone isonicotinate.]
[C08CA13, lercanidipine, The metabolism of Lercanidipine can be increased when combined with Dexamethasone isonicotinate.]
[N06DA02, donepezil, The therapeutic efficacy of Donepezil can be decreased when used in combination with Dexamethasone isonicotinate.]
[N03AX22, perampanel, The metabolism of Perampanel can be increased when combined with Dexamethasone isonicotinate.]
[L04AA29, tofacitinib, Dexamethasone isonicotinate may increase the immunosuppressive activities of Tofacitinib.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be increased when combined with Dexamethasone isonicotinate.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be increased when combined with Dexamethasone isonicotinate.]
[B01AF02, apixaban, The metabolism of Apixaban can be increased when combined with Dexamethasone isonicotinate.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be increased when combined with Dexamethasone isonicotinate.]
[A10BH04, alogliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Alogliptin.]
[A16AX09, glycerol phenylbutyrate, The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Dexamethasone isonicotinate.]
[C03AA01, bendroflumethiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone isonicotinate is combined with Bendroflumethiazide.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be increased when combined with Dexamethasone isonicotinate.]
[N02BA10, benorilate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Benorilate.]
[A10BK02, canagliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Canagliflozin.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Dexamethasone isonicotinate.]
[J01MA15, gemifloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Moxifloxacin.]
[H03AA04, tiratricol, The therapeutic efficacy of Tiratricol can be decreased when used in combination with Dexamethasone isonicotinate.]
[A10AE05, insulin detemir, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin detemir.]
[A10BX05, pramlintide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Pramlintide.]
[M01AH01, celecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Celecoxib.]
[L04AA18, everolimus, The metabolism of Everolimus can be increased when combined with Dexamethasone isonicotinate.]
[L01EC02, dabrafenib, The serum concentration of Dexamethasone isonicotinate can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Benzydamine.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be increased when combined with Dexamethasone isonicotinate.]
[A10BJ03, lixisenatide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Lixisenatide.]
[L01EL01, ibrutinib, The risk or severity of adverse effects can be increased when Ibrutinib is combined with Dexamethasone isonicotinate.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be increased when combined with Dexamethasone isonicotinate.]
[G03AC08, etonogestrel, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Etonogestrel.]
[J05AP05, simeprevir, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Simeprevir.]
[A10BK01, dapagliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Dapagliflozin.]
[C01CA27, droxidopa, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Droxidopa.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be increased when combined with Dexamethasone isonicotinate.]
[A16AA07, metreleptin, The metabolism of Dexamethasone isonicotinate can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The risk or severity of adverse effects can be increased when Apremilast is combined with Dexamethasone isonicotinate.]
[L02BG02, formestane, The risk or severity of edema formation can be increased when Formestane is combined with Dexamethasone isonicotinate.]
[A16AA06, betaine, The therapeutic efficacy of Betaine can be decreased when used in combination with Dexamethasone isonicotinate.]
[S03BA03, betamethasone, The risk or severity of adverse effects can be increased when Betamethasone is combined with Dexamethasone isonicotinate.]
[A10BJ04, albiglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Albiglutide.]
[L04AC11, siltuximab, The risk or severity of adverse effects can be increased when Siltuximab is combined with Dexamethasone isonicotinate.]
[L01ED02, ceritinib, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Ceritinib.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be increased when combined with Dexamethasone isonicotinate.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Vedolizumab is combined with Dexamethasone isonicotinate.]
[B01AA07, acenocoumarol, Dexamethasone isonicotinate may increase the anticoagulant activities of Acenocoumarol.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Belinostat is combined with Dexamethasone isonicotinate.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be increased when combined with Dexamethasone isonicotinate.]
[A10BK03, empagliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Empagliflozin.]
[R03AC19, olodaterol, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Olodaterol.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Peginterferon beta-1a is combined with Dexamethasone isonicotinate.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be increased when combined with Dexamethasone isonicotinate.]
[V04CX03, methacholine, Dexamethasone isonicotinate may decrease effectiveness of Methacholine as a diagnostic agent.]
[A10BJ05, dulaglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Dulaglutide.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Decitabine is combined with Dexamethasone isonicotinate.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Pirfenidone is combined with Dexamethasone isonicotinate.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be increased when combined with Dexamethasone isonicotinate.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Blinatumomab is combined with Dexamethasone isonicotinate.]
[L01XK01, olaparib, The metabolism of Olaparib can be increased when combined with Dexamethasone isonicotinate.]
[B01AA01, dicumarol, Dexamethasone isonicotinate may increase the anticoagulant activities of Dicoumarol.]
[L04AC10, secukinumab, The risk or severity of adverse effects can be increased when Secukinumab is combined with Dexamethasone isonicotinate.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be increased when combined with Dexamethasone isonicotinate.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be increased when combined with Dexamethasone isonicotinate.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be increased when combined with Dexamethasone isonicotinate.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Dexamethasone isonicotinate.]
[B01AA11, tioclomarol, Dexamethasone isonicotinate may increase the anticoagulant activities of Tioclomarol.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be increased when combined with Dexamethasone isonicotinate.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be increased when combined with Dexamethasone isonicotinate.]
[A06AD03, magnesium peroxide, The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Magnesium peroxide.]
[A10BF01, acarbose, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Acarbose.]
[M02AA25, aceclofenac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Acemetacin.]
[A10AE06, insulin degludec, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin degludec.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be increased when combined with Dexamethasone isonicotinate.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Mepolizumab is combined with Dexamethasone isonicotinate.]
[J02AC05, isavuconazole, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be increased when combined with Dexamethasone isonicotinate.]
[J05AF13, tenofovir alafenamide, The metabolism of Tenofovir alafenamide can be increased when combined with Dexamethasone isonicotinate.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be increased when combined with Dexamethasone isonicotinate.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be increased when combined with Dexamethasone isonicotinate.]
[L01ED03, alectinib, The metabolism of Alectinib can be increased when combined with Dexamethasone isonicotinate.]
[A10BB31, acetohexamide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Acetohexamide.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be increased when combined with Dexamethasone isonicotinate.]
[M01AE16, alminoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Alminoprofen.]
[A02AB06, aloglutamol, The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Aloglutamol.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Ixekizumab.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be increased when combined with Dexamethasone isonicotinate.]
[N04BC01, bromocriptine, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Bromocriptine.]
[A02AD05, aluminum magnesium silicate, The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Almasilate.]
[A02AB03, aluminum phosphate, The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Aluminium phosphate.]
[C08CA01, amlodipine, The metabolism of Amlodipine can be increased when combined with Dexamethasone isonicotinate.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be increased when combined with Dexamethasone isonicotinate.]
[C03CA02, bumetanide, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Bumetanide.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be increased when combined with Dexamethasone isonicotinate.]
[N05BE01, buspirone, The metabolism of Buspirone can be increased when combined with Dexamethasone isonicotinate.]
[L01AB01, busulfan, The metabolism of Busulfan can be increased when combined with Dexamethasone isonicotinate.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Dexamethasone isonicotinate.]
[N06DA03, rivastigmine, The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Dexamethasone isonicotinate.]
[P01BE02, artemether, The metabolism of Artemether can be increased when combined with Dexamethasone isonicotinate.]
[J01MA09, sparfloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Sparfloxacin.]
[S01GX07, azelastine, The metabolism of Azelastine can be increased when combined with Dexamethasone isonicotinate.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be increased when combined with Dexamethasone isonicotinate.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Brodalumab.]
[L01EF02, ribociclib, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Balsalazide.]
[R03CC12, bambuterol, The therapeutic efficacy of Bambuterol can be decreased when used in combination with Dexamethasone isonicotinate.]
[L04AA36, ocrelizumab, Ocrelizumab may increase the immunosuppressive activities of Dexamethasone isonicotinate.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be increased when combined with Dexamethasone isonicotinate.]
[A10BX06, benfluorex, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Benfluorex.]
[H05BX05, calcifediol, The therapeutic efficacy of Calcifediol can be decreased when used in combination with Dexamethasone isonicotinate.]
[D05AX03, calcitriol, The therapeutic efficacy of Calcitriol can be decreased when used in combination with Dexamethasone isonicotinate.]
[A12AA04, calcium carbonate, The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Calcium carbonate.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Dexamethasone isonicotinate.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Linezolid is combined with Dexamethasone isonicotinate.]
[J05AE09, tipranavir, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be increased when combined with Dexamethasone isonicotinate.]
[L04AB02, infliximab, The risk or severity of adverse effects can be increased when Infliximab is combined with Dexamethasone isonicotinate.]
[L01EX10, midostaurin, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be increased when combined with Dexamethasone isonicotinate.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Sarilumab.]
[J01MA23, delafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Delafloxacin.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Guselkumab.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Capecitabine is combined with Dexamethasone isonicotinate.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be increased when combined with Dexamethasone isonicotinate.]
[L01EH02, neratinib, The metabolism of Neratinib can be increased when combined with Dexamethasone isonicotinate.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Vorinostat is combined with Dexamethasone isonicotinate.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be increased when combined with Dexamethasone isonicotinate.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be increased when combined with Dexamethasone isonicotinate.]
[R03AC17, bitolterol, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Bitolterol.]
[J05AG03, efavirenz, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Efavirenz.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Dexamethasone isonicotinate.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Dexamethasone isonicotinate.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Budesonide is combined with Dexamethasone isonicotinate.]
[M01AB07, bumadizone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be increased when combined with Dexamethasone isonicotinate.]
[C01AA02, acetyldigoxins, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Acetyldigoxin.]
[A10BJ06, semaglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Semaglutide.]
[N01BX04, capsaicin, The therapeutic efficacy of Capsaicin can be decreased when used in combination with Dexamethasone isonicotinate.]
[A10BK04, ertugliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Ertugliflozin.]
[V04CD06, macimorelin, The therapeutic efficacy of Macimorelin can be decreased when used in combination with Dexamethasone isonicotinate.]
[L02BB05, apalutamide, The metabolism of Dexamethasone isonicotinate can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be increased when combined with Dexamethasone isonicotinate.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dexamethasone isonicotinate.]
[L04AA37, baricitinib, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Baricitinib.]
[C07AB08, celiprolol, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Celiprolol.]
[L01XX62, ivosidenib, The metabolism of Dexamethasone isonicotinate can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Stiripentol.]
[J05AG06, doravirine, The metabolism of Doravirine can be increased when combined with Dexamethasone isonicotinate.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be increased when combined with Dexamethasone isonicotinate.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be increased when combined with Dexamethasone isonicotinate.]
[A10BB06, carbutamide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Carbutamide.]
[M01AC05, lornoxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Lornoxicam.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be increased when combined with Dexamethasone isonicotinate.]
[L04AA39, emapalumab, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Dexamethasone isonicotinate.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be increased when combined with Dexamethasone isonicotinate.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Ravulizumab.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be increased when combined with Dexamethasone isonicotinate.]
[L04AA42, siponimod, The metabolism of Siponimod can be increased when combined with Dexamethasone isonicotinate.]
[J01FA09, clarithromycin, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Clarithromycin.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be increased when combined with Dexamethasone isonicotinate.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Cloprednol.]
[L04AB01, etanercept, The risk or severity of adverse effects can be increased when Etanercept is combined with Dexamethasone isonicotinate.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Risankizumab.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be increased when combined with Dexamethasone isonicotinate.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be increased when combined with Dexamethasone isonicotinate.]
[L04AA44, upadacitinib, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Upadacitinib.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be increased when combined with Dexamethasone isonicotinate.]
[N07XX11, pitolisant, The serum concentration of Dexamethasone isonicotinate can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be increased when combined with Dexamethasone isonicotinate.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be increased when combined with Dexamethasone isonicotinate.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be increased when combined with Dexamethasone isonicotinate.]
[C03AA09, cyclothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone isonicotinate is combined with Cyclothiazide.]
[A10AE03, insulin, regular, pork, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin pork.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be increased when combined with Dexamethasone isonicotinate.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Deflazacort.]
[G03DB05, demegestone, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Demegestone.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Dexamethasone isonicotinate.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be increased when combined with Dexamethasone isonicotinate.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Diroximel fumarate.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be increased when combined with Dexamethasone isonicotinate.]
[G03AC09, desogestrel, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Desogestrel.]
[N03AX25, cenobamate, The serum concentration of Dexamethasone isonicotinate can be decreased when it is combined with Cenobamate.]
[S01XA12, dexpanthenol, The therapeutic efficacy of Dexpanthenol can be decreased when used in combination with Dexamethasone isonicotinate.]
[N05CM21, lemborexant, The metabolism of Lemborexant can be increased when combined with Dexamethasone isonicotinate.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be increased when combined with Dexamethasone isonicotinate.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Teprotumumab is combined with Dexamethasone isonicotinate.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be decreased when it is combined with Dexamethasone isonicotinate.]
[S01AE06, gatifloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Gatifloxacin.]
[J05AE05, amprenavir, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Amprenavir.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be increased when combined with Dexamethasone isonicotinate.]
[L04AA38, ozanimod, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Ozanimod.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be increased when combined with Dexamethasone isonicotinate.]
[G03DB08, dienogest, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Dienogest.]
[M01AH02, rofecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Rofecoxib.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Bexarotene is combined with Dexamethasone isonicotinate.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be increased when combined with Dexamethasone isonicotinate.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Dexamethasone isonicotinate.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Dexamethasone isonicotinate.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Dexamethasone isonicotinate.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Fluprednidene is combined with Dexamethasone isonicotinate.]
[M01AC04, droxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Droxicam.]
[M02AA27, dexketoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Dexketoprofen.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Dexamethasone isonicotinate is combined with Inebilizumab.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Stepronin is combined with Dexamethasone isonicotinate.]
[C08CA17, levamlodipine, The metabolism of Levamlodipine can be increased when combined with Dexamethasone isonicotinate.]
[R06AX22, ebastine, The metabolism of Ebastine can be increased when combined with Dexamethasone isonicotinate.]
[L04AC19, satralizumab, The serum concentration of Dexamethasone isonicotinate can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be decreased when it is combined with Dexamethasone isonicotinate.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be increased when combined with Dexamethasone isonicotinate.]
[C03AA04, chlorothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone isonicotinate is combined with Chlorothiazide.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be increased when combined with Dexamethasone isonicotinate.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Dexamethasone isonicotinate.]
[A10BB02, chlorpropamide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Chlorpropamide.]
[C03BA04, chlorthalidone, Dexamethasone isonicotinate may increase the hypokalemic activities of Chlorthalidone.]
[A11CC05, cholecalciferol, The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Dexamethasone isonicotinate.]
[N02BA07, ethenzamide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Ethenzamide.]
[C10AC01, cholestyramine resin, Cholestyramine may increase the excretion rate of Dexamethasone isonicotinate which could result in a lower serum level and potentially a reduction in efficacy.]
[G03DC06, ethynodiol, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Etynodiol.]
[M01AB08, etodolac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Etofenamate.]
[B06AC06, berotralstat, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Lonafarnib.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Fludarabine is combined with Dexamethasone isonicotinate.]
[L02BX04, relugolix, The metabolism of Relugolix can be increased when combined with Dexamethasone isonicotinate.]
[L04AD03, voclosporin, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Voclosporin.]
[P03AX07, abametapir, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Abametapir.]
[M01AE05, fenbufen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Fenbufen.]
[G04CB01, finasteride, The metabolism of Finasteride can be increased when combined with Dexamethasone isonicotinate.]
[J01MB07, flumequine, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Flumequine.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Dexamethasone isonicotinate.]
[R03CC15, formoterol, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Formoterol.]
[A10AF01, insulin, regular, human, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin human.]
[L04AA50, ponesimod, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Ponesimod.]
[L01EK03, tivozanib, The metabolism of Tivozanib can be increased when combined with Dexamethasone isonicotinate.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dexamethasone isonicotinate.]
[J01MB06, cinoxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Dexamethasone isonicotinate can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be increased when combined with Dexamethasone isonicotinate.]
[S03AA07, ciprofloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Ciprofloxacin.]
[L01XA01, cisplatin, The therapeutic efficacy of Cisplatin can be decreased when used in combination with Dexamethasone isonicotinate.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Pegcetacoplan.]
[H01AC07, somapacitan, The serum concentration of the active metabolites of Dexamethasone isonicotinate can be decreased when Dexamethasone isonicotinate is used in combination with Somapacitan.]
[L04AA48, belumosudil, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Belumosudil.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be increased when combined with Dexamethasone isonicotinate.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Anifrolumab.]
[H01AC09, lonapegsomatropin, The serum concentration of the active metabolites of Dexamethasone isonicotinate can be decreased when Dexamethasone isonicotinate is used in combination with Lonapegsomatropin.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be increased when combined with Dexamethasone isonicotinate.]
[A10BB12, glimepiride, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Gliquidone.]
[R03CC13, clenbuterol, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Clenbuterol.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be increased when combined with Dexamethasone isonicotinate.]
[N06AX25, St. John's wort extract, The metabolism of Dexamethasone isonicotinate can be increased when combined with St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Ropeginterferon alfa-2b.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be increased when combined with Dexamethasone isonicotinate.]
[N03AE01, clonazepam, The metabolism of Clonazepam can be increased when combined with Dexamethasone isonicotinate.]
[S01EA04, clonidine, The metabolism of Clonidine can be increased when combined with Dexamethasone isonicotinate.]
[C01EB24, mavacamten, The serum concentration of Dexamethasone isonicotinate can be decreased when it is combined with Mavacamten.]
[A10BX16, tirzepatide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Tirzepatide.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be increased when combined with Dexamethasone isonicotinate.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Deucravacitinib.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be increased when combined with Dexamethasone isonicotinate.]
[N05AH02, clozapine, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Clozapine.]
[A10BX01, guar gum, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Guar gum.]
[A10BK06, sotagliflozin, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Sotagliflozin.]
[H01AC08, somatrogon, The serum concentration of the active metabolites of Dexamethasone isonicotinate can be reduced when Dexamethasone isonicotinate is used in combination with Somatrogon resulting in a loss in efficacy.]
[L04AC21, bimekizumab, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Proquazone.]
[M03AC05, hexafluorenium, The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Dexamethasone isonicotinate.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Leflunomide.]
[A02AD04, hydrotalcite, The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Hydrotalcite.]
[A10BX03, nateglinide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Imidazole salicylate.]
[H01AC03, mecasermin, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Mecasermin.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Nelarabine is combined with Dexamethasone isonicotinate.]
[A10AE04, insulin glargine, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin glargine.]
[J01FA15, telithromycin, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Ciclesonide is combined with Dexamethasone isonicotinate.]
[B01AC10, indobufen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Indobufen.]
[M01AH03, valdecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Valdecoxib.]
[H01AX01, pegvisomant, The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Dexamethasone isonicotinate.]
[C01AA06, lanatoside C, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Lanatoside C.]
[M01AH04, parecoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Itraconazole.]
[M01AA06, kebuzone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Kebuzone.]
[L01EA01, imatinib, The risk or severity of adverse effects can be increased when Imatinib is combined with Dexamethasone isonicotinate.]
[J02AC04, posaconazole, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Posaconazole.]
[S01AE04, lomefloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Lomefloxacin.]
[M01AB09, lonazolac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Lonazolac.]
[M02AA31, loxoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Loxoprofen.]
[A02AD02, magaldrate, The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Magaldrate.]
[A06AD01, magnesium carbonate, The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Magnesium carbonate.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Meprednisone is combined with Dexamethasone isonicotinate.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be increased when combined with Dexamethasone isonicotinate.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Dexamethasone isonicotinate.]
[C03AA07, cyclopenthiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone isonicotinate is combined with Cyclopenthiazide.]
[A10BF02, miglitol, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Miglitol.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be increased when combined with Dexamethasone isonicotinate.]
[N06AX07, minaprine, The therapeutic efficacy of Minaprine can be decreased when used in combination with Dexamethasone isonicotinate.]
[S01XA18, cyclosporine, Dexamethasone isonicotinate may increase the immunosuppressive activities of Cyclosporine.]
[N06BA07, modafinil, The metabolism of Modafinil can be increased when combined with Dexamethasone isonicotinate.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be increased when combined with Dexamethasone isonicotinate.]
[M02AA02, mofebutazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Cytarabine is combined with Dexamethasone isonicotinate.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be increased when combined with Dexamethasone isonicotinate.]
[M01AH05, etoricoxib, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Etoricoxib.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Dexamethasone isonicotinate.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Dactinomycin is combined with Dexamethasone isonicotinate.]
[G03XA01, danazol, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Dapsone can be increased when combined with Dexamethasone isonicotinate.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Daunorubicin is combined with Dexamethasone isonicotinate.]
[M01AX01, nabumetone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Nabumetone.]
[N06AX06, nefazodone, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, The risk or severity of ulceration can be increased when Dexamethasone isonicotinate is combined with Nicorandil.]
[G03DB04, nomegestrol, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Nomegestrol.]
[M03AC11, cisatracurium, The risk or severity of myopathy and weakness can be increased when Cisatracurium is combined with Dexamethasone isonicotinate.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Dexamethasone isonicotinate.]
[A07EC03, olsalazine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Olsalazine.]
[C01AA07, deslanoside, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Deslanoside.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Desoximetasone is combined with Dexamethasone isonicotinate.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Dexamethasone isonicotinate.]
[M01AE12, oxaprozin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Oxaprozin.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Dexamethasone isonicotinate.]
[S01AA13, fusidic acid, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Fusidic acid.]
[J01MB04, pipemidic acid, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Pipemidic acid.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Dexamethasone isonicotinate.]
[M01AG01, mefenamic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Mefenamic acid.]
[G04BD04, oxybutynin, The metabolism of Oxybutynin can be increased when combined with Dexamethasone isonicotinate.]
[L04AB04, adalimumab, The risk or severity of adverse effects can be increased when Adalimumab is combined with Dexamethasone isonicotinate.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be increased when combined with Dexamethasone isonicotinate.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be increased when combined with Dexamethasone isonicotinate.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be increased when combined with Dexamethasone isonicotinate.]
[N05BA01, diazepam, The metabolism of Diazepam can be increased when combined with Dexamethasone isonicotinate.]
[S02DA04, dibucaine, The therapeutic efficacy of Cinchocaine can be decreased when used in combination with Dexamethasone isonicotinate.]
[S01BC03, diclofenac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Diclofenac.]
[A10BG03, pioglitazone, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Pioglitazone.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be increased when combined with Dexamethasone isonicotinate.]
[L01EB02, erlotinib, The serum concentration of Erlotinib can be decreased when it is combined with Dexamethasone isonicotinate.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Pirarubicin.]
[R03CC07, pirbuterol, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Pirbuterol.]
[C03CA03, piretanide, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Piretanide.]
[P02CB02, diethylcarbamazine, The therapeutic efficacy of Diethylcarbamazine can be decreased when used in combination with Dexamethasone isonicotinate.]
[L02AA01, diethylstilbestrol, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Difluocortolone is combined with Dexamethasone isonicotinate.]
[N02BA11, diflunisal, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Diflunisal.]
[C01AA04, digitoxin, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Digitoxin.]
[C01AA05, digoxin, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Digoxin.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Dexamethasone isonicotinate.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be increased when combined with Dexamethasone isonicotinate.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be increased when combined with Dexamethasone isonicotinate.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Dexamethasone isonicotinate.]
[A11CC02, dihydrotachysterol, The therapeutic efficacy of Dihydrotachysterol can be decreased when used in combination with Dexamethasone isonicotinate.]
[J05AE08, atazanavir, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Atazanavir.]
[C08DB01, diltiazem, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Diltiazem.]
[R03CC08, procaterol, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Procaterol.]
[N02BB04, propyphenazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Proglumetacin.]
[A03FA02, cisapride, The metabolism of Cisapride can be increased when combined with Dexamethasone isonicotinate.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be increased when combined with Dexamethasone isonicotinate.]
[C01BA03, disopyramide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Disopyramide.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Natalizumab.]
[N07AA03, distigmine, The therapeutic efficacy of Distigmine can be decreased when used in combination with Dexamethasone isonicotinate.]
[P03AA04, disulfiram, The metabolism of Disulfiram can be increased when combined with Dexamethasone isonicotinate.]
[S02AA12, rifamycin SV, The metabolism of Dexamethasone isonicotinate can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Dexamethasone isonicotinate can be increased when combined with Rifapentine.]
[N05AX08, risperidone, The metabolism of Risperidone can be increased when combined with Dexamethasone isonicotinate.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Dexamethasone isonicotinate.]
[J01MB01, rosoxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Rosoxacin.]
[L01EX01, sunitinib, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Sunitinib.]
[A04AD12, aprepitant, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be increased when combined with Dexamethasone isonicotinate.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be increased when combined with Dexamethasone isonicotinate.]
[G04BE08, tadalafil, The metabolism of Tadalafil can be increased when combined with Dexamethasone isonicotinate.]
[S01BC05, ketorolac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Ketorolac.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be increased when combined with Dexamethasone isonicotinate.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be increased when combined with Dexamethasone isonicotinate.]
[N02BA06, salsalate, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Salsalate.]
[R03AC12, salmeterol, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Salmeterol.]
[C01CA07, dobutamine, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Dobutamine.]
[A03FA03, domperidone, The metabolism of Domperidone can be increased when combined with Dexamethasone isonicotinate.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be increased when combined with Dexamethasone isonicotinate.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be increased when combined with Dexamethasone isonicotinate.]
[B05XA02, sodium bicarbonate, The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Sodium bicarbonate.]
[V04CX07, edrophonium, The therapeutic efficacy of Edrophonium can be decreased when used in combination with Dexamethasone isonicotinate.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Corticotropin is combined with Dexamethasone isonicotinate.]
[J01MA05, temafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Temafloxacin.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Temozolomide is combined with Dexamethasone isonicotinate.]
[M01AC02, tenoxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Tenoxicam.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be increased when combined with Dexamethasone isonicotinate.]
[M01AG02, tolfenamic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Tolfenamic acid.]
[C03CA04, torsemide, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Torasemide.]
[H02CA01, trilostane, The risk or severity of edema formation can be increased when Trilostane is combined with Dexamethasone isonicotinate.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Trofosfamide.]
[J01MA04, enoxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Enoxacin.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be increased when combined with Dexamethasone isonicotinate.]
[S01FB02, ephedrine, Ephedrine may increase the excretion rate of Dexamethasone isonicotinate which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA12, mepirodipine, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Epinephrine.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Dexamethasone isonicotinate.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be increased when combined with Dexamethasone isonicotinate.]
[M01AB04, zomepirac, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Zomepirac.]
[N03AX15, zonisamide, The metabolism of Zonisamide can be increased when combined with Dexamethasone isonicotinate.]
[A10AB06, insulin glulisine, human, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin glulisine.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Carboplatin is combined with Dexamethasone isonicotinate.]
[A11CC01, ergocalciferol, The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Dexamethasone isonicotinate.]
[N02CA02, ergotamine, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Erythromycin.]
[G03CA03, estradiol, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Estradiol.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Estramustine is combined with Dexamethasone isonicotinate.]
[R03BA09, fluticasone furoate, The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Dexamethasone isonicotinate.]
[R03BA05, fluticasone, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be increased when combined with Dexamethasone isonicotinate.]
[L02AA03, ethinyl estradiol, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Ethinylestradiol.]
[N04AA05, profenamine, The therapeutic efficacy of Profenamine can be decreased when used in combination with Dexamethasone isonicotinate.]
[M01AC06, meloxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Meloxicam.]
[L01CB01, etoposide, The metabolism of Etoposide can be increased when combined with Dexamethasone isonicotinate.]
[L04AD02, tacrolimus, Tacrolimus may increase the immunosuppressive activities of Dexamethasone isonicotinate.]
[A02BA04, nizatidine, The therapeutic efficacy of Nizatidine can be decreased when used in combination with Dexamethasone isonicotinate.]
[J01MA08, fleroxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Fleroxacin.]
[R06AX11, astemizole, The metabolism of Astemizole can be increased when combined with Dexamethasone isonicotinate.]
[R06AX12, terfenadine, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Terfenadine.]
[N06AB08, fluvoxamine, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Fluvoxamine.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Dexamethasone isonicotinate.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Dexamethasone isonicotinate.]
[P02CA03, albendazole, The metabolism of Albendazole can be increased when combined with Dexamethasone isonicotinate.]
[C08CA02, felodipine, The metabolism of Felodipine can be increased when combined with Dexamethasone isonicotinate.]
[M01AE04, fenoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Fenoprofen.]
[R03CC04, fenoterol, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Fenoterol.]
[R03CC02, albuterol, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Salbutamol.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Dexamethasone isonicotinate.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Dexamethasone isonicotinate.]
[N02BG04, floctafenine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Floctafenine.]
[J02AC01, fluconazole, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Flucytosine is combined with Dexamethasone isonicotinate.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Dexamethasone isonicotinate.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Fluocinonide is combined with Dexamethasone isonicotinate.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Fluocortolone is combined with Dexamethasone isonicotinate.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Dexamethasone isonicotinate.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Dexamethasone isonicotinate.]
[L01BC02, fluorouracil, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Dexamethasone isonicotinate.]
[G03BA01, fluoxymesterone, The risk or severity of fluid retention can be increased when Dexamethasone isonicotinate is combined with Fluoxymesterone.]
[S01BC04, flurbiprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Flurbiprofen.]
[L02BB01, flutamide, The metabolism of Flutamide can be increased when combined with Dexamethasone isonicotinate.]
[L01BC03, tegafur, The metabolism of Tegafur can be increased when combined with Dexamethasone isonicotinate.]
[M03AA01, alcuronium, The risk or severity of myopathy and weakness can be increased when Alcuronium is combined with Dexamethasone isonicotinate.]
[J05AE10, darunavir, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Darunavir.]
[C03CA01, furosemide, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Furosemide.]
[N05CF04, eszopiclone, The serum concentration of Eszopiclone can be decreased when it is combined with Dexamethasone isonicotinate.]
[N06DA04, galantamine, The therapeutic efficacy of Galantamine can be decreased when used in combination with Dexamethasone isonicotinate.]
[M03AC02, gallamine, The risk or severity of myopathy and weakness can be increased when Gallamine is combined with Dexamethasone isonicotinate.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be increased when combined with Dexamethasone isonicotinate.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be increased when combined with Dexamethasone isonicotinate.]
[A10BJ02, liraglutide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Liraglutide.]
[G03XA02, gestrinone, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Gestrinone.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be increased when combined with Dexamethasone isonicotinate.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be increased when combined with Dexamethasone isonicotinate.]
[A10BB01, glyburide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Glyburide.]
[A10BB09, gliclazide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Gliclazide.]
[A10BB07, glipizide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Glipizide.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be increased when combined with Dexamethasone isonicotinate.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be increased when combined with Dexamethasone isonicotinate.]
[H01AB01, thyrotropin alfa, The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dexamethasone isonicotinate.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be increased when combined with Dexamethasone isonicotinate.]
[B01AA12, fluindione, Dexamethasone isonicotinate may increase the anticoagulant activities of Fluindione.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be increased when combined with Dexamethasone isonicotinate.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Dexamethasone isonicotinate.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be increased when combined with Dexamethasone isonicotinate.]
[A10AD05, insulin aspart, human, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin aspart.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be increased when combined with Dexamethasone isonicotinate.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be increased when combined with Dexamethasone isonicotinate.]
[A07EC02, mesalamine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Mesalazine.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Dexamethasone isonicotinate.]
[R03CC05, hexoprenaline, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be increased when combined with Dexamethasone isonicotinate.]
[C08CA10, nilvadipine, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Nimesulide.]
[C03AA03, hydrochlorothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone isonicotinate is combined with Hydrochlorothiazide.]
[S02BA01, hydrocortisone, The metabolism of Hydrocortisone can be increased when combined with Dexamethasone isonicotinate.]
[C03AA02, hydroflumethiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone isonicotinate is combined with Hydroflumethiazide.]
[P01BA02, hydroxychloroquine, The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Dexamethasone isonicotinate.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Dexamethasone isonicotinate.]
[N05BB01, hydroxyzine, The metabolism of Hydroxyzine can be increased when combined with Dexamethasone isonicotinate.]
[R02AX02, ibuprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Ibuprofen.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Idarubicin is combined with Dexamethasone isonicotinate.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be increased when combined with Dexamethasone isonicotinate.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be increased when combined with Dexamethasone isonicotinate.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Tixocortol is combined with Dexamethasone isonicotinate.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Topotecan is combined with Dexamethasone isonicotinate.]
[C03BA11, indapamide, Dexamethasone isonicotinate may increase the hypokalemic activities of Indapamide.]
[S01BC01, indomethacin, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Indomethacin.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Dexamethasone isonicotinate.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Dexamethasone isonicotinate.]
[N06AX17, milnacipran, The metabolism of Milnacipran can be increased when combined with Dexamethasone isonicotinate.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Eculizumab is combined with Dexamethasone isonicotinate.]
[A10BH01, sitagliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Sitagliptin.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be increased when combined with Dexamethasone isonicotinate.]
[A10BH02, vildagliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Vildagliptin.]
[C10AA06, cerivastatin, The metabolism of Cerivastatin can be increased when combined with Dexamethasone isonicotinate.]
[C03BA02, quinethazone, Dexamethasone isonicotinate may increase the hypokalemic activities of Quinethazone.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Dexamethasone isonicotinate.]
[R03CC06, isoetharine, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Isoetharine.]
[S01EB07, isoflurophate, The therapeutic efficacy of Isoflurophate can be decreased when used in combination with Dexamethasone isonicotinate.]
[J04AC01, isoniazid, The serum concentration of Isoniazid can be decreased when it is combined with Dexamethasone isonicotinate.]
[R03CB01, isoproterenol, The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Dexamethasone isonicotinate.]
[A10BJ01, exenatide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Exenatide.]
[H01AC01, somatropin, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Dexamethasone isonicotinate.]
[A02AB01, aluminum hydroxide, The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Aluminum hydroxide.]
[L04AC07, tocilizumab, The risk or severity of adverse effects can be increased when Tocilizumab is combined with Dexamethasone isonicotinate.]
[N01AX03, ketamine, The therapeutic efficacy of Ketamine can be decreased when used in combination with Dexamethasone isonicotinate.]
[J02AB02, ketoconazole, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Ketoconazole.]
[M02AA10, ketoprofen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Ketoprofen.]
[V03AC03, deferasirox, The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Deferasirox.]
[L04AA24, abatacept, The risk or severity of adverse effects can be increased when Abatacept is combined with Dexamethasone isonicotinate.]
[C01CA22, arbutamine, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Arbutamine.]
[J01MB02, nalidixic acid, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Tiaprofenic acid.]
[N07AA30, ambenonium, The therapeutic efficacy of Ambenonium can be decreased when used in combination with Dexamethasone isonicotinate.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be increased when combined with Dexamethasone isonicotinate.]
[C03CC01, ethacrynic acid, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Etacrynic acid.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Dexamethasone isonicotinate.]
[G03AD01, levonorgestrel, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Levonorgestrel.]
[S02DA01, lidocaine, The metabolism of Lidocaine can be increased when combined with Dexamethasone isonicotinate.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be increased when combined with Dexamethasone isonicotinate.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Lomustine is combined with Dexamethasone isonicotinate.]
[C10AA02, lovastatin, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Lovastatin.]
[G03DC03, lynestrenol, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Lynestrenol.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be increased when combined with Dexamethasone isonicotinate.]
[G04BX01, magnesium hydroxide, The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Magnesium hydroxide.]
[A12CC10, magnesium oxide, The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Magnesium oxide.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Pralatrexate is combined with Dexamethasone isonicotinate.]
[L01EA03, nilotinib, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Nilotinib.]
[L01AA05, mechlorethamine, The therapeutic efficacy of Mechlorethamine can be decreased when used in combination with Dexamethasone isonicotinate.]
[M02AA18, meclofenamic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Meclofenamic acid.]
[C01AA08, medigoxin, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Metildigoxin.]
[P01BC02, mefloquine, The therapeutic efficacy of Mefloquine can be decreased when used in combination with Dexamethasone isonicotinate.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Melphalan is combined with Dexamethasone isonicotinate.]
[N06DX01, memantine, The therapeutic efficacy of Memantine can be decreased when used in combination with Dexamethasone isonicotinate.]
[N02AB02, meperidine, The metabolism of Meperidine can be increased when combined with Dexamethasone isonicotinate.]
[L02BG01, aminoglutethimide, The therapeutic efficacy of Dexamethasone isonicotinate can be decreased when used in combination with Aminoglutethimide.]
[G03BB01, mesterolone, The risk or severity of edema formation can be increased when Mesterolone is combined with Dexamethasone isonicotinate.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be increased when combined with Dexamethasone isonicotinate.]
[A10BA02, metformin, The therapeutic efficacy of Metformin can be decreased when used in combination with Dexamethasone isonicotinate.]
[A14AA04, methenolone, The risk or severity of edema formation can be increased when Metenolone is combined with Dexamethasone isonicotinate.]
[H03BB02, methimazole, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Pemetrexed is combined with Dexamethasone isonicotinate.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be increased when combined with Dexamethasone isonicotinate.]
[C03AA08, methyclothiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone isonicotinate is combined with Methyclothiazide.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be increased when combined with Dexamethasone isonicotinate.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Dexamethasone isonicotinate.]
[G03EK01, methyltestosterone, The risk or severity of edema formation can be increased when Methyltestosterone is combined with Dexamethasone isonicotinate.]
[N02CA04, methysergide, The metabolism of Methysergide can be increased when combined with Dexamethasone isonicotinate.]
[A03FA01, metoclopramide, The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Dexamethasone isonicotinate.]
[C03BA08, metolazone, Dexamethasone isonicotinate may increase the hypokalemic activities of Metolazone.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be increased when combined with Dexamethasone isonicotinate.]
[S02AA13, miconazole, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Aminophenazone.]
[N05CD08, midazolam, The metabolism of Midazolam can be increased when combined with Dexamethasone isonicotinate.]
[G03XB01, mifepristone, The therapeutic efficacy of Dexamethasone isonicotinate can be decreased when used in combination with Mifepristone.]
[L01XX23, mitotane, The serum concentration of Dexamethasone isonicotinate can be decreased when it is combined with Mitotane.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Dexamethasone isonicotinate.]
[L03AC01, aldesleukin, The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Dexamethasone isonicotinate.]
[C01BD01, amiodarone, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be increased when combined with Dexamethasone isonicotinate.]
[L04AB05, certolizumab pegol, The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Dexamethasone isonicotinate.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Ofatumumab is combined with Dexamethasone isonicotinate.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be increased when combined with Dexamethasone isonicotinate.]
[L04AA06, mycophenolic acid, The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Dexamethasone isonicotinate.]
[M03AC03, vecuronium, The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Dexamethasone isonicotinate.]
[N03AB05, fosphenytoin, The serum concentration of Dexamethasone isonicotinate can be decreased when it is combined with Fosphenytoin.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Dexamethasone isonicotinate.]
[V03AB15, naloxone, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The risk or severity of adverse effects can be increased when Anakinra is combined with Dexamethasone isonicotinate.]
[S01XA11, nandrolone, The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Dexamethasone isonicotinate.]
[M02AA12, naproxen, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Naproxen.]
[A10BG01, troglitazone, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Troglitazone.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be increased when combined with Dexamethasone isonicotinate.]
[A10BX02, repaglinide, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Repaglinide.]
[S01EB06, neostigmine, The therapeutic efficacy of Neostigmine can be decreased when used in combination with Dexamethasone isonicotinate.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be increased when combined with Dexamethasone isonicotinate.]
[J02AA01, amphotericin B, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Amphotericin B.]
[N06AX23, desvenlafaxine, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Desvenlafaxine.]
[H05BX02, paricalcitol, The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Dexamethasone isonicotinate.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Dexamethasone isonicotinate.]
[C08CA04, nicardipine, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Nicardipine.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be increased when combined with Dexamethasone isonicotinate.]
[M02AA17, niflumic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Niflumic acid.]
[C08CA07, nisoldipine, The metabolism of Nisoldipine can be increased when combined with Dexamethasone isonicotinate.]
[C08CA08, nitrendipine, The metabolism of Nitrendipine can be increased when combined with Dexamethasone isonicotinate.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be increased when combined with Dexamethasone isonicotinate.]
[C01CA03, norepinephrine, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Norepinephrine.]
[G03DC02, norethindrone, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Norethisterone.]
[S01AE02, norfloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Norfloxacin.]
[G03AC07, norgestrienone, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Norgestrienone.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be increased when combined with Dexamethasone isonicotinate.]
[S02AA16, ofloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Ofloxacin.]
[L04AC04, rilonacept, The risk or severity of adverse effects can be increased when Rilonacept is combined with Dexamethasone isonicotinate.]
[R03CB03, metaproterenol, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Orciprenaline.]
[A14AA08, oxandrolone, The risk or severity of fluid retention can be increased when Dexamethasone isonicotinate is combined with Oxandrolone.]
[J01MB05, oxolinic acid, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Oxolinic acid.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be increased when combined with Dexamethasone isonicotinate.]
[A14AA05, oxymetholone, The risk or severity of fluid retention can be increased when Dexamethasone isonicotinate is combined with Oxymetholone.]
[S01BC02, oxyphenbutazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Oxyphenbutazone.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be decreased when used in combination with Dexamethasone isonicotinate.]
[G03DB06, chlormadinone, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Chlormadinone.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Paramethasone is combined with Dexamethasone isonicotinate.]
[J01MA03, pefloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Pefloxacin.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Penicillamine is combined with Dexamethasone isonicotinate.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Dexamethasone isonicotinate.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Dexamethasone isonicotinate.]
[N05CA01, pentobarbital, The metabolism of Dexamethasone isonicotinate can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Pentostatin is combined with Dexamethasone isonicotinate.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Dexamethasone isonicotinate.]
[A10BA01, phenformin, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Phenformin.]
[B01AA02, phenindione, Dexamethasone isonicotinate may increase the anticoagulant activities of Phenindione.]
[N03AA02, phenobarbital, The metabolism of Dexamethasone isonicotinate can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, Dexamethasone isonicotinate may increase the anticoagulant activities of Phenprocoumon.]
[M02AA01, phenylbutazone, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Phenylbutazone.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be increased when Dexamethasone isonicotinate is combined with Phenylephrine.]
[R01BA01, phenylpropanolamine, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Phenylpropanolamine.]
[N03AB02, phenytoin, The serum concentration of Dexamethasone isonicotinate can be decreased when it is combined with Phenytoin.]
[L04AB06, golimumab, The risk or severity of adverse effects can be increased when Golimumab is combined with Dexamethasone isonicotinate.]
[S01AE05, levofloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Levofloxacin.]
[V03AB19, physostigmine, The therapeutic efficacy of Physostigmine can be decreased when used in combination with Dexamethasone isonicotinate.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be increased when combined with Dexamethasone isonicotinate.]
[N05AG02, pimozide, The metabolism of Pimozide can be increased when combined with Dexamethasone isonicotinate.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be increased when combined with Dexamethasone isonicotinate.]
[J05AE01, saquinavir, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Saquinavir.]
[S01BC06, piroxicam, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Piroxicam.]
[J01MA11, grepafloxacin, The risk or severity of tendinopathy can be increased when Dexamethasone isonicotinate is combined with Grepafloxacin.]
[J05AG02, delavirdine, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Delavirdine.]
[A10BG02, rosiglitazone, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Rosiglitazone.]
[L04AC08, canakinumab, The risk or severity of adverse effects can be increased when Canakinumab is combined with Dexamethasone isonicotinate.]
[C03AA05, polythiazide, The risk or severity of electrolyte imbalance can be increased when Dexamethasone isonicotinate is combined with Polythiazide.]
[J05AE03, ritonavir, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Saxagliptin.]
[A10AD04, insulin lispro, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin lispro.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be increased when combined with Dexamethasone isonicotinate.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Prednisolone is combined with Dexamethasone isonicotinate.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Prednisone is combined with Dexamethasone isonicotinate.]
[P01BA03, primaquine, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Dexamethasone isonicotinate can be increased when combined with Primidone.]
[C01BA02, procainamide, The therapeutic efficacy of Procainamide can be decreased when used in combination with Dexamethasone isonicotinate.]
[S01HA05, procaine, The therapeutic efficacy of Procaine can be decreased when used in combination with Dexamethasone isonicotinate.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Procarbazine is combined with Dexamethasone isonicotinate.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be increased when combined with Dexamethasone isonicotinate.]
[G03DA04, progesterone, The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Progesterone.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be increased when combined with Dexamethasone isonicotinate.]
[C07AA05, propranolol, The metabolism of Propranolol can be increased when combined with Dexamethasone isonicotinate.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Dexamethasone isonicotinate.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be increased when combined with Dexamethasone isonicotinate.]
[P02CC01, pyrantel, The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Dexamethasone isonicotinate.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Dexamethasone isonicotinate.]
[N07AA02, pyridostigmine, The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Dexamethasone isonicotinate.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be increased when combined with Dexamethasone isonicotinate.]
[C01BA01, quinidine, The metabolism of Quinidine can be increased when combined with Dexamethasone isonicotinate.]
[P01BC01, quinine, The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Quinine.]
[J04AB02, rifampin, The metabolism of Dexamethasone isonicotinate can be increased when combined with Rifampicin.]
[G02CA01, ritodrine, The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Ritodrine.]
[N02BA05, salicylamide, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Salicylic acid.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Dexamethasone isonicotinate.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Dexamethasone isonicotinate.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be increased when combined with Dexamethasone isonicotinate.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Dexamethasone isonicotinate.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Hydrocortisone butyrate.]
[H02CA04, levoketoconazole, The metabolism of Dexamethasone isonicotinate can be decreased when combined with Levoketoconazole.]
